☐ |
REGISTRATION STATEMENT PURSUANT TO SECTION 12(b) OR 12(g) OF THE SECURITIES EXCHANGE ACT OF 1934 |
☒ |
ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 |
☐ |
TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 |
☐ |
SHELL COMPANY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 |
Title of each class |
Trading Symbol(s) |
Name of each exchange on which registered | ||
American depositary shares (each ADS represents ten of our Class A ordinary shares, par value US$0.000005 per share) |
WDH |
New York Stock Exchange | ||
Class A ordinary shares, par value US$0.000005 per share* |
New York Stock Exchange |
* |
Not for trading, but only in connection with the listing on the New York Stock Exchange of American depositary shares. |
Large accelerated filer ☐ |
Accelerated filer ☐ |
Non-accelerated filer ☒ |
Emerging growth company ☒ |
U.S. GAAP |
☒ |
International Financial Reporting Standards as issued |
Other ☐ | |||
by the International Accounting Standards Board ☐ |
Page |
||||||
1 |
||||||
2 |
||||||
3 |
||||||
Item 1. |
3 |
|||||
Item 2. |
3 |
|||||
Item 3. |
3 |
|||||
Item 4. |
60 |
|||||
Item 4A. |
97 |
|||||
Item 5. |
98 |
|||||
Item 6. |
114 |
|||||
Item 7. |
124 |
|||||
Item 8. |
126 |
|||||
Item 9. |
127 |
|||||
Item 10. |
128 |
|||||
Item 11. |
142 |
|||||
Item 12. |
143 |
|||||
146 |
||||||
Item 13. |
146 |
|||||
Item 14. |
146 |
|||||
Item 15. |
146 |
|||||
Item 16A. |
147 |
|||||
Item 16B. |
148 |
|||||
Item 16C. |
148 |
|||||
Item 16D. |
148 |
|||||
Item 16E. |
148 |
|||||
Item 16F. |
149 |
|||||
Item 16G. |
149 |
|||||
Item 16H. |
149 |
|||||
Item 16I. |
149 |
|||||
150 |
||||||
Item 17. |
150 |
|||||
Item 18. |
150 |
|||||
Item 19. |
150 |
|||||
154 |
• | “ADRs” are to the American depositary receipts which may evidence the ADSs; |
• | “ADSs” are to the American depositary shares, each of which represents ten Class A ordinary shares; |
• | “China” or the “PRC” are to the People’s Republic of China, excluding, for the purposes of this annual report only, Hong Kong, Macau and Taiwan; |
• | “Class A ordinary shares” refer to our Class A ordinary shares, par value US$0.000005 per share; |
• | “Class B ordinary shares” refer to our Class B ordinary shares, par value US$0.000005 per share; |
• | “FYP” are to first year premiums, which include all premiums that policyholders are obligated to pay for short-term policies and the premiums that policyholders are obligated to pay in the first policy year for long-term policies; |
• | “ordinary shares” are to our Class A ordinary shares and Class B ordinary shares, par value US$0.000005 per share; |
• | “the VIEs” are to Beijing Zhuiqiu Jizhi Technology Co., Ltd., or Zhuiqiu Jizhi, Beijing Shuidi Hubao Technology Co., Ltd., or Shuidi Hubao, Beijing Shuidi Hulian Technology Co., Ltd., or Shuidi Hulian, Beijing Zongqing Xiangqian Technology Co., Ltd., or Zongqing Xiangqian, and Beijing Guangmu Weichen Technology Co., Ltd., or Guangmu Weichen; |
• | “our WFOE” are to Beijing Absolute Health Co., Ltd., or Absolute Health; |
• | “RMB” and “Renminbi” are to the legal currency of China; |
• | “US$,” “U.S. dollars,” “$,” and “dollars” are to the legal currency of the United States; and |
• | “Waterdrop,” “we,” “us,” “our company” and “our” are to Waterdrop Inc., our Cayman Islands holding company and its subsidiaries, and, in the context of describing the consolidated financial information, its consolidated variable interest entities and the subsidiaries of the consolidated variable interest entities in China, including, but not limited to, the VIEs. |
• | our mission, goals and strategies; |
• | our future business development, financial conditions and results of operations; |
• | the expected growth of the insurance and online healthcare industry in China; |
• | our expectations regarding demand for and market acceptance of our products and services; |
• | our expectations regarding our relationships with consumers, insurance carriers and other partners; |
• | competition in our industry; |
• | our proposed use of proceeds; and |
• | relevant government policies and regulations relating to our industry. |
Item 1. |
Identity of Directors, Senior Management and Advisers |
Item 2. |
Offer Statistics and Expected Timetable |
Item 3. |
Key Information |
(1) | Mr. Peng Shen holds 100% of the equity interests in Beijing Shuidi Hubao Technology Co., Ltd. |
(2) | Mr. Peng Shen and Mr. Wei Ran, an employee of the Company, each holds 99% and 1% of the equity interests in Beijing Shuidi Hulian Technology Co., Ltd. |
(3) | Mr. Peng Shen and Mr. Guang Yang, each holds 99% and 1% of the equity interests in Beijing Zhuiqiu Jizhi Technology Co., Ltd. |
(4) | Mr. Peng Shen and Mr. Wei Ran, an employee of the Company, each holds 99% and 1% of the equity interests in Beijing Zongqing Xiangqian Technology Co., Ltd. |
(5) | Ms. Xiaolei Sun and Ms. Nian Liu, both employees of the Company, each holds 99% and 1% of the equity interests in Beijing Guangmu Weichen Technology Co., Ltd. |
Years Ended December 31, |
||||||||||||
2019 |
2020 |
2021 |
||||||||||
(RMB in millions) |
||||||||||||
Capital contributions from Parent to its subsidiaries |
1,468 | 1,555 | 2,679 | |||||||||
Loans from its subsidiaries to Parent |
— | — | 382 | |||||||||
Loans repayment received by its subsidiaries from Parent |
— | — | 35 | |||||||||
Loans from its subsidiaries to the VIEs and their subsidiaries |
892 | 1,477 | 4,418 | |||||||||
Loans repayment received by subsidiaries from VIEs and their subsidiaries |
367 | 372 | 3,010 | |||||||||
Service fees received by WOFE from the VIEs and their subsidiaries * |
— | 455 | 718 |
* | The cash flows between our WFOE, and the VIEs and their subsidiaries included the service fees paid for services contemplated by the exclusive business cooperation agreements. |
Taxation Scenario (1) |
||||
Statutory Tax and Standard Rates |
||||
Hypothetical pre-tax earnings(2) |
100 | % | ||
Tax on earnings at statutory rate of 25% (3) |
(25 | %) | ||
Net earnings available for distribution |
75 | % | ||
Withholding tax at standard rate of 10% (4) |
(7.5 | %) | ||
Net distribution to Parent/Shareholders |
67.5 | % |
(1) | For purposes of this example, the tax calculation has been simplified. The hypothetical book pre-tax earnings amount, not considering timing differences, is assumed to equal taxable income in China. |
(2) | Under the terms of VIE agreements, our WFOE may charge the VIEs for services provided to the VIEs. These fees shall be recognized as expenses of the VIEs, with a corresponding amount as service income by our WFOE and eliminate in consolidation. For income tax purposes, our our WFOE and the VIEs file income tax returns on a separate company basis. The fees paid are recognized as a tax deduction by the VIEs and as income by our WFOE and are tax neutral. |
(3) | Certain of our subsidiaries qualifies for a 15% preferential income tax rate in China. However, such rate is subject to qualification, is temporary in nature, and may not be available in a future period when distributions are paid. For purposes of this hypothetical example, the table above reflects a maximum tax scenario under which the full statutory rate would be effective. |
(4) | The PRC Enterprise Income Tax Law imposes a withholding income tax of 10% on dividends distributed by a foreign invested enterprise, or FIE, to its immediate holding company outside of China. A lower withholding income tax rate of 5% is applied if the FIE’s immediate holding company is registered in Hong Kong or other jurisdictions that have a tax treaty arrangement with China, subject to a qualification review at the time of the distribution. For purposes of this hypothetical example, the table above assumes a maximum tax scenario under which the full withholding tax would be applied. |
As of December 31, 2021 |
As of December 31, 2020 |
|||||||||||||||||||||||||||||||||||||||
Parent |
Non-VIE subsidiaries |
VIEs and their subsidiaries |
Elimination |
Consolidated |
Parent |
Non-VIE subsidiaries |
VIEs and their subsidiaries |
Elimination |
Consolidated |
|||||||||||||||||||||||||||||||
(RMB in thousands) | ||||||||||||||||||||||||||||||||||||||||
Cash and cash equivalents |
8,483 | 78,047 | 731,189 | — | 817,719 | 32,145 | 273,876 | 755,941 | — | 1,061,962 | ||||||||||||||||||||||||||||||
Restricted cash |
— | — | 667,664 | — | 667,664 | — | 7,830 | 253,557 | — | 261,387 | ||||||||||||||||||||||||||||||
Short-term investments |
414,921 | 1,202,990 | 351,451 | — | 1,969,362 | 653,609 | 265,161 | 274,390 | — | 1,193,160 | ||||||||||||||||||||||||||||||
Accounts receivable |
— | 8,608 | 635,235 | — | 643,843 | — | 3,147 | 536,644 | — | 539,791 | ||||||||||||||||||||||||||||||
Current contract assets |
— | — | 563,611 | — | 563,611 | — | — | 824,544 | — | 824,544 | ||||||||||||||||||||||||||||||
Amount due from related parties |
— | — | 1,049 | — | 1,049 | — | — | 813 | — | 813 | ||||||||||||||||||||||||||||||
Prepaid expense and other assets |
14,993 | 39,361 | 315,440 | — | 369,794 | — | 31,183 | 619,897 | — | 651,080 | ||||||||||||||||||||||||||||||
Amounts due from the entities within our Group |
1,786 | 4,323,023 | 121 | (4,324,930 | ) | — | 2,073 | 2,517,756 | 127,405 | (2,647,234 | ) | — | ||||||||||||||||||||||||||||
Non-current contract assets |
— | — | 29,889 | — | 29,889 | — | — | 24,006 | — | 24,006 | ||||||||||||||||||||||||||||||
Property, equipment and software, net |
— | 31,506 | 13,256 | — | 44,762 | — | 19,553 | 9,171 | — | 28,724 | ||||||||||||||||||||||||||||||
Intangible assets, net |
— | 20,535 | 53,202 | (16,984 | ) | 56,753 | — | 25,986 | 49,406 | (22,358 | ) | 53,034 | ||||||||||||||||||||||||||||
Long-term investments |
1,912 | — | 9,900 | — | 11,812 | 1,957 | — | 784 | — | 2,741 | ||||||||||||||||||||||||||||||
Investment in Non-VIE subsidiaries |
3,883,806 | — | — | (3,883,806 | ) | — | 2,551,008 | — | — | (2,551,008 | ) | — | ||||||||||||||||||||||||||||
Investment in VIEs |
— | (1,341,046 | ) | — | 1,341,046 | — | — | (87,217 | ) | — | 87,217 | — | ||||||||||||||||||||||||||||
Right of use assets, net |
— | 28,503 | 30,578 | — | 59,081 | — | 39,940 | 20,754 | — | 60,694 | ||||||||||||||||||||||||||||||
Deferred tax assets |
— | — | 11,840 | — | 11,840 | — | — | — | — | — | ||||||||||||||||||||||||||||||
Goodwill |
— | — | 3,420 | — | 3,420 | — | — | 3,119 | — | 3,119 | ||||||||||||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||||
Total assets |
4,325,901 |
4,391,527 |
3,417,845 |
(6,884,674 |
) |
5,250,599 |
3,240,792 |
3,097,215 |
3,500,431 |
(5,133,383 |
) |
4,705,055 |
||||||||||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||||
Amount due to related parties |
— | 20,449 | — | — | 20,449 | — | 9,789 | — | — | 9,789 | ||||||||||||||||||||||||||||||
Insurance premium payables |
— | — | 685,028 | — | 685,028 | — | — | 607,326 | — | 607,326 | ||||||||||||||||||||||||||||||
Deferred revenue |
— | — | 803 | — | 803 | — | — | 22,017 | — | 22,017 | ||||||||||||||||||||||||||||||
Accrued expenses and other current liabilities |
3,734 | 81,580 | 413,438 | — | 498,752 | 60,480 | 87,915 | 447,211 | — | 595,606 | ||||||||||||||||||||||||||||||
Current lease liabilities |
— | 27,661 | 16,452 | — | 44,113 | — | 25,957 | 10,594 | — | 36,551 | ||||||||||||||||||||||||||||||
Amounts due to the entities within our Group |
348,741 | 1,491 | 3,617,123 | (3,967,355 | ) | — | — | 21,559 | 2,266,999 | (2,288,558 | ) | — | ||||||||||||||||||||||||||||
Non-current lease liabilities |
— | 1,556 | 12,921 | — | 14,477 | — | 19,528 | 8,181 | — | 27,709 | ||||||||||||||||||||||||||||||
Deferred tax liabilities |
— | — | 13,126 | 425 | 13,551 | — | 425 | 225,320 | — | 225,745 | ||||||||||||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||||
Total liabilities |
352,475 |
132,737 |
4,758,891 |
(3,966,930 |
) |
1,277,173 |
60,480 |
165,173 |
3,587,648 |
(2,288,558 |
) |
1,524,743 |
||||||||||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
For the year ended December 31, 2021 |
For the year ended December 31, 2020 |
For the year ended December 31, 2019 |
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Parent |
Non-VIE subsidiaries |
VIEs and their subsidiaries |
Elimination |
Consolidated |
Parent |
Non-VIE subsidiaries |
VIEs and their subsidiaries |
Elimination |
Consolidated |
Parent |
Non-VIE subsidiaries |
VIEs and their subsidiaries |
Elimination |
Consolidated |
||||||||||||||||||||||||||||||||||||||||||||||
(RMB in thousands) | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Operating revenue, net |
2,279 |
757,798 |
3,193,807 |
(747,970 |
) |
3,205,914 |
— |
535,486 |
3,035,904 |
(543,442 |
) |
3,027,948 |
— |
154,890 |
1,511,010 |
(154,935 |
) |
1,510,965 |
||||||||||||||||||||||||||||||||||||||||||
Operating costs |
— | (171,728 | ) | (882,747 | ) | — | (1,054,475 | ) | — | (150,457 | ) | (591,801 | ) | — | (742,258 | ) | — | (62,659 | ) | (228,651 | ) | — | (291,310 | ) | ||||||||||||||||||||||||||||||||||||
Sales and marketing expenses |
(10,902 | ) | (161,598 | ) | (2,932,269 | ) | — | (3,104,769 | ) | (4,538 | ) | (59,354 | ) | (2,066,643 | ) | — | (2,130,535 | ) | (1,927 | ) | (40,540 | ) | (1,014,027 | ) | — | (1,056,494 | ) | |||||||||||||||||||||||||||||||||
General and administrative expenses |
(214,856 | ) | (208,605 | ) | (853,908 | ) | 746,847 | (530,522 | ) | (211,596 | ) | (123,631 | ) | (583,583 | ) | 511,639 | (407,171 | ) | (19,834 | ) | (87,915 | ) | (201,044 | ) | 165,798 | (142,995 | ) | |||||||||||||||||||||||||||||||||
Research and development expenses |
(25,056 | ) | (329,291 | ) | (24,643 | ) | — | (378,990 | ) | (13,279 | ) | (202,495 | ) | (28,456 | ) | — | (244,230 | ) | (8,329 | ) | (152,291 | ) | (54,026 | ) | — | (214,646 | ) | |||||||||||||||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||||||||||||||
Total operating costs and expenses |
(250,814 |
) |
(871,222 |
) |
(4,693,567 |
) |
746,847 |
(5,068,756 |
) |
(229,413 |
) |
(535,937 |
) |
(3,270,483 |
) |
511,639 |
(3,524,194 |
) |
(30,090 |
) |
(343,405 |
) |
(1,497,748 |
) |
165,798 |
(1,705,445 |
) | |||||||||||||||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||||||||||||||
Operating (loss)/income |
(248,535 |
) |
(113,424 |
) |
(1,499,760 |
) |
(1,123 |
) |
(1,862,842 |
) |
(229,413 |
) |
(451 |
) |
(234,579 |
) |
(31,803 |
) |
(496,246 |
) |
(30,090 |
) |
(188,515 |
) |
13,262 |
10,863 |
(194,480 |
) | ||||||||||||||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||||||||||||||
Equity in loss of subsidiaries and VIEs |
(1,332,101 | ) | (1,250,773 | ) | — | 2,582,874 | — | (286,022 | ) | (287,649 | ) | — | 573,671 | — | (292,523 | ) | (116,494 | ) | — | 409,017 | — | |||||||||||||||||||||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||||||||||||||
Net (loss)/income |
(1,574,080 |
) |
(1,332,101 |
) |
(1,253,808 |
) |
2,585,909 |
(1,574,080 |
) |
(663,869 |
) |
(286,022 |
) |
(253,807 |
) |
539,829 |
(663,869 |
) |
(321,535 |
) |
(292,523 |
) |
(184,632 |
) |
477,155 |
(321,535 |
) | |||||||||||||||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
For the year ended December 31, 2021 |
For the year ended December 31, 2020 |
For the year ended December 31, 2019 |
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Parent |
Non-VIE subsidiaries |
VIEs and their subsidiaries |
Elimination |
Consolidated |
Parent |
Non-VIE subsidiaries |
VIEs and their subsidiaries |
Elimination |
Consolidated |
Parent |
Non-VIE subsidiaries |
VIEs and their subsidiaries |
Elimination |
Consolidated |
||||||||||||||||||||||||||||||||||||||||||||||
(RMB in thousands) | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Net cash provided by/(used in) operating activities |
320,097 | (497,069 | ) | (919,680 | ) | — | (1,096,652 | ) | (28 | ) | (224,548 | ) | (552,532 | ) | — | (777,108 | ) | (2,827 | ) | (148,151 | ) | (381,917 | ) | — | (532,895 | ) | ||||||||||||||||||||||||||||||||||
Net cash (used in)/provided by investing activities |
(2,458,126 | ) | (2,376,786 | ) | (99,240 | ) | 4,087,254 | (846,898 | ) | (2,209,098 | ) | (1,391,055 | ) | (277,521 | ) | 2,659,973 | (1,217,701 | ) | (1,434,140 | ) | (680,046 | ) | 75,528 | 1,992,703 | (45,955 | ) | ||||||||||||||||||||||||||||||||||
Net cash provided by/(used in) financing activities |
2,128,529 | 2,670,120 | 1,408,275 | (4,087,254 | ) | 2,119,670 | 2,048,986 | 1,556,899 | 1,104,978 | (2,659,973 | ) | 2,050,890 | 1,491,983 | 1,467,522 | 505,973 | (1,992,703 | ) | 1,472,775 |
For the Year Ended December 31, |
||||||||||||||||||||
2018 |
2019 |
2020 |
2021 |
|||||||||||||||||
RMB |
RMB |
RMB |
RMB |
US$ |
||||||||||||||||
(in thousands, except for share and per share data) |
||||||||||||||||||||
Operating revenue, net |
238,149 |
1,510,965 |
3,027,948 |
3,205,914 |
503,078 |
|||||||||||||||
Operating costs and expenses |
||||||||||||||||||||
Operating costs |
(45,932 | ) | (291,310 | ) | (742,258 | ) | (1,054,475 | ) | (165,470 | ) | ||||||||||
Sales and marketing expenses |
(184,943 | ) | (1,056,494 | ) | (2,130,535 | ) | (3,104,769 | ) | (487,206 | ) | ||||||||||
General and administrative expenses |
(126,242 | ) | (142,995 | ) | (407,171 | ) | (530,522 | ) | (83,250 | ) | ||||||||||
Research and development expenses |
(69,196 | ) | (214,646 | ) | (244,230 | ) | (378,990 | ) | (59,472 | ) | ||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
Total operating costs and expenses |
(426,313 |
) |
(1,705,445 |
) |
(3,524,194 |
) |
(5,068,756 |
) |
(795,398 |
) | ||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
Operating loss |
(188,164 |
) |
(194,480 |
) |
(496,246 |
) |
(1,862,842 |
) |
(292,320 |
) | ||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
Other income/(expenses) |
||||||||||||||||||||
Interest income |
2,428 | 10,533 | 26,515 | 48,662 | 7,636 | |||||||||||||||
Fair value change of warrant |
— | — | (150,685 | ) | — | — | ||||||||||||||
Foreign currency exchange gain/(loss) |
66 | 4,152 | (1,335 | ) | 9,349 | 1,467 | ||||||||||||||
Others, net |
(1,967 | ) | 817 | 8,052 | 9,764 | 1,532 | ||||||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
Loss before income tax, and share of results of equity method investee |
(187,637 |
) |
(178,978 |
) |
(613,699 |
) |
(1,795,067 |
) |
(281,685 |
) | ||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
Income tax (expense)/benefit |
(21,503 | ) | (142,528 | ) | (50,155 | ) | 220,987 | 34,678 | ||||||||||||
Share of results of equity method investee |
(54 | ) | (29 | ) | (15 | ) | — | — | ||||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
Net loss attributable to Waterdrop Inc. |
(209,194 |
) |
(321,535 |
) |
(663,869 |
) |
(1,574,080 |
) |
(247,007 |
) | ||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
Deemed dividend on modification on preferred shares |
— |
— |
(67,975 | ) | — | — | ||||||||||||||
Deemed dividend upon issuance of warrants |
— | — | (90,268 | ) | — | — | ||||||||||||||
Preferred shares redemption value accretion |
(22,230 | ) | (136,839 | ) | (285,668 | ) | (152,287 | ) | (23,897 | ) | ||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
Net loss attributable to ordinary shareholders |
(231,424 |
) |
(458,374 |
) |
(1,107,780 |
) |
(1,726,367 |
) |
(270,904 |
) | ||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
Weighted average number of ordinary shares used in computing net loss per share |
||||||||||||||||||||
Basic and diluted |
839,572,645 | 1,203,526,000 | 1,174,583,516 | 2,990,507,749 | 2,990,507,749 | |||||||||||||||
Net loss per share attributable to ordinary shareholders |
||||||||||||||||||||
Basic and diluted |
(0.28 | ) | (0.38 | ) | (0.94 | ) | (0.58 | ) | (0.09 | ) |
As of December 31, |
||||||||||||||||
2019 |
2020 |
2021 |
||||||||||||||
RMB |
RMB |
RMB |
US$ |
|||||||||||||
(in thousands) |
||||||||||||||||
Selected Consolidated Balance Sheet Data: |
||||||||||||||||
Cash and cash equivalents |
964,476 | 1,061,962 | 817,719 | 128,318 | ||||||||||||
Restricted cash |
329,676 | 261,387 | 667,664 | 104,771 | ||||||||||||
Short-term investments |
60,278 | 1,193,160 | 1,969,362 | 309,036 | ||||||||||||
Accounts receivable |
252,499 | 539,791 | 643,843 | 101,033 | ||||||||||||
Contract assets |
617,688 | 848,550 | 593,500 | 93,133 | ||||||||||||
|
|
|
|
|
|
|
|
|||||||||
Total assets |
2,555,906 |
4,705,055 |
5,250,599 |
823,933 |
||||||||||||
|
|
|
|
|
|
|
|
|||||||||
Insurance premium payables (1) |
320,327 | 607,326 | 685,028 | 107,496 | ||||||||||||
Deferred revenue (2) |
21,670 | 22,017 | 803 | 126 | ||||||||||||
Accrued expenses and other current liabilities (3) |
496,530 | 595,606 | 498,752 | 78,265 | ||||||||||||
Deferred tax liabilities (4) |
167,601 | 225,745 | 13,551 | 2,126 | ||||||||||||
|
|
|
|
|
|
|
|
|||||||||
Total liabilities |
1,054,394 |
1,524,743 |
1,277,173 |
200,416 |
||||||||||||
|
|
|
|
|
|
|
|
|||||||||
Total mezzanine equity |
2,207,831 |
4,837,336 |
— |
— |
||||||||||||
|
|
|
|
|
|
|
|
|||||||||
Total shareholders’ (deficit)/equity |
(706,319 |
) |
(1,657,024 |
) |
3,973,426 |
623,517 |
||||||||||
|
|
|
|
|
|
|
|
(1) | Includes amounts of the consolidated VIEs and subsidiaries of VIEs without recourse to the Company of RMB320.2 million, RMB607.3 million and RMB685.0 million as of December 31, 2019, 2020 and 2021, respectively. |
(2) | Includes amounts of the consolidated VIEs and subsidiaries of VIEs without recourse to the Company of RMB21.7 million, RMB22.0 million and RMB0.8 million as of December 31, 2019, 2020 and 2021, respectively. |
(3) | Includes amounts of the consolidated VIEs and subsidiaries of VIEs without recourse to the Company of RMB428.8 million, RMB447.2 million and RMB413.4 million as of December 31, 2019, 2020 and 2021, respectively. |
(4) | Includes amounts of the consolidated VIEs and subsidiaries of VIEs without recourse to the Company of RMB167.2 million, RMB225.3 million and RMB13.1 million as of December 31, 2019, 2020 and 2021, respectively. |
For the Year Ended December 31, |
||||||||||||||||||||
2018 |
2019 |
2020 |
2021 |
|||||||||||||||||
RMB |
RMB |
RMB |
RMB |
US$ |
||||||||||||||||
(in thousands) |
||||||||||||||||||||
Net cash used in operating activities |
(211,029 | ) | (532,895 | ) | (777,108 | ) | (1,096,652 | ) | (172,089 | ) | ||||||||||
Net cash provided by/(used in) investing activities |
31,988 | (45,955 | ) | (1,217,701 | ) | (846,898 | ) | (132,897 | ) | |||||||||||
Net cash provided by financing activities |
362,669 | 1,472,775 | 2,050,890 | 2,119,670 | 332,622 | |||||||||||||||
Effect of exchange rate changes on cash and cash equivalents |
(1,973 | ) | 27,342 | (26,884 | ) | (14,086 | ) | (2,209 | ) | |||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
Net increase in cash and cash equivalents and restricted cash |
181,655 | 921,267 | 29,197 | 162,034 | 25,427 | |||||||||||||||
Total cash and cash equivalents and restricted cash at beginning of year |
191,230 | 372,885 | 1,294,152 | 1,323,349 | 207,662 | |||||||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
Total cash and cash equivalents and restricted cash at end of year |
372,885 | 1,294,152 | 1,323,349 | 1,485,383 | 233,089 | |||||||||||||||
|
|
|
|
|
|
|
|
|
|
• | Our business and growth are significantly affected by the future prospects of third-party insurance brokerage and agency, medical crowdfunding and healthcare industries, which are rapidly evolving. |
• | Our limited operating history and evolving business model make it difficult to evaluate our business and future prospects and the risks and challenges we may encounter. |
• | We face intense competition and could lose market share, which could adversely affect our results of operations. |
• | We have a history of net losses and negative cash flows from operating activities, which may continue in the future. |
• | We face uncertainties relating to the change of regulatory regime. |
• | We face reputational, monetary, and legal risks in relation to our discontinuation of the Waterdrop Mutual Aid business. |
• | The administration, interpretation and enforcement of the regulations applicable to us are evolving and involve uncertainties. We may not be able to stay in constant compliance with the rapidly evolving regulations. |
• | Any lack of requisite approvals, licenses or permits applicable to our business operation may have a material and adverse impact on our business and results of operations. |
• | We have been or may be subject to penalties for failure to manage our personnel engaging in insurance brokerage activities. |
• | We face reputational, monetary, and legal risks in relation to our discontinuation of the Waterdrop Mutual Aid business. |
• | Our historical growth rate may not be indicative of our future performance and if we fail to effectively manage our growth, our business, financial condition and results of operations could be adversely affected. |
• | We are a Cayman Islands holding company with no equity ownership in the VIEs and we conduct our operations in China primarily through (i) our PRC subsidiaries and (ii) the VIEs, with which we have maintained contractual arrangements. Investors in our ADSs thus are not purchasing equity interest in our operating entities in China but instead are purchasing equity interest in a Cayman Islands holding company. If the PRC government finds that the agreements that establish the structure for operating our business do not comply with the PRC laws and regulations, or if these regulations or their interpretations change in the future, we could be subject to severe penalties or be forced to relinquish our interests in those operations. Our holding company, our PRC subsidiaries, the VIEs, and investors of our company face uncertainty about potential future actions by the PRC government that could affect the enforceability of the contractual arrangements with the VIEs and, consequently, significantly affect the financial performance of the VIEs and our company as a whole. |
• | Changes in China’s economic, political or social conditions or government policies could have a material adverse effect on our business and operations. |
• | PRC government’s significant authority in regulating our operations and its oversight and control over securities offerings conducted overseas by, and foreign investment in, China-based issuers could significantly limit or completely hinder our ability to offer or continue to offer securities to investors. Implementation of industry-wide regulations in this nature may cause the value of such securities to significantly decline. |
• | Risks and uncertainties arising from the legal system in China, including risks and uncertainties regarding the enforcement of laws and quickly evolving rules and regulations in China, could result in a material adverse change in our operations and the value of our ADSs. |
• | We may rely on dividends and other distributions on equity paid by our PRC subsidiaries to fund any cash and financing requirements we may have, and any limitation on the ability of our PRC subsidiaries to make payments to us could have a material and adverse effect on our ability to conduct our business. |
• | Our auditor is currently not subject to inspections by the PCAOB. Our ADSs may be delisted under the Holding Foreign Companies Accountable Act. The delisting of our ADSs, or the threat of their being delisted, may materially and adversely affect the value of your investment. Additionally, the inability of the PCAOB to conduct inspections deprives our investors with the benefits of such inspections. |
• | Our ADSs will be prohibited from trading in the United States under the Holding Foreign Companies Accountable Act, in 2024 if the PCAOB is unable to inspect or fully investigate auditors located in China, or in 2023 if proposed changes to the law are enacted. The delisting of our ADSs, or the threat of their being delisted, may materially and adversely affect the value of your investment. |
• | The trading price of the ADSs is likely to be volatile, which could result in substantial losses to investors. |
• | If securities or industry analysts cease to publish research or reports about our business, or if they adversely change their recommendations regarding the ADSs, the market price for the ADSs and trading volume could decline. |
• | Our dual-class voting structure will limit your ability to influence corporate matters and could discourage others from pursuing any change of control transactions that holders of our Class A ordinary shares and ADSs may view as beneficial. |
• | operational and compliance challenges caused by distance, language, and cultural differences; |
• | the resources required to build a local management team in each new market and to localize our service offerings to appeal to consumers in that market; |
• | compliance challenges caused by unfamiliar laws and regulations; |
• | competition with businesses that understand local markets better than we do, that have pre-existing relationships with potential consumers in those markets, or that are favored by government or regulatory authorities in those markets; |
• | international geopolitical tensions; |
• | political, social and economic instability in any jurisdiction where we operate; |
• | international export controls and economic and trade sanctions; |
• | legal uncertainty including uncertainty resulting from unique local laws or a lack of clear legal precedent; |
• | regulatory press and licenses requirements from local authorities in insurance, crowdfunding or other industries; |
• | fluctuations in currency exchange rates; |
• | managing operations in markets in which offline activities are favored over online platform or service; |
• | adverse tax consequences, including the complexities of foreign value added tax systems, and restrictions on the repatriation of earnings; |
• | increased financial accounting and reporting burdens, and complexities associated with implementing and maintaining adequate internal controls; |
• | difficulties in implementing and maintaining the financial systems and processes needed to enable compliance across multiple offerings and jurisdictions; and |
• | reduced or varied protection for intellectual property rights in some markets. |
• | exercise effective control over the VIEs; |
• | receive substantially all of the economic benefits and bear the obligation to absorb substantially all of the losses of the VIEs; and have an exclusive option to purchase all or part of the equity interests and assets in the VIEs when and to the extent permitted by PRC law. |
• | revoking the business licenses and/or operating licenses of such entities; |
• | imposing fines on us; |
• | confiscating any of our income that they deem to be obtained through illegal operations; |
• | discontinuing or placing restrictions or onerous conditions on our operations; |
• | placing restrictions on our right to collect revenues; |
• | shutting down our servers or blocking our app/websites; |
• | requiring us to restructure our ownership structure or operations; |
• | restricting or prohibiting our use of the proceeds from our financing activities to finance the business and operations of the VIEs and their subsidiaries; or |
• | taking other regulatory or enforcement actions that could be harmful to our business. |
• | variations in our revenues, earnings, cash flow; |
• | fluctuations in operating metrics; |
• | announcements of new investments, acquisitions, strategic partnerships or joint ventures by us or our competitors; |
• | announcements of new solutions and services and expansions by us or our competitors; |
• | termination or non-renewal of contracts or any other material adverse change in our relationship with our key customers or strategic investors; |
• | changes in financial estimates by securities analysts; |
• | detrimental negative publicity about us, our competitors or our industry; |
• | additions or departures of key personnel; |
• | release of lockup or other transfer restrictions on our outstanding equity securities or sales of additional equity securities; |
• | regulatory developments affecting us or our industry; and |
• | potential litigation or regulatory investigations. |
• | we have instructed the depositary that we do not wish a discretionary proxy to be given; |
• | we have informed the depositary that there is substantial opposition as to a matter to be voted on at the meeting; |
• | a matter to be voted on at the meeting would have a material adverse impact on shareholders; or |
• | the voting at the meeting is to be made on a show of hands. |
• | the rules under the Exchange Act requiring the filing with the SEC of quarterly reports on Form 10-Q or current reports on Form 8-K; |
• | the sections of the Exchange Act regulating the solicitation of proxies, consents, or authorizations in respect of a security registered under the Exchange Act; |
• | the sections of the Exchange Act requiring insiders to file public reports of their stock ownership and trading activities and liability for insiders who profit from trades made in a short period of time; |
• | the selective disclosure rules by issuers of material nonpublic information under Regulation FD; and |
• | certain audit committee independence requirements in Rule 10A-3 of the Exchange Act. |
Item 4. |
Information on the Company |
For the Years Ended December 31, |
||||||||||||||||||||||||
2019 |
2020 |
2021 |
||||||||||||||||||||||
FYP |
(RMB million) |
(%) |
(RMB million) |
(%) |
(RMB million) |
(%) |
||||||||||||||||||
Short-term insurance |
6,118 | 91.7 | 11,916 | 82.6 | 13,717 | 83.8 | ||||||||||||||||||
Long-term insurance |
550 | 8.3 | 2,510 | 17.4 | 2,646 | 16.2 | ||||||||||||||||||
Total |
6,668 |
100.0 |
14,426 |
100.0 |
16,363 |
100.0 |
||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
For the Years Ended December 31, |
||||||||||||||||||||||||
Number of Policies |
(thousand) |
(%) |
(thousand) |
(%) |
(thousand) |
(%) |
||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||
Short-term insurance |
10,638 |
98.9 |
17,007 |
96.6 |
18,254 |
96.6 |
||||||||||||||||||
Long-term insurance |
118 |
1.1 |
605 |
3.4 |
633 |
3.4 |
||||||||||||||||||
Total |
10,756 |
100.0 |
17,612 |
100.0 |
18,887 |
100.0 |
||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
For the Years Ended December 31, |
||||||||||||||||||||||||
2019 |
2020 |
2021 |
||||||||||||||||||||||
FYP |
(RMB million) |
(%) |
(RMB million) |
(%) |
(RMB million) |
(%) |
||||||||||||||||||
Health insurance |
||||||||||||||||||||||||
Medical insurance |
5,339 | 80.1 | 10,426 | 72.3 | 11,003 | 67.3 | ||||||||||||||||||
Casualty insurance |
527 | 7.9 | 1,280 | 8.9 | 1,194 | 7.3 | ||||||||||||||||||
Critical illness insurance |
699 | 10.5 | 1,907 | 13.2 | 2,833 | 17.3 | ||||||||||||||||||
Life insurance |
103 | 1.5 | 813 | 5.6 | 1,333 | 8.1 | ||||||||||||||||||
Total |
6,668 |
100.0 |
14,426 |
100.0 |
16,363 |
100.0 |
||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
For the Years Ended December 31, |
||||||||||||||||||||||||
2019 |
2020 |
2021 |
||||||||||||||||||||||
Number of Polices |
(thousand) |
(%) |
(thousand) |
(%) |
(thousand) |
(%) |
||||||||||||||||||
Health insurance |
||||||||||||||||||||||||
Medical insurance |
8,406 |
78.2 |
13,571 |
77.0 |
14,577 |
77.2 |
||||||||||||||||||
Casualty insurance |
1,743 |
16.2 |
3,162 |
18.0 |
2,386 |
12.6 |
||||||||||||||||||
Critical illness insurance |
584 |
5.4 |
681 |
3.9 |
1,609 |
8.5 |
||||||||||||||||||
Life insurance |
23 |
0.2 |
198 |
1.1 |
315 |
1.7 |
||||||||||||||||||
Total |
10,756 |
100.0 |
17,612 |
100.0 |
18,887 |
100.0 |
||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
• | the ownership structures of the VIEs in China and our WFOE currently do not and will not result in violation of any explicit provisions of PRC laws, rules or regulations currently in effect; and |
• | each of the agreements under the contractual arrangements among our WFOE, the VIEs and their respective shareholders governed by PRC law, rules and regulations currently is valid, binding and enforceable, and will not result in violation of any explicit provisions of PRC laws, rules or regulations currently in effect. |
Item 4A. |
Unresolved Staff Comments |
Item 5. |
Operating and Financial Review and Prospects |
For the Year Ended December 31, |
||||||||||||||||||||||||||||
2019 |
2020 |
2021 |
||||||||||||||||||||||||||
RMB |
% |
RMB |
% |
RMB |
US$ |
% |
||||||||||||||||||||||
(in thousands, except for percentage data) |
||||||||||||||||||||||||||||
Operating revenue, net: |
||||||||||||||||||||||||||||
Brokerage income |
||||||||||||||||||||||||||||
Short-term insurance brokerage income |
1,134,984 | 75.1 | 2,045,191 | 67.6 | 2,037,677 | 319,756 | 63.6 | |||||||||||||||||||||
Long-term insurance brokerage income |
173,192 | 11.5 | 650,129 | 21.5 | 789,790 | 123,935 | 24.6 | |||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||
Subtotal |
1,308,176 | 86.6 | 2,695,320 | 89.1 | 2,827,467 | 443,691 | 88.2 | |||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||
Management fee income |
142,683 | 9.4 | 109,828 | 3.6 | 2,745 | 431 | 0.1 | |||||||||||||||||||||
Technical service income |
51,705 | 3.4 | 194,130 | 6.4 | 243,542 | 38,217 | 7.6 | |||||||||||||||||||||
Other revenues |
8,401 | 0.6 | 28,670 | 0.9 | 132,160 | 20,739 | 4.1 | |||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||
Total |
1,510,965 |
100.0 |
3,027,948 |
100.0 |
3,205,914 |
503,078 |
100.0 |
|||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
For the Year Ended December 31, |
||||||||||||||||||||||||||||
2019 |
2020 |
2021 |
||||||||||||||||||||||||||
RMB |
% |
RMB |
% |
RMB |
US$ |
% |
||||||||||||||||||||||
(in thousands, except for percentage data) |
||||||||||||||||||||||||||||
Operating costs and expenses: |
||||||||||||||||||||||||||||
Operating costs. |
291,310 | 19.3 | 742,258 | 24.5 | 1,054,475 | 165,470 | 32.9 | |||||||||||||||||||||
Sales and marketing expenses |
1,056,494 | 69.9 | 2,130,535 | 70.4 | 3,104,769 | 487,206 | 96.8 | |||||||||||||||||||||
General and administrative expenses |
142,995 | 9.5 | 407,171 | 13.4 | 530,522 | 83,250 | 16.5 | |||||||||||||||||||||
Research and development expenses |
214,646 | 14.2 | 244,230 | 8.1 | 378,990 | 59,472 | 11.8 | |||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||
Total operating costs and expenses: |
1,705,445 |
112.9 |
3,524,194 |
116.4 |
5,068,756 |
795,398 |
158.0 |
|||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
For the Year Ended December 31, |
||||||||||||||||||||||||||||
2019 |
2020 |
2021 |
||||||||||||||||||||||||||
RMB |
% |
RMB |
% |
RMB |
US$ |
% |
||||||||||||||||||||||
(in thousands, except for percentage data) |
||||||||||||||||||||||||||||
Operating revenue, net |
1,510,965 |
100.0 |
3,027,948 |
100.0 |
3,205,914 |
503,078 |
100.0 |
|||||||||||||||||||||
Operating costs and expenses |
||||||||||||||||||||||||||||
Operating costs |
(291,310 | ) | (19.3 | ) | (742,258 | ) | (24.5 | ) | (1,054,475 | ) | (165,470 | ) | (32.9 | ) | ||||||||||||||
Sales and marketing expenses (l) |
(1,056,494 | ) | (69.9 | ) | (2,130,535 | ) | (70.4 | ) | (3,104,769 | ) | (487,206 | ) | (96.8 | ) | ||||||||||||||
General and administrative expenses |
(142,995 | ) | (9.5 | ) | (407,171 | ) | (13.4 | ) | (530,522 | ) | (83,250 | ) | (16.5 | ) | ||||||||||||||
Research and development expenses |
(214,646 | ) | (14.2 | ) | (244,230 | ) | (8.1 | ) | (378,990 | ) | (59,472 | ) | (11.8 | ) | ||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||
Total operating costs and expenses: |
(1,705,445 |
) |
(112.9 |
) |
(3,524,194 |
) |
(116.4 |
) |
(5,068,756 |
) |
(795,398 |
) |
(158.0 |
) | ||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||
Operating loss |
(194,480 |
) |
(12.9 |
) |
(496,246 |
) |
(16.4 |
) |
(1,862,842 |
) |
(292,320 |
) |
(58.0 |
) | ||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||
Other income/(expenses) |
||||||||||||||||||||||||||||
Interest income |
10,533 | 0.7 | 26,515 | 0.9 | 48,662 | 7,636 | 1.5 | |||||||||||||||||||||
Fair value change of warrant |
— | — | (150,685 | ) | (5.0 | ) | — | — | — | |||||||||||||||||||
Foreign currency exchange gain/(loss) |
4,152 | 0.3 | (1,335 | ) | (0.0 | ) | 9,349 | 1,467 | 0.3 | |||||||||||||||||||
Others, net |
817 | 0.1 | 8,052 | 0.3 | 9,764 | 1,532 | 0.3 | |||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||
Loss before income tax, and share of results of equity method investee |
(178,978 |
) |
(11.8 |
) |
(613,699 |
) |
(20.2 |
) |
(1,795,067 |
) |
(281,685 |
) |
(55.9 |
) | ||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||
Income tax (expense)/benefit |
(142,528 | ) | (9.4 | ) | (50,155 | ) | (1.7 | ) | 220,987 | 34,678 | 6.9 | |||||||||||||||||
Share of results of equity method investee |
(29 | ) | (0.0 | ) | (15 | ) | (0.0 | ) | — | — | — | |||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||
Net loss attributable to Waterdrop Inc |
(321,535 |
) |
(21.2 |
) |
(663,869 |
) |
(21.9 |
) |
(1,574,080 |
) |
(247,007 |
) |
(49.0 |
) | ||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||
Deemed dividend on modification on preferred shares |
— | — | (67,975 | ) | (2.2 | ) | — | — | — | |||||||||||||||||||
Deemed dividend upon issuance of warrants |
— | — | (90,268 | ) | (3.0 | ) | — | — | — | |||||||||||||||||||
Preferred shares redemption value accretion |
(136,839 | ) | (9.1 | ) | (285,668 | ) | (9.4 | ) | (152,287 | ) | (23,897 | ) | (4.8 | ) | ||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||
Net loss attributable to ordinary shareholders |
(458,374 |
) |
(30.3 |
) |
(1,107,780 |
) |
(36.5 |
) |
(1,726,367 |
) |
(270,904 |
) |
(53.8 |
) | ||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||
Other comprehensive income/(loss): |
||||||||||||||||||||||||||||
Foreign currency translation adjustment |
27,771 | 1.8 | (14,008 | ) | (0.5 | ) | (36,640 | ) | (5,750 | ) | (1.1 | ) | ||||||||||||||||
Unrealized gains on available for sale investments, net of tax |
209 | 0.0 | 1,724 | 0.1 | 192 | 30 | 0.0 | |||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||
Total comprehensive loss |
(293,555 |
) |
(19.4 |
) |
(676,153 |
) |
(22.3 |
) |
(1,610,528 |
) |
(252,727 |
) |
(50.1 |
) | ||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(1) | The breakdown of sales and marketing expenses is as follows: |
For the Year Ended December 31, |
||||||||||||||||
2019 |
2020 |
2021 |
||||||||||||||
RMB |
RMB |
RMB |
US$ |
|||||||||||||
(in thousands) |
||||||||||||||||
Marketing expenses for user acquisition and brand building |
793,419 | 1,743,014 | 2,232,942 | 350,397 | ||||||||||||
Payroll and related expenses for employees |
201,147 | 210,308 | 295,434 | 46,360 | ||||||||||||
Expenses of facilities and equipment |
11,333 | 17,274 | 21,023 | 3,299 | ||||||||||||
Promotional rewards to our users |
25,701 | 43,652 | 10,896 | 1,710 | ||||||||||||
Outsourced sales and marketing service fee to third parties |
11,685 | 94,218 | 507,421 | 79,625 | ||||||||||||
Others |
13,209 | 22,069 | 37,053 | 5,815 | ||||||||||||
|
|
|
|
|
|
|
|
|||||||||
Total sales and marketing expenses |
1,056,494 |
2,130,535 |
3,104,769 |
487,206 |
||||||||||||
|
|
|
|
|
|
|
|
For the Year Ended December 31, |
||||||||||||||||
2019 |
2020 |
2021 |
||||||||||||||
RMB |
RMB |
RMB |
US$ |
|||||||||||||
Selected Consolidated Cash Flow Data: |
(in thousands) |
|||||||||||||||
Net cash used in operating activities |
(532,895 | ) | (777,108 | ) | (1,096,652 | ) | (172,089 | ) | ||||||||
Net cash used in investing activities |
(45,955 | ) | (1,217,701 | ) | (846,898 | ) | (132,897 | ) | ||||||||
Net cash provided by financing activities |
1,472,775 | 2,050,890 | 2,119,670 | 332,622 | ||||||||||||
Effect of exchange rate changes on cash and cash equivalents |
27,342 | (26,884 | ) | (14,086 | ) | (2,209 | ) | |||||||||
|
|
|
|
|
|
|
|
|||||||||
Net increase in cash and cash equivalents and restricted cash |
921,267 | 29,197 | 162,034 | 25,427 | ||||||||||||
Total cash and cash equivalents and restricted cash at beginning of year |
372,885 | 1,294,152 | 1,323,349 | 207,662 | ||||||||||||
|
|
|
|
|
|
|
|
|||||||||
Total cash and cash equivalents and restricted cash at end of year |
1,294,152 | 1,323,349 | 1,485,383 | 233,089 | ||||||||||||
|
|
|
|
|
|
|
|
Directors and Executive Officers |
Age |
Position/Title | ||
Peng Shen | 34 | Chairman of the Board of Directors and Chief Executive Officer | ||
Guang Yang | 36 | Director and General Manager of Insurance Marketplace | ||
Yao Hu | 35 | Director and General Manager of Crowdfunding and Healthcare | ||
Haiyang Yu | 39 | Director | ||
Kai Huang | 35 | Director | ||
Nina Zhou | 46 | Director | ||
Heping Feng | 62 | Independent Director | ||
Chenyang Wei | 49 | Independent Director | ||
Kangping Shi | 46 | Chief Financial Officer | ||
Hui Teng | 43 | Chief Actuary |
Name |
Ordinary Shares Underlying Options |
Exercise Price (US$/Share) |
Date of Grant |
Date of Expiration |
||||||||||||
Yao Hu |
* | 0.003 | September 1, 2018 | September 1, 2028 | ||||||||||||
* | 0.08 | March 25, 2021 | March 25, 2031 | |||||||||||||
Kangping Shi |
* | 0.003 | November 16, 2020 | November 16, 2030 | ||||||||||||
* | 0.08 | March 25, 2021 | March 25, 2031 | |||||||||||||
Hui Teng |
* | 0.003 | May 1, 2020 | May 1, 2030 | ||||||||||||
* | 0.003 | October 31, 2020 | October 31, 2030 | |||||||||||||
* | 0.08 | March 25, 2021 | March 25, 2031 | |||||||||||||
Heping Feng |
* | 0.08 | June 25, 2021 | June 25, 2030 | ||||||||||||
Chenyang Wei |
* | 0.08 | June 25, 2021 | June 25, 2030 | ||||||||||||
All directors and executive officers as a group |
18,420,000 |
Less | than 1% of our total ordinary shares on an as-converted basis outstanding as of March 31, 2022. |
• | appointing the independent auditors and pre-approving all auditing and non-auditing services permitted to be performed by the independent auditors; |
• | reviewing with the independent auditors any audit problems or difficulties and management’s response; |
• | discussing the annual audited financial statements with management and the independent auditors; |
• | reviewing the adequacy and effectiveness of our accounting and internal control policies and procedures and any steps taken to monitor and control major financial risk exposures; |
• | reviewing and approving all proposed related party transactions; |
• | meeting separately and periodically with management and the independent auditors; and |
• | monitoring compliance with our code of business conduct and ethics, including reviewing the adequacy and effectiveness of our procedures to ensure proper compliance. |
• | reviewing and approving, or recommending to the board for its approval, the compensation for our chief executive officer and other executive officers; |
• | reviewing and recommending to the board for determination with respect to the compensation of our non-employee directors; |
• | reviewing periodically and approving any incentive compensation or equity plans, programs or similar arrangements; and |
• | selecting compensation consultant, legal counsel or other adviser only after taking into consideration all factors relevant to that person’s independence from management. |
• | selecting and recommending to the board nominees for election by the shareholders or appointment by the board; |
• | reviewing annually with the board the current composition of the board with regards to characteristics such as independence, knowledge, skills, experience and diversity; |
• | making recommendations on the frequency and structure of board meetings and monitoring the functioning of the committees of the board; and |
• | advising the board periodically with regards to significant developments in the law and practice of corporate governance as well as our compliance with applicable laws and regulations, and making recommendations to the board on all matters of corporate governance and on any remedial action to be taken. |
• | convening shareholders’ annual and extraordinary general meetings and reporting its work to shareholders at such meetings; |
• | declaring dividends and distributions; |
• | appointing officers and determining the term of office of the officers; |
• | exercising the borrowing powers of our company and mortgaging the property of our company; and |
• | approving the transfer of shares in our company, including the registration of such shares in our share register. |
Function |
Number of Employees |
|||
Operating |
1,696 | |||
Sales and marketing |
581 | |||
General and administrative |
286 | |||
Research and development |
373 | |||
|
|
|||
Total |
2,936 |
|||
|
|
• | each of our directors and executive officers; and |
• | each of our principal shareholders who beneficially own more than 5% of our total issued and outstanding shares. |
Ordinary Shares Beneficially Owned |
||||||||||||||||||||
Class A Ordinary Shares |
Class B Ordinary Shares |
Total Ordinary Shares on an As-converted Basis |
% of Total Ordinary Shares on an As- converted Basis |
% of Aggregate Voting Power† |
||||||||||||||||
Directors and Executive Officers**: |
||||||||||||||||||||
Peng Shen(1) |
159,835,949 | 801,904,979 | 961,740,928 | 24.5 | 71.3 | |||||||||||||||
Guang Yang(2) |
— | — | — | — | — | |||||||||||||||
Yao Hu(3) |
* | — | * | * | — | |||||||||||||||
Haiyang Yu |
— | — | — | — | — | |||||||||||||||
Kai Huang |
— | — | — | — | — | |||||||||||||||
Nina Zhou |
— | — | — | — | — | |||||||||||||||
Heping Feng |
|
* |
|
* | — | * | — | |||||||||||||
Chenyang Wei |
* | * | — | * | — | |||||||||||||||
Kangping Shi |
* | * | — | * | — | |||||||||||||||
Hui Teng |
|
* |
|
* | — | * | — | |||||||||||||
All Directors and Executive Officers as a Group |
167,265,909 | 801,904,979 | 969,170,888 | 24.6 | 71.3 | |||||||||||||||
Principal Shareholders: |
||||||||||||||||||||
Neptune Max Holdings Limited(l) |
— | 801,904,979 | 801,904,979 | 20.4 | 69.7 | |||||||||||||||
Entities affiliated with Tencent(4) |
830,085,007 | — | 830,085,007 | 21.1 | 8.0 | |||||||||||||||
Investment funds affiliated with Boyu Capital(5) |
470,735,258 | — | 470,735,258 | 12.0 | 4.5 | |||||||||||||||
Investment funds affiliated with Gaorong Capital(6) |
238,203,080 | — | 238,203,080 | 6.1 | 2.3 | |||||||||||||||
Swiss Re Principal Investments Company Asia Pte. Ltd.(7) |
206,362,384 | — | 206,362,384 | 5.2 | 2.0 |
Notes: |
* | Less than 1% of our total ordinary shares on an as-converted basis outstanding as of March 31, 2022. |
** | Except as indicated otherwise below, the business address of our directors and executive officers is Block C, Wangjing Science and Technology Park, No. 2 Lize Zhonger Road, Chaoyang District, Beijing, China. The business address of Mr. Kai Huang is Suite 3601B-3604, 36/F, Tower 2, Jing An Kerry Centre, 1539 Nanjing West Road, Jing An District, Shanghai, China. The business address of Mr. Haiyang Yu is 29/F, Three Pacific Place, No. 1 Queen’s Road East, Wanchai, Hong Kong. The business address of Ms. Nina Zhou is 12 Marina View, #16-01, Asia Square Tower 2, Singapore. The business address of Mr. Heping Feng is Room 1401, Beijing Mansion, 58 Dong Si Huan Zhong Road, Chaoyang District, Beijing, China. The business address of Mr. Chenyang Wei is Shuangqing Building 2-801, 77 Shuangqing Road, Haidian District, Beijing, China. |
† | For each person or group included in this column, percentage of total voting power represents voting power based on both Class A and Class B ordinary shares held by such person or group with respect to all outstanding shares of our Class A and Class B ordinary shares as a single class. Each holder of our Class A ordinary shares is entitled to one vote per share. Each holder of our Class B ordinary shares is entitled to nine votes per share. Our Class B ordinary shares are convertible at any time by the holder into Class A ordinary shares on a one-for-one |
(1) | Represents (i) 801,904,979 Class B Ordinary Share held of record by Neptune Max Holdings Limited, a British Virgin Islands company. Neptune Max Holdings Limited is 99% owned by a family trust set up by Mr. Shen and 1% owned by Mr. Shen. Mr. Shen acts as the sole director of Neptune Max Holdings Limited, and possesses the sole voting power over the shares held by Neptune Max Holdings Limited; (ii) 86,386,000 Class A Ordinary Shares held of record by Proton Fortune Holdings Limited, a British Virgin Islands company that is 98% owned by a family trust set up by Mr. Guang Yang, 1% owned by Mr. Guang Yang, and 1% owned by Mr. Shen. Mr. Shen owns 100% of the voting power of Proton Fortune Holdings Limited and acts as the sole director of Proton Fortune Holdings Limited; (iii) 73,445,939 Class A Ordinary Shares held of record by Xibo Holdings Limited, a British Virgin Islands company that is 98% owned by a family trust set up by Mr. Yao Hu, 1% owned by Mr. Yao Hu, and 1% owned by Mr. Shen. Mr. Shen owns 100% of the voting power of Xibo Holdings Limited and acts as the sole director of Xibo Holdings Limited; and (iv) 4,010 Class A Ordinary Shares directly held by Maple Ocean L.P., a British Virgin Islands limited partnership. First Principles Z Holdings Limited, a British Virgin Islands company, is the general partner of Maple Ocean L.P. Mr. Shen acts as the sole director of First Principles Z Holdings Limited. |
(2) | See Footnote (1) above. |
(3) | See Footnote (1) above. Represents the Class A ordinary shares Mr. Hu has the right to acquire within 60 days through the exercise of options. |
(4) | Represents (i) 805,085,007 Class A ordinary shares directly held by Image Frame Investment (HK) Limited, a company incorporated in Hong Kong, and (ii) 25,000,000 Class A ordinary shares represented by 2,500,000 ADSs, directly held by Tencent Mobility Limited, a company incorporated in Hong Kong. Information regarding beneficial ownership is reported as of May 6, 2021. Image Frame Investment (HK) Limited and Tencent Mobility Limited are investing entities wholly owned by Tencent Holdings Limited. Tencent Holdings Limited is a limited liability company incorporated in the Cayman Islands and is listed on the Hong Kong Stock Exchange. The registered address of Image Frame Investment (HK) Limited, Tencent Mobility Limited and Tencent Holdings Limited is 29/F, Three Pacific Place, No. 1 Queen’s Road East, Wanchai, Hong Kong. |
(5) | Represents (i) 434,235,258 Class A ordinary shares directly held by Harmonious Ocean Limited, an exempted company with limited liability incorporated under the laws of the Cayman Islands, and (ii) 36,500,000 Class A ordinary shares represented by 3,650,000 ADSs, directly held by Boyu Capital Opportunities Master Fund. Boyu Capital Fund IV, L.P., a limited partnership organized under the laws of the Cayman Islands, holds 100% of the outstanding shares of Harmonious Ocean Limited. Boyu Capital General Partner IV, Ltd., an exempted company incorporated under the laws of the Cayman Islands, is the general partner of Boyu Capital Fund IV, L.P. Boyu Capital Group Holdings Ltd., an exempted company incorporated under the laws of the Cayman Islands, holds 100% of the outstanding shares of Boyu Capital General Partner IV, Ltd. XYXY Holdings Ltd., a company incorporated in the British Virgin Islands, is the controlling shareholder of Boyu Capital Group Holdings Ltd. Mr. Xiaomeng Tong holds 100% of the outstanding shares in XYXY Holdings Ltd. The registered office of Harmonious Ocean Limited is do Maples Corporate Services Limited, PO Box 309 Ugland House, Grand Cayman, KY1-1104, Cayman Islands. |
(6) | Represents (i) 118,230,053 Class A ordinary shares directly held by Gaorong Technology Consulting Limited, a company limited by shares incorporated under the laws of the British Virgin Islands, (ii) 86,052,718 Class A ordinary shares directly held by Gaorong Group Holdings Limited, a company limited by shares incorporated under the laws of the British Virgin Islands, (iii) 31,880,733 Class A ordinary shares directly held by Banyan Partners Fund III, L.P., an exempted partnership with limited liability formed under the laws of the Cayman Islands, and (iv) 2,039,576 Class A ordinary shares held by Banyan Partners Fund III-A, L.P., an exempted partnership with limited liability formed under the laws of the Cayman Islands. Information regarding beneficial ownership is reported as of December 31, 2021, based on the information contained in the Schedule 13G jointly filed by Gaorong Technology Consulting Limited and others with SEC on February 11, 2022. |
(7) | Represents 206,362,384 Class A ordinary shares directly held by Swiss Re Principal Investments Company Asia Pte. Ltd., a corporation incorporated under the laws of Singapore. Information regarding beneficial ownership is reported as of December 31, 2021, based on the information contained in the Schedule 13G jointly filed by Swiss Re Ltd and others with SEC on January 28, 2022. Swiss Re Principal Investments Company Asia Pte. Ltd. is an investment entity indirectly wholly owned by Swiss Re Ltd, a company limited by shares with its registered office in Zurich, Switzerland, with its shares listed on the SIX Swiss Exchange and trading under the symbol SREN. |
Item 8. |
Financial Information |
Item 9. |
The Offer and Listing |
Item 10. |
Additional Information |
• | the instrument of transfer is lodged with us, accompanied by the certificate for the ordinary shares to which it relates and such other evidence as our board of directors may reasonably require to show the right of the transferor to make the transfer; |
• | the instrument of transfer is in respect of only one class of ordinary shares; |
• | the instrument of transfer is properly stamped, if required; |
• | in the case of a transfer to joint holders, the number of joint holders to whom the ordinary share is to be transferred does not exceed four; and |
• | a fee of such maximum sum as the New York Stock Exchange may determine to be payable or such lesser sum as our directors may from time to time require is paid to us in respect thereof. |
• | the designation of the series; |
• | the number of shares of the series; |
• | the dividend rights, dividend rates, conversion rights, voting rights; and |
• | the rights and terms of redemption and liquidation preferences. |
• | authorize our board of directors to issue preferred shares in one or more series and to designate the price, rights, preferences, privileges and restrictions of such preferred shares without any further vote or action by our shareholders; and |
• | limit the ability of shareholders to requisition and convene general meetings of shareholders. |
• | does not have to file an annual return of its shareholders with the Registrar of Companies; |
• | is not required to open its register of members for inspection; |
• | does not have to hold an annual general meeting; |
• | may obtain an undertaking against the imposition of any future taxation (such undertakings are usually given for 20 years in the first instance); |
• | may register by way of continuation in another jurisdiction and be deregistered in the Cayman Islands; |
• | may register as a limited duration company; and may register as a segregated portfolio company. |
• | the statutory provisions as to the required majority vote have been met; |
• | the shareholders have been fairly represented at the meeting in question and the statutory majority are acting bona fide without coercion of the minority to promote interests adverse to those of the class; |
• | the arrangement is such that may be reasonably approved by an intelligent and honest man of that class acting in respect of his interest; and the arrangement is not one that would more properly be sanctioned under some other provision of the Companies Act. |
• | a company acts or proposes to act illegally or ultra vires (and is therefore incapable of ratification by the shareholder); |
• | the act complained of, although not ultra vires, could only be effected duly if authorized by more than a simple majority vote that has not been obtained; and those who control the company are perpetrating a “fraud on the minority.” |
• | banks and other financial institutions; |
• | insurance companies; |
• | pension plans; |
• | cooperatives; |
• | regulated investment companies; |
• | real estate investment trusts; |
• | broker-dealers; |
• | traders that elect to use a mark-to-market |
• | certain former U.S. citizens or long-term residents; |
• | tax-exempt entities (including private foundations); |
• | holders who acquire their ADSs or ordinary shares pursuant to any employee share option or otherwise as compensation; |
• | investors that will hold their ADSs or ordinary shares as part of a straddle, hedge, conversion, constructive sale or other integrated transaction for U.S. federal income tax purposes; |
• | investors that have a functional currency other than the U.S. dollar; |
• | persons holding their ADSs or ordinary shares in connection with a trade or business conducted outside the United States; |
• | persons that actually or constructively own 10% or more of our stock (by vote or value); or |
• | partnerships or other entities taxable as partnerships for U.S. federal income tax purposes, or persons holding the ADSs or ordinary shares through such entities, all of whom may be subject to tax rules that differ significantly from those discussed below. |
• | an individual who is a citizen or resident of the United States; |
• | a corporation (or other entity treated as a corporation for U.S. federal income tax purposes) created in or organized under the law of the United States or any state thereof or the District of Columbia; |
• | an estate the income of which is includible in gross income for U.S. federal income tax purposes regardless of its source; or |
• | a trust (A) the administration of which is subject to the primary supervision of a U.S. court and which has one or more U.S. persons who have the authority to control all substantial decisions of the trust or (B) that has otherwise validly elected to be treated as a U.S. person under the Code. |
• | the excess distribution or gain will be allocated ratably over the U.S. Holder’s holding period for the ADSs or ordinary shares; |
• | the amount allocated to the current taxable year and any taxable years in the U.S. Holder’s holding period prior to the first taxable year in which we are a PFIC (each, a “pre-PFIC year”) will be taxable as ordinary income; and |
• | the amount allocated to each prior taxable year, other than a pre-PFIC year, will be subject to tax at the highest tax rate in effect for individuals or corporations, as appropriate, for that year, increased by an additional tax equal to the interest on the resulting tax deemed deferred with respect to each such taxable year. |
For the Year Ended December 31, |
||||||||||||||||||||||||
2019 |
2020 |
2021 |
||||||||||||||||||||||
RMB in thousands |
% |
RMB in thousands |
% |
RMB in thousands |
% |
|||||||||||||||||||
Customer A |
667,376 | 44.2 | 602,985 | 19.9 | 240,650 | 7.5 | ||||||||||||||||||
Customer B |
331,533 | 21.9 | 753,456 | 24.9 | 457,995 | 14.3 | ||||||||||||||||||
Customer C |
52,754 | 3.5 | 335,514 | 11.1 | 367,434 | 11.5 | ||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||
1,051,663 | 69.6 | 1,691,955 | 55.9 | 1,066,079 | 33.3 | |||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
As of December 31, |
||||||||||||||||
2020 |
2021 |
|||||||||||||||
RMB in thousands |
% |
RMB in thousands |
% |
|||||||||||||
Customer A |
258,060 | 18.6 | 134,292 | 10.9 | ||||||||||||
Customer B |
411,637 | 29.7 | 190,284 | 15.4 | ||||||||||||
Customer C |
118,887 | 8.6 | 109,676 | 8.9 | ||||||||||||
|
|
|
|
|
|
|
|
|||||||||
788,584 | 56.9 | 434,252 | 35.2 | |||||||||||||
|
|
|
|
|
|
|
|
Service |
Fees | |
Issuance of ADSs (e.g., an issuance of ADS upon a deposit of Class A ordinary shares, upon a change in the ADS(s)-to-Class |
Up to US$0.05 per ADS issued | |
Cancellation of ADSs (e.g., a cancellation of ADSs for delivery of deposited property, upon a change in the ADS(s)-to-Class |
Up to US$0.05 per ADS cancelled | |
Distribution of cash dividends or other cash distributions (e.g., upon a sale of rights and other entitlements) | Up to US$0.05 per ADS held | |
Distribution of ADSs pursuant to (i) stock dividends or other free stock distributions, or (ii) exercise of rights to purchase additional ADSs | Up to US$0.05 per ADS held | |
Distribution of securities other than ADSs or rights to purchase additional ADSs (e.g., upon a spin-off) |
Up to US$0.05 per ADS held | |
ADS Services | Up to US$0.05 per ADS held on the applicable record date(s) established by the depositary | |
Registration of ADS transfers (e.g., upon a registration of the transfer of registered ownership of ADSs, upon a transfer of ADSs into DTC and vice versa, |
Up to US$0.05 per ADS (or fraction thereof) transferred | |
Conversion of ADSs of one series for ADSs of another series (e.g., upon conversion of Partial Entitlement ADSs for Full Entitlement ADSs, or upon conversion of Restricted ADSs (each as defined in the Deposit Agreement) into freely transferable ADSs, and vice versa). | Up to US$0.05 per ADS (or fraction thereof) converted |
• | taxes (including applicable interest and penalties) and other governmental charges; |
• | the registration fees as may from time to time be in effect for the registration of Class A ordinary shares on the share register and applicable to transfers of Class A ordinary shares to or from the name of the custodian, the depositary or any nominees upon the making of deposits and withdrawals, respectively; |
• | certain cable, telex and facsimile transmission and delivery expenses; |
• | the fees, expenses, spreads, taxes and other charges of the depositary and/or service providers (which may be a division, branch or affiliate of the depositary) in the conversion of foreign currency; |
• | the reasonable and customary out-of-pocket |
• | the fees, charges, costs and expenses incurred by the depositary, the custodian, or any nominee in connection with the ADR program. |
2020 |
2021 |
|||||||||||||||
(in thousands) |
||||||||||||||||
Audit fees (1) |
US$ | 768 | US$ | 1,967 | ||||||||||||
All other fees (2) |
US$ | 27 | US$ | — |
(1) | “Audit fees” means the aggregate fees billed in each of the fiscal years listed for professional services rendered by our principal auditors for the audit of our annual financial statements and assistance with and review of documents filed with the SEC. In 2020 and 2021, the audit refers to financial audit. |
(2) | “All other fees” means the aggregate fees billed in each of the fiscal years listed for professional services rendered by our principal auditors associated with certain permitted tax services. |
Period |
(a) Total Number of ADSs Purchased |
(b) Average Price Paid per ADS (US$) |
(c) Total Number of ADSs Purchased as Part of Publicly Announced Plans or Programs |
(d) Maximum Dollar Value of ADSs that May Yet be Purchased Under the Plans or Programs (US$ in thousands) |
||||||||||||
September 1 – September 30, 2021 |
492,496 | 2.78 | 492,496 | 48,630 | ||||||||||||
October 1 – October 31, 2021 |
— | N/A | 492,496 | 48,630 | ||||||||||||
November 1 – November 30, 2021 |
— | N/A | 492,496 | 48,630 | ||||||||||||
December 1 – December 31, 2021 |
868,127 | 1.39 | 1,360,623 | 47,421 | ||||||||||||
January 1 – January 31, 2022 |
246,768 | 1.39 | 1,607,391 | 47,078 | ||||||||||||
February 1 – February 28, 2022 |
566,891 | 1.58 | 2,174,282 | 46,182 | ||||||||||||
March 1 – March 31, 2022 |
912,140 | 1.38 | 3,086,422 | 44,924 | ||||||||||||
|
|
|
|
|
|
|
|
|||||||||
Total |
3,086,422 |
1.64 |
3,086,422 |
N/A | ||||||||||||
|
|
|
|
|
|
|
|
Item 17. |
Financial Statements |
Item 18. |
Financial Statements |
Item 19. |
Exhibits |
* | Filed with this Annual Report on Form 20-F. |
** | Furnished with this Annual Report on Form 20-F. |
Waterdrop Inc. | ||||
By: | /s/ Peng Shen | |||
Name: | Peng Shen | |||
Title: | Chairman of the Board of Directors and Chief Executive Office |
PAGE | ||||
F-2 |
||||
F-3 |
||||
F-6 |
||||
F-7 |
||||
F-8 |
||||
F-10 |
||||
F-52 |
As of December 31, |
||||||||||||
2020 |
2021 |
|||||||||||
RMB |
RMB |
USD |
||||||||||
(Note 2) |
||||||||||||
Assets |
||||||||||||
Current assets |
||||||||||||
Cash and cash equivalents |
1,061,962 | 817,719 | 128,318 | |||||||||
Restricted cash |
261,387 | 667,664 | 104,771 | |||||||||
Short-term investments |
1,193,160 | 1,969,362 | 309,036 | |||||||||
Accounts receivable |
539,791 | 643,843 | 101,033 | |||||||||
Current contract assets |
824,544 | 563,611 | 88,443 | |||||||||
Amount due from related parties |
813 | 1,049 | 165 | |||||||||
Prepaid expense and other assets |
651,080 | 369,794 | 58,027 | |||||||||
|
|
|
|
|
|
|||||||
Total current assets |
4,532,737 |
5,033,042 |
789,793 |
|||||||||
|
|
|
|
|
|
|||||||
Non-current assets |
||||||||||||
Non-current contract assets |
24,006 | 29,889 | 4,690 | |||||||||
Property, equipment and software, net |
28,724 | 44,762 | 7,024 | |||||||||
Intangible assets, net |
53,034 | 56,753 | 8,906 | |||||||||
Long-term investments |
2,741 | 11,812 | 1,854 | |||||||||
Right of use assets, net |
60,694 | 59,081 | 9,271 | |||||||||
Deferred tax assets |
— | 11,840 | 1,858 | |||||||||
Goodwill |
3,119 | 3,420 | 537 | |||||||||
Total non-current assets |
172,318 |
217,557 |
34,140 |
|||||||||
|
|
|
|
|
|
|||||||
Total assets |
4,705,055 |
5,250,599 |
823,933 |
|||||||||
|
|
|
|
|
|
As of December 31, |
||||||||||||
2020 |
2021 |
|||||||||||
RMB |
RMB |
USD |
||||||||||
(Note 2) |
||||||||||||
Liabilities, Mezzanine Equity and Shareholders’ (Deficit)/Equity |
||||||||||||
Current liabilities |
||||||||||||
Amount due to related parties (including amounts of the consolidated VIEs and subsidiaries of VIEs without recourse to the Company of RMB nil and RMB nil as of December 31, 2020 and 2021, respectively) |
9,789 | 20,449 | 3,209 | |||||||||
Insurance premium payables (including amounts of the consolidated VIEs and subsidiaries of VIEs without recourse to the Company of RMB respectively) |
607,326 | 685,028 | 107,496 | |||||||||
Deferred revenue (including amounts of the consolidated VIEs and subsidiaries of VIEs without recourse to the Company of RMB 22,017 and RMB 803 as of December 31, 2020 and 2021, respectively) |
22,017 | 803 | 126 | |||||||||
Accrued expenses and other current liabilities (including amounts of the consolidated VIEs and subsidiaries of VIEs without recourse to the Company of RMB 447,211 and RMB 413,438 as of December 31, 2020 and 2021, respectively) |
595,606 | 498,752 | 78,265 | |||||||||
Current lease liabilities (including amounts of the consolidated VIEs and subsidiaries of VIEs without recourse to the Company of RMB 10,594 and RMB 16,452 as of December 31, 2020 and 2021, respectively) |
36,551 | 44,113 | 6,922 | |||||||||
|
|
|
|
|
|
|||||||
Total current liabilities |
1,271,289 |
1,249,145 |
196,018 |
|||||||||
|
|
|
|
|
|
|||||||
Non-current liabilities |
||||||||||||
Non-current lease liabilities (including amounts of the consolidated VIEs and subsidiaries of VIEs without recourse to the Company of RMB 8,181 and RMB 12,921 as of December 31, 2020 and 2021, respectively) |
27,709 | 14,477 | 2,272 | |||||||||
Deferred tax liabilities (including amounts of the consolidated VIEs and subsidiaries of VIEs without recourse to the Company of RMB 225,320 and RMB 13,126 as of December 31, 2020 and 2021, respectively) |
225,745 | 13,551 | 2,126 | |||||||||
Total non-current liabilities |
253,454 |
28,028 |
4,398 |
|||||||||
|
|
|
|
|
|
|||||||
Total liabilities |
1,524,743 |
1,277,173 |
200,416 |
|||||||||
|
|
|
|
|
|
As of December 31, |
||||||||||||
2020 |
2021 |
|||||||||||
RMB |
RMB |
USD |
||||||||||
(Note 2) |
||||||||||||
Liabilities, Mezzanine Equity and Shareholders’ (Deficit)/Equity (Continued) |
||||||||||||
Commitments and contingencies (Note 20) |
||||||||||||
Mezzanine equity |
||||||||||||
Series Pre-A convertible redeemable preferred shares (US$0.000005 par value per share; 241,148,000 and nil shares authorized, issued and outstanding as of December 31, 2020 and 2021, respectively) |
56,185 | — | — | |||||||||
Series A convertible redeemable preferred shares (US$ 0.000005 par value per share; 334,926,000 and nil shares authorized, issued and outstanding as of December 31, 2020 and 2021, respectively) |
129,323 | — | — | |||||||||
Series A+ convertible redeemable preferred shares (US$ 0.000005 par value per share; 157,896,000 and nil shares authorized, issued and outstanding as of December 31, 2020 and 2021, respectively) |
77,520 | — | — | |||||||||
Series B convertible redeemable preferred shares (US$ 0.000005 par value per share; 352,107,646 and nil shares authorized, issued and outstanding as of December 31, 2020 and 2021, respectively) |
497,106 | — | — | |||||||||
Series C convertible redeemable preferred shares (US$ 0.000005 par value per share; 542,794,072 and nil shares authorized, issued and outstanding as of December 31, 2020 and 2021, respectively) |
1,222,224 | — | — | |||||||||
Series C+ convertible redeemable preferred shares (US$ 0.000005 par value per share; 170,632,018 and nil shares authorized, issued and outstanding as of December 31, 2020 and 2021, respectively) |
490,571 | — | — | |||||||||
Series C++ convertible redeemable preferred shares (US$ 0.000005 par value per share; 120,971,053 and nil shares authorized, issued and outstanding as of December 31, 2020 and 2021, respectively) |
388,925 | — | — | |||||||||
Series D convertible redeemable preferred shares (US$ 0.000005 par value per share; 517,264,501 and nil shares authorized, issued and outstanding as of December 31, 2020 and 2021, respectively) |
1,975,482 | — | — | |||||||||
|
|
|
|
|
|
|||||||
Total mezzanine equity |
4,837,336 |
— |
— |
|||||||||
|
|
|
|
|
|
|
||||||
Shareholders’ (deficit)/equity |
||||||||||||
Ordinary shares (US$ 0.000005 par value; 10,000,000,000 shares authorized, 1,203,526,000 shares issued and outstanding as of December 31, 2020; 8,900,000,000 Class A ordinary shares authorized, 3,206,653,701 Class A ordinary shares issued, 3,140,896,631 Class A ordinary shares outstanding as of December 31, 2021; 1,000,000,000 Class B ordinary shares authorized, 801,904,979 Class B ordinary shares issued and outstanding as of December 31, 2021) |
41 | 134 | 21 | |||||||||
Additional paid-in capital |
— | 7,329,420 | 1,150,146 | |||||||||
Accumulated other comprehensive income/(loss) |
14,956 | (21,492 | ) | (3,373 | ) | |||||||
Accumulated deficit |
(1,672,021 | ) | (3,334,636 | ) | (523,277 | ) | ||||||
|
|
|
|
|
|
|||||||
Total shareholders’ (deficit)/equity |
(1,657,024 |
) |
3,973,426 |
623,517 |
||||||||
|
|
|
|
|
|
|||||||
Total liabilities, mezzanine equity and shareholders’ (deficit)/equity |
4,705,055 |
5,250,599 |
823,933 |
|||||||||
|
|
|
|
|
|
Year Ended December 31, |
||||||||||||||||
2019 |
2020 |
2021 |
||||||||||||||
RMB |
RMB |
RMB |
USD |
|||||||||||||
(Note 2) |
||||||||||||||||
Operating revenue, net |
1,510,965 |
3,027,948 |
3,205,914 |
503,078 |
||||||||||||
|
|
|
|
|
|
|
|
|||||||||
Operating costs and expenses |
||||||||||||||||
Operating costs |
(291,310 | ) | (742,258 | ) | (1,054,475 | ) | (165,470 | ) | ||||||||
Sales and marketing expenses |
(1,056,494 | ) | (2,130,535 | ) | (3,104,769 | ) | (487,206 | ) | ||||||||
General and administrative expenses |
(142,995 | ) | (407,171 | ) | (530,522 | ) | (83,250 | ) | ||||||||
Research and development expenses |
(214,646 | ) | (244,230 | ) | (378,990 | ) | (59,472 | ) | ||||||||
|
|
|
|
|
|
|
|
|||||||||
Total operating costs and expenses |
(1,705,445 |
) |
(3,524,194 |
) |
(5,068,756 |
) |
(795,398 |
) | ||||||||
|
|
|
|
|
|
|
|
|||||||||
Operating loss |
(194,480 |
) |
(496,246 |
) |
(1,862,842 |
) |
(292,320 |
) | ||||||||
|
|
|
|
|
|
|
|
|||||||||
Other income/(expenses) |
||||||||||||||||
Interest income |
10,533 | 26,515 | 48,662 | 7,636 | ||||||||||||
Fair value change of warrant |
— | (150,685 | ) | — | — | |||||||||||
Foreign currency exchange gain/(loss) |
4,152 | (1,335 | ) | 9,349 | 1,467 | |||||||||||
Others, net |
817 | 8,052 | 9,764 | 1,532 | ||||||||||||
|
|
|
|
|
|
|
|
|||||||||
Loss before income tax, and share of results of equity method investee |
(178,978 |
) |
(613,699 |
) |
(1,795,067 |
) |
(281,685 |
) | ||||||||
|
|
|
|
|
|
|
|
|||||||||
Income tax (expense)/bebefit |
(142,528 | ) | (50,155 | ) | 220,987 | 34,678 | ||||||||||
Share of results of equity method investee |
(29 | ) | (15 | ) | — | — | ||||||||||
|
|
|
|
|
|
|
|
|||||||||
Net loss attributable to Waterdrop Inc. |
(321,535 |
) |
(663,869 |
) |
(1,574,080 |
) |
(247,007 |
) | ||||||||
|
|
|
|
|
|
|
|
|||||||||
Deemed dividend on modification on preferred shares |
— | (67,975 | ) | — | — | |||||||||||
Deemed dividend upon issuance of warrants |
— | (90,268 | ) | — | — | |||||||||||
Preferred shares redemption value accretion |
(136,839 | ) | (285,668 | ) | (152,287 | ) | (23,897 | ) | ||||||||
|
|
|
|
|
|
|
|
|||||||||
Net loss attributable to ordinary shareholders |
(458,374 |
) |
(1,107,780 |
) |
(1,726,367 |
) |
(270,904 |
) | ||||||||
|
|
|
|
|
|
|
|
|||||||||
Other comprehensive income/(loss): |
||||||||||||||||
Foreign currency translation adjustment |
27,771 | (14,008 | ) | (36,640 | ) | (5,750 | ) | |||||||||
Unrealized gains on available for sale investments, net of tax |
209 | 1,724 | 192 | 30 | ||||||||||||
|
|
|
|
|
|
|
|
|||||||||
Total comprehensive loss |
(293,555 |
) |
(676,153 |
) |
(1,610,528 |
) |
(252,727 |
) | ||||||||
|
|
|
|
|
|
|
|
|||||||||
Weighted average number of ordinary shares used in computing net loss per share |
||||||||||||||||
Basic and diluted |
1,203,526,000 | 1,174,583,516 | 2,990,507,749 | 2,990,507,749 | ||||||||||||
Net loss per share attributable to ordinary shareholders |
||||||||||||||||
Basic and diluted |
(0.38 | ) | (0.94 | ) | (0.58 | ) | (0.09 | ) |
Ordinary shares |
Treasury stock |
Additional paid-in capital |
Accumulated other comprehensive income/(loss) |
Accumulated deficit |
Total shareholders’ (deficit)/equity |
|||||||||||||||||||||||||||
Number |
Amount |
Number |
Amount |
|||||||||||||||||||||||||||||
RMB |
RMB |
RMB |
RMB |
RMB |
RMB |
|||||||||||||||||||||||||||
Balance at January 1, 2019 |
1,203,526,000 |
41 |
— | — | 38,831 |
(740 |
) |
(338,923 |
) |
(300,791 |
) | |||||||||||||||||||||
Preferred shares redemption value accretion |
— | — | — | — | (63,697 | ) | — | (73,142 | ) | (136,839 | ) | |||||||||||||||||||||
Share-based payment compensation |
— | — | — | — | 24,866 | — | — | 24,866 | ||||||||||||||||||||||||
Net loss for the year |
— | — | — | — | — | — | (321,535 | ) | (321,535 | ) | ||||||||||||||||||||||
Other comprehensive income |
— | — | — | — | — | 27,980 | — | 27,980 | ||||||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||
Balance at December 31, 2019 |
1,203,526,000 |
41 |
— |
— |
— |
27,240 |
(733,600 |
) |
(706,319 |
) | ||||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||
Preferred shares redemption value accretion |
— | — | — | — | (169,359 | ) | — | (116,309 | ) | (285,668 | ) | |||||||||||||||||||||
Share-based payment compensation |
— | — | — | — | 169,359 | — | — | 169,359 | ||||||||||||||||||||||||
Net loss for the year |
— | — | — | — | — | — | (663,869 | ) | (663,869 | ) | ||||||||||||||||||||||
Deemed dividend on modification on preferred shares (Note 16) |
— | — | — | — | — | — | (67,975 | ) | (67,975 | ) | ||||||||||||||||||||||
Deemed dividend upon issuance of warrants (Note 16) |
— | — | — | — | — | — | (90,268 | ) | (90,268 | ) | ||||||||||||||||||||||
Other comprehensive loss |
— | — | — | — | — | (12,284 | ) | — | (12,284 | ) | ||||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||
Balance at December 31, 2020 |
1,203,526,000 |
41 |
— |
— |
— |
14,956 |
(1,672,021 |
) |
(1,657,024 |
) | ||||||||||||||||||||||
Preferred shares redemption value accretion |
— | — | — | — | (63,752 | ) | — | (88,535 | ) | (152,287 | ) | |||||||||||||||||||||
Share-based payment compensation |
— | — | — | — | 283,291 | — | — | 283,291 | ||||||||||||||||||||||||
Issuance of ordinary shares, net of issuance cost of RMB (Note 15) |
300,000,000 | 10 | — | — | 2,133,427 | — | — | 2,133,437 | ||||||||||||||||||||||||
Conver s ion of convertible redeemable preferred shares upon initial public offering (Note 16) |
2,437,739,290 | 83 | — | — | 4,989,540 | — | — | 4,989,623 | ||||||||||||||||||||||||
Share repurchase |
— | — | (13,606,230 | ) | — | * |
(16,546 | ) | — | — | (16,546 | ) | ||||||||||||||||||||
Exercise of share options (Note 17) |
15,142,550 | — | — | — | 3,460 | — | — | 3,460 | ||||||||||||||||||||||||
Net loss for the year |
— | — | — | — | — | — | (1,574,080 | ) | (1,574,080 | ) | ||||||||||||||||||||||
Other comprehensive loss |
— | — | — | — | — | (36,448 | ) | — | (36,448 | ) | ||||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||
Balance at December 31, 2021 |
3,956,407,840 |
134 |
(13,606,230 |
) |
— |
7,329,420 |
(21,492 |
) |
(3,334,636 |
) |
3,973,426 |
|||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
* |
Less than RMB1 thousand |
Year Ended December 31, |
||||||||||||||||
2019 |
2020 |
2021 |
||||||||||||||
RMB |
RMB |
RMB |
USD |
|||||||||||||
(Note 2) |
||||||||||||||||
Cash flows from operating activities: |
||||||||||||||||
Net loss |
(321,535 | ) | (663,869 | ) | (1,574,080 | ) | (247,007 | ) | ||||||||
Adjustments to reconcile net loss to net cash used in operating activities: |
||||||||||||||||
Depreciation of property, equipment and software |
6,687 | 12,892 | 17,906 | 2,810 | ||||||||||||
Amortization of intangible assets |
— | 173 | 186 | 29 | ||||||||||||
Fair value change of warrant |
— | 150,685 | — | — | ||||||||||||
Share of results of equity method investee |
29 | 15 | — | — | ||||||||||||
Share-based compensation expense |
27,996 | 227,828 | 226,161 | 35,490 | ||||||||||||
Loss from disposal of property and equipment |
12 | 178 | 548 | 86 | ||||||||||||
(Gain)/loss from disposals of subsidiaries |
— | (180 | ) | 252 | 40 | |||||||||||
Impairment loss |
— | — | 40,501 | 6,355 | ||||||||||||
Changes in operating assets and liabilities: |
||||||||||||||||
Accounts receivable |
(147,327 | ) | (286,839 | ) | (104,052 | ) | (16,328 | ) | ||||||||
Contract assets |
(528,614 | ) | (230,862 | ) | 255,050 | 40,023 | ||||||||||
Prepaid expense and other assets |
(153,730 | ) | (385,554 | ) | 254,815 | 39,985 | ||||||||||
Amount due from/to related party |
2,671 | 3,918 | 10,424 | 1,636 | ||||||||||||
Deferred revenue |
(12,713 | ) | 347 | (21,214 | ) | (3,329 | ) | |||||||||
Insurance premium payables |
154,254 | 287,089 | 77,702 | 12,193 | ||||||||||||
Deferred tax assets |
— | — | (11,840 | ) | (1,858 | ) | ||||||||||
Deferred tax liabilities |
142,348 | 49,514 | (213,121 | ) | (33,443 | ) | ||||||||||
Accrued expenses and other current liabilities |
303,361 | 47,400 | (52,025 | ) | (8,164 | ) | ||||||||||
Right of use assets, net |
(49,197 | ) | (10,974 | ) | 1,613 | 253 | ||||||||||
Operating lease liabilities |
42,863 | 21,131 | (5,478 | ) | (860 | ) | ||||||||||
|
|
|
|
|
|
|
|
|||||||||
Net cash used in operating activities |
(532,895 |
) |
(777,108 |
) |
(1,096,652 |
) |
(172,089 |
) | ||||||||
|
|
|
|
|
|
|
|
|||||||||
Cash flows from investing activities: |
||||||||||||||||
Purchase of property, equipment and software. |
(13,267 | ) | (26,709 | ) | (35,659 | ) | (5,595 | ) | ||||||||
Disposal of property, equipment and software |
— | — | 27 | 4 | ||||||||||||
Purchase of intangible assets |
— | — | (816 | ) | (128 | ) | ||||||||||
Purchase of short-term investments |
(528,719 | ) | (1,282,428 | ) | (13,054,640 | ) | (2,048,558 | ) | ||||||||
Proceeds from maturity of short-term investments |
503,260 | 110,000 | 12,253,325 | 1,922,814 | ||||||||||||
Purchase of long-term investments |
(2,072 | ) | — | (9,900 | ) | (1,554 | ) | |||||||||
Acquisitions of subsidiaries, net of cash acquired |
(5,070 | ) | (28,710 | ) | 765 | 120 | ||||||||||
Disposal of subsidiaries, net of cash disposed |
— | 8,355 | — | — | ||||||||||||
Loans to related parties |
(1,220 | ) | (1 | ) | — | — | ||||||||||
Repayment of loans to related parties |
1,133 | 1,792 | — | — | ||||||||||||
|
|
|
|
|
|
|
|
|||||||||
Net cash used in investing activities |
(45,955 |
) |
(1,217,701 |
) |
(846,898 |
) |
(132,897 |
) | ||||||||
|
|
|
|
|
|
|
|
Year Ended December 31, |
||||||||||||||||
2019 |
2020 |
2021 |
||||||||||||||
RMB |
RMB |
RMB |
USD |
|||||||||||||
(Note 2) |
||||||||||||||||
Cash flows from financing activities: |
||||||||||||||||
Proceeds from issuance of convertible redeemable preferred shares, net |
1,491,983 | 2,048,986 | — | — | ||||||||||||
Proceeds from initial public offering, net of offering cost |
— | — | 2,133,437 | 334,782 | ||||||||||||
Repayment of short-term borrowings |
(19,140 | ) | — | — | — | |||||||||||
Proceeds from exercise of share option |
— | 2,073 | 2,971 | 466 | ||||||||||||
Payment for share repurchase |
— | — | (16,546 | ) | (2,596 | ) | ||||||||||
Principal payments under finance lease obligation |
(68 | ) | (169 | ) | (192 | ) | (30 | ) | ||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net cash provided by financing activities |
1,472,775 |
2,050,890 |
2,119,670 |
332,622 |
||||||||||||
|
|
|
|
|
|
|
|
|||||||||
Effect of exchange rate changes on cash and cash equivalents |
27,342 | (26,884 | ) | (14,086 | ) | (2,209 | ) | |||||||||
|
|
|
|
|
|
|
|
|||||||||
Net increase in cash and cash equivalents and restricted cash |
921,267 |
29,197 |
162,034 |
25,427 |
||||||||||||
|
|
|
|
|
|
|
|
|||||||||
Total cash and cash equivalents and restricted cash at beginning of year |
372,885 |
1,294,152 |
1,323,349 |
207,662 |
||||||||||||
Total cash and cash equivalents and restricted cash at end of year |
1,294,152 |
1,323,349 |
1,485,383 |
233,089 |
||||||||||||
Reconciliation to amounts on consolidated balance sheets: |
||||||||||||||||
Cash and cash equivalents |
964,476 | 1,061,962 | 817,719 | 128,318 | ||||||||||||
Restricted cash |
329,676 | 261,387 | 667,664 | 104,771 | ||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total cash and cash equivalents and restricted cash at end of year |
1,294,152 |
1,323,349 |
1,485,383 |
233,089 |
||||||||||||
Supplemental disclosure of cash flow information |
||||||||||||||||
Cash paid for interest |
311 | — | — | — | ||||||||||||
Cash paid for income tax |
149 | 704 | 2,532 | 397 | ||||||||||||
Supplemental disclosure of non-cash investing and financing activities |
||||||||||||||||
Accrued expenses and other current liabilities related to purchase of property and equipment |
7,507 | 1,203 | 71 | 11 | ||||||||||||
Accrued expenses and other current liabilities related to acquisitions of subsidiaries |
612 | — | — | — | ||||||||||||
Issuance of preferred share upon conversion of warrant |
— | 226,876 | — | — |
1. |
Principal activities and reorganization |
(a) |
History and Reorganization |
1. |
Principal activities and reorganization (continued) |
(a) |
History and Reorganization (continued) |
Name of Company |
Date of Incorporation/ Establishment |
Place of Incorporation/ Establishment |
Percentage Of Direct or Indirect Economic Interest |
Principal Activities | ||||||||||
Principal Subsidiaries |
||||||||||||||
Waterdrop Group HK Limited (“Waterdrop HK”) |
May 31, 2018 | Hong Kong | 100% | Investment holding | ||||||||||
Absolute Health |
October 17, 2018 | PRC | 100% | Research and development service for the Group | ||||||||||
VIEs and its principal subsidiaries |
||||||||||||||
Zongqing Xiangqian |
August 2, 2013 | PRC | 100% | Operating management service for the Group | ||||||||||
Shuidi Hubao |
December 12, 2016 | PRC | 100% | Medical crowdfunding platform services | ||||||||||
Shuidi Hulian |
December 12, 2016 | PRC | 100% | Mutual aid platform services1 | ||||||||||
Shuidi Insurance Brokerage Co., Ltd |
October 19, 2012 | PRC | 100% | Insurance brokerage services |
1 |
The business was terminated in March, 2021. |
2. |
Summary of Significant Accounting Policies |
(a) |
Basis of Presentation |
(b) |
Basis of Consolidation |
2. |
Summary of Significant Accounting Policies (continued) |
(b) |
Basis of Consolidation (continued) |
2. |
Summary of Significant Accounting Policies (continued) |
(b) |
Basis of Consolidation (continued) |
• | revoke or refuse to grant or renew the Group’s business and operating licenses; |
• | restrict or prohibit related party transactions between the wholly-owned subsidiaries of the Group and the VIEs; |
• | impose fines, confiscate income or other requirements which the Group may find difficult or impossible to comply with; |
• | require the Group to alter, discontinue or restrict its operations; |
• | restrict or prohibit the Group’s ability to finance its operations; |
• | place restrictions on the Group’s right to collect revenues; |
• | shut down the Group’s servers or blocking the Group’s app/websites; or |
• | take other regulatory or enforcement actions against the Group that could be harmful to the Group’s business. |
2. |
Summary of Significant Accounting Policies (continued) |
(b) |
Basis of Consolidation (continued) |
As of December 31, |
||||||||
2020 |
2021 |
|||||||
RMB |
RMB |
|||||||
ASSETS |
||||||||
Current assets |
||||||||
Cash and cash equivalents |
755,941 | 731,189 | ||||||
Restricted cash |
253,557 | 667,664 | ||||||
Short-term investments |
274,390 | 351,451 | ||||||
Accounts receivable |
536,644 | 635,235 | ||||||
Current contract assets |
824,544 | 563,611 | ||||||
Other current assets |
620,710 | 316,489 | ||||||
|
|
|
|
|||||
Total current assets |
3,265,786 |
3,265,639 |
||||||
|
|
|
|
|||||
Non-current assets |
||||||||
Non-current contract assets |
24,006 | 29,889 | ||||||
Intangible assets, net |
49,406 | 53,202 | ||||||
Deferred tax assets |
— | 11,840 | ||||||
Other non-current assets |
33,828 | 57,154 | ||||||
|
|
|
|
|||||
Total non-current assets |
107,240 |
152,085 |
||||||
|
|
|
|
|||||
Total assets |
3,373,026 |
3,417,724 |
||||||
|
|
|
|
|||||
LIABILITIES |
||||||||
Current liabilities |
||||||||
Insurance premium payables |
607,326 | 685,028 | ||||||
Deferred revenue |
22,017 | 803 | ||||||
Accrued expenses and other current liabilities |
447,211 | 413,438 | ||||||
Current lease liabilities |
10,594 | 16,452 | ||||||
|
|
|
|
|||||
Total current liabilities |
1,087,148 |
1,115,721 |
||||||
|
|
|
|
|||||
Total non-current liabilities |
233,501 |
26,047 |
||||||
|
|
|
|
|||||
Total liabilities |
1,320,649 |
1,141,768 |
||||||
|
|
|
|
2. |
Summary of Significant Accounting Policies (continued) |
(b) |
Basis of Consolidation (continued) |
Year Ended December 31, |
||||||||||||
2019 |
2020 |
2021 |
||||||||||
RMB |
RMB |
RMB |
||||||||||
Operating revenue, net |
1,510,965 | 3,013,546 | 3,193,807 | |||||||||
Net income/(loss) |
20,477 | 233,434 | (505,603 | ) | ||||||||
Net cash used in operating activities |
(381,917 | ) | (301,869 | ) | (240,527 | ) | ||||||
Net cash provided by/(used in) investing activities |
75,528 | (277,521 | ) | (99,240 | ) | |||||||
Net cash used in financing activities |
(19,190 | ) | — | — |
(c) |
Use of Estimates |
(d) |
Comprehensive Income and Foreign Currency Translation |
2. |
Summary of Significant Accounting Policies (continued) |
(d) |
Comprehensive Income and Foreign Currency Translation (continued) |
(e) |
Convenience Translation |
(f) |
Cash and Cash Equivalents |
(g) |
Restricted Cash |
(h) |
Short-term Investments |
(i) |
Accounts Receivable |
2. |
Summary of Significant Accounting Policies (continued) |
(i) |
Accounts Receivable (continued) |
(j) |
Fair Value Measurement |
• | Level 1—inputs are based upon unadjusted quoted prices for identical assets or liabilities traded in active markets. |
• | Level 2—inputs are based upon quoted prices for similar assets and liabilities in active markets, quoted prices for identical or similar assets and liabilities in markets that are not active and model-based valuation techniques for which all significant assumptions are observable in the market or can be corroborated by observable market data for substantially the full term of the assets or liabilities. |
• | Level 3—inputs are generally unobservable and typically reflect management’s estimates of assumptions that market participants would use in pricing the asset or liability. The fair value are therefore determined using model based valuation techniques that include option pricing models, discounted cash flow models, and similar techniques. |
(k) |
Financial Instruments |
2. |
Summary of Significant Accounting Policies (continued) |
(l) |
Property, Equipment and Software, Net |
(m) |
Intangible Assets, Net |
(n) |
Asset Acquisition |
(o) |
Long-Term Investments |
2. |
Summary of Significant Accounting Policies (continued) |
(o) |
Long-Term Investments (continued) |
(p) |
Short-Term Borrowings |
(q) |
Insurance Premium Payables |
(r) |
Share-Based Compensation |
2. |
Summary of Significant Accounting Policies (continued) |
(r) |
Share-Based Compensation (continued) |
(s) |
Revenue recognition |
2. |
Summary of Significant Accounting Policies (continued) |
(s) |
Revenue recognition (continued) |
2. |
Summary of Significant Accounting Policies (continued) |
(s) |
Revenue recognition (continued) |
2. |
Summary of Significant Accounting Policies (continued) |
(s) |
Revenue recognition (continued) |
Year Ended December 31, |
||||||||||||
2019 |
2020 |
2021 |
||||||||||
RMB |
RMB |
RMB |
||||||||||
Operating revenue |
||||||||||||
Insurance brokerage income |
||||||||||||
Short-term insurance brokerage income |
1,134,984 | 2,045,191 | 2,037,677 | |||||||||
Long-term insurance brokerage income |
173,192 | 650,129 | 789,790 | |||||||||
|
|
|
|
|
|
|||||||
Subtotal |
1,308,176 | 2,695,320 | 2,827,467 | |||||||||
|
|
|
|
|
|
|||||||
Management fee income |
142,683 | 109,828 | 2,745 | |||||||||
Technical service income |
51,705 | 194,130 | 243,542 | |||||||||
Other revenues |
8,401 | 28,670 | 132,160 | |||||||||
|
|
|
|
|
|
|||||||
Total |
1,510,965 |
3,027,948 |
3,205,914 |
|||||||||
|
|
|
|
|
|
2. |
Summary of Significant Accounting Policies (continued) |
(s) |
Revenue recognition (continued) |
December 31, 2020 |
December 31, 2021 |
|||||||
RMB |
RMB |
|||||||
Contract assets |
848,550 | 593,500 | ||||||
Less: Allowance for uncollectible accounts |
— | — | ||||||
|
|
|
|
|||||
Total |
848,550 |
593,500 |
||||||
|
|
|
|
(t) |
Operating cost |
(u) |
Sales and Marketing Expenses |
(v) |
Research and Development Expenses |
2. |
Summary of Significant Accounting Policies (continued) |
(v) |
Research and Development Expenses (continued) |
(w) |
Taxation |
(x) |
Net Loss Per Share |
(y) |
Leases |
2. |
Summary of Significant Accounting Policies (continued) |
(y) |
Leases (continued) |
(z) |
Significant Risk and Uncertainties |
Year Ended December 31, |
||||||||||||||||||||||||
2019 |
2020 |
2021 |
||||||||||||||||||||||
RMB |
% |
RMB |
% |
RMB |
% |
|||||||||||||||||||
Customer A |
667,376 | 44.17% | 602,985 | 19.91% | 240,650 | 7.51% | ||||||||||||||||||
Customer B |
331,533 | 21.94% | 753,456 | 24.88% | 457,995 | 14.29% | ||||||||||||||||||
Customer C |
52,754 | 3.49% | 335,514 | 11.08% | 367,434 | 11.46% | ||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||
1,051,663 |
69.60% |
1,691,955 |
55.87% |
1,066,079 |
33.26% |
|||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
As of December 31, |
||||||||||||||||
2020 |
2021 |
|||||||||||||||
RMB |
% |
RMB |
% |
|||||||||||||
Customer A |
258,060 | 18.59% | 134,292 | 10.85% | ||||||||||||
Customer B |
411,637 | 29.65% | 190,284 | 15.38% | ||||||||||||
Customer C |
118,887 | 8.56% | 109,676 | 8.86% | ||||||||||||
|
|
|
|
|
|
|
|
|||||||||
788,584 |
56.80% |
434,252 |
35.09% |
|||||||||||||
|
|
|
|
|
|
|
|
2. |
Summary of Significant Accounting Policies (continued) |
(z) |
Significant Risk and Uncertainties (continued) |
(aa) |
Recent Accounting Pronouncements not yet adopted |
3. |
Acquisitions and disposal of subsidiary |
3. |
Acquisitions and disposal of subsidiary (continued) |
As of December 31, |
||||||||
2020 |
2021 |
|||||||
Cash |
5,858 | — | ||||||
Intangible assets-Insurance agency licenses |
35,130 | — | ||||||
Intangible assets- Medical institution license |
— | 3,708 | ||||||
Intangible assets- Trademark and software copyright |
— | 98 | ||||||
Total assets acquired |
40,988 |
3,806 |
||||||
Deferred tax liabilities |
(8,630 | ) | (927 | ) | ||||
Accrued expenses and other current liabilities |
— | (816 | ) | |||||
Total liabilities assumed |
(8,630 |
) |
(1,743 |
) | ||||
Net assets acquired |
32,358 |
2,063 |
4. |
Short-term Investments |
As of December 31, |
||||||||
2020 |
2021 |
|||||||
RMB |
RMB |
|||||||
Held-to-maturity |
195,878 | 1,360,304 | ||||||
Available-for-sale |
997,282 | 609,058 | ||||||
Total |
1,193,160 |
1,969,362 |
||||||
5. |
Prepaid Expense and Other Assets |
As of December 31, |
|||||||||
2020 |
2021 |
||||||||
RMB |
RMB |
||||||||
Fund receivable from external payment network providers (1) |
435,816 | 87,609 | |||||||
Advances to suppliers |
115,135 | 162,136 | |||||||
Prepayments and deposits |
58,220 | 65,200 | |||||||
Value-added tax recoverable |
12,053 | 33,688 | |||||||
Claims receivable on behalf of insurers |
11,410 | 33,870 | |||||||
Others |
18,446 | 26,291 | |||||||
Total |
651,080 |
408,794 |
|||||||
Less: impairment provision (2) |
— | (39,000 | ) | ||||||
Prepaid expense and other assets, net |
651,080 |
369,794 |
|||||||
(1) | The Group opened accounts with external online payment service providers to collect and transfer insurance premiums to insurance companies, as well as to collect donor’s donation and mutual aid funds prior to transferring them to custodian bank. The balance of funds receivable from external payment network providers mainly includes accumulated amounts of donation, mutual aid fund received at the balance sheet date, which were subsequently transferred to the Group’s bank accounts or custodian accounts if they related to donor’s donations. The balance also includes insurance premium collected by the Group on behalf of insurance companies but not yet transferred to the insurance companies deposited in accounts of external online payment service providers. The amount w settled shortly after year end. as |
(2) | Impairme A provision of RMB39,000 was provided over prepayment, which was recorded in general and administrative expenses for the year ended December 31, nt provision for the y e ars ended December 31, 2020 and 2021 re RMB nil and RMB 39,000 respectively. 2021 . |
6. |
Fair Value of Assets and Liabilities |
December 31, 2020 |
Level 1 |
Level 2 |
Level 3 |
Balance at Fair Value |
||||||||||||
RMB |
RMB |
RMB |
RMB |
|||||||||||||
Assets |
||||||||||||||||
Available for sale investments |
— | 997,282 | — | 997,282 | ||||||||||||
Total Assets |
— |
997,282 |
— |
997,282 |
||||||||||||
Liabilities |
||||||||||||||||
Share-based compensation liabilities |
— | — | 58,213 | 58,213 | ||||||||||||
Total Liabilities |
— |
— |
58,213 |
58,213 |
||||||||||||
6. |
Fair Value of Assets and Liabilities (continued) |
December 31, 2021 |
Level 1 |
Level 2 |
Level 3 |
Balance at Fair Value |
||||||||||||
RMB |
RMB |
RMB |
RMB |
|||||||||||||
Assets |
||||||||||||||||
Available-for-sale investments |
— | 609,058 | — | 609,058 | ||||||||||||
|
|
|
|
|
|
|
|
|||||||||
Total Assets |
— |
609,058 |
— |
609,058 |
||||||||||||
|
|
|
|
|
|
|
|
Share-based compensation liabilities |
||||
Balance as of December 31, 2019 |
3,153 |
|||
Changes in estimated fair value |
7,037 | |||
Addition in share-based compensation liabilities |
48,023 | |||
|
|
|||
Balance as of December 31, 2020 |
58,213 |
|||
|
|
|||
Changes in estimated fair value |
74,178 | |||
Addition in share-based compensation liabilities |
4,762 | |||
Foreign currency translation adjustment |
(1,081 | ) | ||
Reclassification of share-based compensation liabilities to equity |
(136,072 | ) | ||
|
|
|||
Balance as of December 31, 2021 |
— |
|||
|
|
Financial instrument |
Unobservable Input |
Inputs as of December 31, 2020 | ||
Share-based compensation liabilities |
Risk free rate of interest | 2.33% | ||
Volatility | 24.73% | |||
Dividend yield | — | |||
Life of options | 4 months | |||
Fair value of underlying ordinary shares | $0.55 |
7. |
Property, Equipment and Software, Net |
As of December 31, |
||||||||
2020 |
2021 |
|||||||
RMB |
RMB |
|||||||
Computer and electronic equipment |
19,138 | 26,853 | ||||||
Office furniture and equipment |
866 | 1,121 | ||||||
Leasehold improvements |
22,156 | 32,053 | ||||||
Software |
8,419 | 22,685 | ||||||
|
|
|
|
|||||
Total |
50,579 |
82,712 |
||||||
Less: accumulated depreciation |
(21,855 | ) | (37,950 | ) | ||||
|
|
|
|
|||||
Property, equipment and software, net |
28,724 |
44,762 |
||||||
|
|
|
|
8. |
Intangible Assets, Net |
As of December 31, |
||||||||
2020 |
2021 |
|||||||
RMB |
RMB |
|||||||
Brokerage licenses |
14,558 | 14,558 | ||||||
Insurance adjusting license |
2,293 | 2,293 | ||||||
Insurance agency license |
35,130 | 35,130 | ||||||
Trademark and software copyright |
1,226 | 2,142 | ||||||
Medical institution license |
— | 3,708 | ||||||
|
|
|
|
|||||
Total |
53,207 |
57,831 |
||||||
|
|
|
|
|||||
Less: Accumulated amortization |
(173 | ) | (361 | ) | ||||
Less: Impairment |
— | (717 | ) | |||||
|
|
|
|
|||||
Intangible assets, net |
53,034 |
56,753 |
||||||
|
|
|
|
9. |
Long-Term Investments |
Equity securities without readily determinable fair value |
Equity Method |
Total |
||||||||||
RMB |
RMB |
RMB |
||||||||||
Balances at January 1, 2019 |
1,784 |
890 |
2,674 |
|||||||||
Additions |
2,089 | — | 2,089 | |||||||||
Share of results of equity method investee |
— | (29 | ) | (29 | ) | |||||||
|
|
|
|
|
|
|||||||
Balances at December 31, 2019 |
3,873 |
861 |
4,734 |
|||||||||
|
|
|
|
|
|
|||||||
Share of results of equity method investee |
— | (15 | ) | (15 | ) | |||||||
Disposal |
(1,000 | ) | (846 | ) | (1,846 | ) | ||||||
Foreign currency translation adjustment |
(132 | ) | — | (132 | ) | |||||||
|
|
|
|
|
|
|||||||
Balances at December 31, 2020 |
2,741 |
— |
2,741 |
|||||||||
|
|
|
|
|
|
|||||||
Additions |
9,900 | — | 9,900 | |||||||||
Impairment |
(784 | ) | — | (784 | ) | |||||||
Foreign currency translation adjustment |
(45 | ) | — | (45 | ) | |||||||
Balances at December 31, 2021 |
11,812 |
— |
11,812 |
10. |
Accrued Expenses and Other Current Liabilities |
As of December 31, |
||||||||
2020 |
2021 |
|||||||
RMB |
RMB |
|||||||
Accrued marketing and customer service expenses (1) |
253,118 | 87,071 | ||||||
Payable related to mutual aid plans and medical crowdfunding (2) |
43,636 | 121,561 | ||||||
Payroll and welfare payable |
118,691 | 184,903 | ||||||
Tax payable |
13,537 | 22,020 | ||||||
Payable related to services fee |
46,884 | 43,889 | ||||||
Share-based compensation liabilities |
58,213 | — | ||||||
Advance from customer (3) |
15,301 | — | ||||||
Others |
46,226 | 39,308 | ||||||
|
|
|
|
|||||
Total |
595,606 |
498,752 |
||||||
|
|
|
|
(1) |
Amount represents the accrued channel cost and customer service expense payable to third-party companies. |
10. |
Accrued Expenses and Other Current Liabilities (continued) |
(2) |
Amount represents the fund collected through the third-party external payment network providers that have not transferred to the custodian bank and the accrued payable for medical expense and one-year health insurance related to termination of mutual aid. The accrued payable for medical expense and one-year health insurance related to termination of mutual aid as of the year ended December 31, 2020 and 2021 are RMB nil and RMB 71,609, respectively. See note 5 for disclosure related to fund receivable from third-party external payment network providers. |
(3) |
Amount represents the membership fee received from the participants related to the upgraded mutual aid plan. The amount is refundable during the initial waiting period and recorded as advance from customers. Advance s from customers for the year ended December 31, 2021 were RMB nil due to the termination of the Waterdrop Mutual Aid business by the end of March 2021. |
11. |
Segment Information |
12. |
Employee Benefits |
13. |
Related Party Balances and Transactions |
Entity or individual name |
Relationship with the Group | |
Shen Peng | Chief Executive Officer and the Founder | |
Tencent Holdings Limited and its subsidiaries (“Tencent Group”) | Shareholder of the Group |
13. |
Related Party Balances and Transactions (continued) |
(1) | Service provided by related parties: |
Year ended December 31, |
||||||||||||
2019 |
2020 |
2021 |
||||||||||
RMB |
RMB |
RMB |
||||||||||
Marketing services from Tencent Group (1) |
— | 187,236 | 487,085 | |||||||||
Payment processing fee to Tencent Group (2) |
77,898 | 34,061 | 37,986 | |||||||||
Others |
15,147 | 26,931 | 45,403 | |||||||||
|
|
|
|
|
|
|||||||
Total |
93,045 |
248,228 |
570,474 |
|||||||||
|
|
|
|
|
|
(1) | The Company entered into a series of cooperation agreements with Tencent Group since 2020. The Company uses Tencent Group as its platform to provide marketing service. |
(2) | The Company entered into a series of agreements with Tencent Group in 2016. The Company uses Tenpay (from Tencent Group) as one of its payment processing platforms to collect cash from insurance policy holders, participa of its mutual aid plan, and users on its medical crowdfunding platform. Tencent Group charges service fee for each transaction processed. n ts |
(2) | Service provided to related parties: |
Year ended December 31, |
||||||||||||
2019 |
2020 |
2021 |
||||||||||
RMB |
RMB |
RMB |
||||||||||
Advertising services to Tencent Group |
— | 844 | 1,988 | |||||||||
|
|
|
|
|
|
|||||||
Total |
— |
844 |
1,988 |
|||||||||
|
|
|
|
|
|
(3) | Amount due from related parties: |
As of December 31, |
||||||||
2020 |
2021 |
|||||||
RMB |
RMB |
|||||||
Tencent Group (1) |
813 | 1,049 | ||||||
|
|
|
|
|||||
Total |
813 |
1,049 |
||||||
|
|
|
|
(1) |
In addition, prepayments of RMB 76,274 and RMB 120,459 were recorded separately as of December 31, 2020 and 2021 under “Prepaid expense and other assets” in relation to the traffic channel service fee paid to Tencent Group, and the balance is amortized based on traffic volume consumed. |
13. |
Related Party Balances and Transactions (continued) |
(4) | Amount due to related parties: |
As of December 31, |
||||||||
2020 |
2021 |
|||||||
RMB |
RMB |
|||||||
Cloud technology services from Tencent Group |
9,789 | 20,449 | ||||||
|
|
|
|
|||||
Total |
9,789 |
20,449 |
||||||
|
|
|
|
14. |
Income Taxes |
Year ended December 31, |
||||||||||||
2019 |
2020 |
2021 |
||||||||||
RMB |
RMB |
RMB |
||||||||||
Current income tax |
181 | 641 | 3,974 | |||||||||
Deferred income tax |
142,347 | 49,514 | (224,961 | ) | ||||||||
|
|
|
|
|
|
|||||||
Income tax expense/(benefit) |
142,528 |
50,155 |
(220,987 |
) | ||||||||
|
|
|
|
|
|
14. |
Income Taxes (continued) |
For the Year ended December 31, |
||||||||||||
2019 |
2020 |
2021 |
||||||||||
RMB |
RMB |
RMB |
||||||||||
Loss before income tax |
(178,978 | ) | (613,699 | ) | (1,795,067 | ) | ||||||
Tax benefit at EIT tax rate of 25% (1) |
(44,745 | ) | (153,425 | ) | (448,767 | ) | ||||||
Expenses not deductible for tax purposes |
23,199 | 65,034 | 52,051 | |||||||||
Research and development super deduction |
(10,343 | ) | (44,143 | ) | (37,492 | ) | ||||||
Effect of different tax rates of subsidiaries operating in other jurisdictions |
376 | 37,673 | 4,149 | |||||||||
Effect of PRC preferential tax rates |
— | — | 52,502 | |||||||||
Changes in valuation allowance |
174,041 | 145,016 | 156,570 | |||||||||
|
|
|
|
|
|
|||||||
Income tax expense/(benefit) |
142,528 |
50,155 |
(220,987 |
) | ||||||||
|
|
|
|
|
|
(1) | The Group’s major operations during the years ended December 31, 2019, 2020 and 2021 were conducted in PRC, and thus all losses were attributable to the Group’s operations in the PRC (or foreign operation). Accordingly, the Group prepared its tax rate reconciliation starting with the PRC statutory tax rate during the years ended December 31, 2019, 2020 and 2021. |
As of December 31, |
||||||||
2020 |
2021 |
|||||||
RMB |
RMB |
|||||||
Deferred tax assets |
||||||||
Deductible advertising expenses exceeding the tax limit (2) |
31,351 | 45,438 | ||||||
Accrued expenses |
16,504 | 41,458 | ||||||
Other deductible expenses exceeding the tax limit (2) |
300 | 427 | ||||||
Provisions for the prepayments and other non-current assets |
— | 10,125 | ||||||
Operating loss carry forward |
361,627 | 579,821 | ||||||
Less: valuation allowances |
(390,833 | ) | (499,090 | ) | ||||
|
|
|
|
|||||
Total deferred tax assets |
18,949 | 178,179 |
||||||
|
|
|
|
|||||
Deferred tax liabilities |
||||||||
Intangible assets |
12,623 | 13,551 | ||||||
Contract assets |
212,138 | 148,375 | ||||||
Advance from customer |
19,933 | 17,964 | ||||||
|
|
|
|
|||||
Total deferred tax liabilities |
244,694 | 179,890 |
||||||
|
|
|
|
As of December 31, |
||||||||
2020 |
2021 |
|||||||
RMB |
RMB |
|||||||
Classification in the consolidated balance sheets: |
||||||||
Deferred tax assets |
— | 11,840 | ||||||
Deferred tax liabilities |
225,745 | 13,551 |
14. |
Income Taxes (continued) |
As of December 31, |
||||||||
2020 |
2021 |
|||||||
RMB |
RMB |
|||||||
Balance at the beginning of the year |
245,817 | 390,833 | ||||||
Additions |
165,581 | 153,780 | ||||||
Reversals |
(20,565 | ) | (45,523 | ) | ||||
|
|
|
|
|||||
Balance at end of the year |
390,833 |
499,090 |
||||||
|
|
|
|
(2) | Deferred income tax assets are recognized for advertising expenses and other deductible expenses that exceeds the tax deduction limit in a particular tax year to the extent that the realization of the related tax benefits through future taxable income is probable. Advertising expenses carry-forwards are permanently available for use by the Group. Other deductible expenses (mainly charitable donations) carry forwards generally expire within 3 years. |
14. |
Income Taxes (continued) |
15. |
Ordinary Shares |
16. |
Convertible Redeemable Preferred Shares |
16. |
Convertible Redeemable Preferred Shares (continued) |
16. |
Convertible Redeemable Preferred Shares (continued) |
16. |
Convertible Redeemable Preferred Shares (continued) |
16. |
Convertible Redeemable Preferred Shares (continued) |
Series Pre-A |
Series A |
Series A+ |
Series B |
Series C |
Series C+ |
Series C++ |
Series D |
Total |
||||||||||||||||||||||||||||
RMB |
RMB |
RMB |
RMB |
RMB |
RMB |
RMB |
||||||||||||||||||||||||||||||
Balances as of January 1, 2019 |
48,122 | 110,806 | 66,447 | 353,634 | — | — | — | — | 579,009 | |||||||||||||||||||||||||||
Settlement of Series B convertible redeemable preferred shares subscription receivable |
— | — | — | 72,201 | — | — | — | — | 72,201 | |||||||||||||||||||||||||||
Issuance of convertible redeemable preferred shares |
— | — | — | — | 993,777 | 426,005 | — | — | 1,419,782 | |||||||||||||||||||||||||||
Accretion on convertible redeemable preferred shares to redemption value |
3,877 | 8,902 | 5,324 | 34,265 | 76,981 | 7,490 | — | — | 136,839 | |||||||||||||||||||||||||||
Balances as of December 31, 2019 |
51,999 | 119,708 | 71,771 | 460,100 | 1,070,758 | 433,495 | — | — | 2,207,831 | |||||||||||||||||||||||||||
Issuance of convertible redeemable preferred shares |
— | — | — | — | — | — | 349,480 | 1,699,506 | 2,048,986 | |||||||||||||||||||||||||||
Deemed dividend on modification on preferred shares |
— | — | — | — | 42,696 | 13,607 | 11,672 | — | 67,975 | |||||||||||||||||||||||||||
Exercise of warrant |
— | — | — | — | — | — | — | 226,876 | 226,876 | |||||||||||||||||||||||||||
Accretion on convertible redeemable preferred shares to redemption value |
4,186 | 9,615 | 5,749 | 37,006 | 108,770 | 43,469 | 27,773 | 49,100 | 285,668 | |||||||||||||||||||||||||||
Balances as of December 31, 2020 |
56,185 |
129,323 |
77,520 |
497,106 |
1,222,224 |
490,571 |
388,925 |
1,975,482 |
4,837,336 |
|||||||||||||||||||||||||||
Accretion on convertible redeemable preferred shares to redemption value |
1,561 | 3,585 | 2,144 | 13,797 | 41,303 | 16,507 | 13,025 | 60,365 | 152,287 | |||||||||||||||||||||||||||
Converted into ordinary shares 1 |
(57,746 | ) | (132,908 | ) | (79,664 | ) | (510,903 | ) | (1,263,527 | ) | (507,078 | ) | (401,950 | ) | (2,035,847 | ) | (4,989,623 | ) | ||||||||||||||||||
Balances as of December 31, 2021 |
— |
— |
— |
— |
— |
— |
— |
— |
— |
|||||||||||||||||||||||||||
1 |
Upon the completion of the initial public offering, all of the Company’s Preferred Share were converted into 2,437,739,290 ordinary shares on an one-to-one basis. |
17. |
Share-Based Compensation |
17. |
Share-Based Compensation (continued) |
Number of shares |
||||
Outstanding as of December 31, 2020 |
12,554,722 | |||
Vested |
12,554,722 | |||
Outstanding as of December 31, 2021 |
— |
17. |
Share-Based Compensation (continued) |
Number of Options |
Weighted Average Exercise Price |
Weighted Average remaining contractual life |
Weighted Average Grant- date Fair Value |
Aggregate Intrinsic Value |
||||||||||||||||
RMB |
RMB |
|||||||||||||||||||
Outstanding as of December 31, 2019 |
146,226,800 |
0.38 |
8.91 |
0.63 |
85,927 |
|||||||||||||||
Granted |
83,521,862 | 0.31 | — |
1.86 | — |
|||||||||||||||
Exercised |
— |
— |
— |
— |
— |
|||||||||||||||
Forfeited |
(12,832,333 | ) | 0.46 | — | 0.63 | — | ||||||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
Outstanding as of December 31, 2020 |
216,916,329 |
0.22 |
8.51 |
1.10 |
255,873 |
|||||||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
Granted |
82,665,350 | 0.51 | — | 4.93 | — | |||||||||||||||
Exercised |
(15,142,550 | ) | 0.41 | — | 1.42 | — | ||||||||||||||
Forfeited |
(37,430,787 | ) | 0.29 | — | 2.41 | — | ||||||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
Outstanding as of December 31, 2021 |
247,008,342 |
0.29 |
7.94 |
2.10 |
543,248 |
|||||||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
Exercisable as of December 31, 2021 |
113,445,534 |
0.20 |
6.98 |
0.85 |
104,682 |
Year ended December 31 |
||||||||
2020 |
2021 |
|||||||
Risk free rate of interest |
2.51%-3.29 |
% | 1.47%-3.20 |
% | ||||
Volatility |
26%-28 |
% | 27%-28 |
% | ||||
Dividend yield |
— | — | ||||||
Exercise multiples |
2.2-2.8 |
2.2-2.8 | ||||||
Life of options (years) |
10 | 10 | ||||||
Fair value of underlying ordinary shares |
$ | 0.17~$0.55 | $0.14~$0.98 |
17. |
Share-Based Compensation (continued) |
(1) | Risk free rate of interest |
(2) | Volatility |
(3) | Dividend yield |
(4) | Exercise multiples |
(5) | Fair value of underlying ordinary shares |
17. |
Share-Based Compensation (continued) |
Year ended December 31, |
||||||||
2020 |
2021 |
|||||||
RMB |
RMB |
|||||||
Sales and marketing expenses |
4,538 | 10,853 | ||||||
General and administrative expenses |
210,011 | 190,252 | ||||||
Research and development expenses |
13,279 | 25,056 | ||||||
|
|
|
|
|||||
227,828 |
226,161 |
|||||||
|
|
|
|
18. |
Net Loss Per Share |
Year ended December 31, |
||||||||||||
2019 |
2020 |
2021 |
||||||||||
RMB |
RMB |
RMB |
||||||||||
Numerator: |
||||||||||||
Net loss for the period attributable to Waterdrop Inc. |
(321,535 | ) | (663,869 | ) | (1,574,080 | ) | ||||||
Deemed dividend |
— | (158,243 | ) | — | ||||||||
Change in redemption value in preferred shares |
(136,839 | ) | (285,668 | ) | (152,287 | ) | ||||||
|
|
|
|
|
|
|||||||
Net loss attributable to ordinary shareholders for computing basic and diluted net loss per ordinary shares |
(458,374 | ) | (1,107,780 | ) | (1,726,367 | ) | ||||||
|
|
|
|
|
|
|||||||
Denominator: |
||||||||||||
Weighted average ordinary shares outstanding used in computing basic and diluted net loss per ordinary shares |
1,203,526,000 | 1,174,583,516 | 2,990,507,749 | |||||||||
Net loss per ordinary share attributable to ordinary shareholders basic and diluted |
(0.38 | ) | (0.94 | ) | (0.58 | ) |
Year ended December 31, |
||||||||||||
2019 |
2020 |
2021 |
||||||||||
RMB |
RMB |
RMB |
||||||||||
Shares issuable upon exercise of share options |
46,239,164 | 140,815,045 | 60,029,916 | |||||||||
Shares issuable upon vesting of nonvested restricted shares |
— | 41,520,896 | 3,983,115 | |||||||||
Shares issuable upon conversion of Series pre-A convertible preferred shares |
241,148,000 | 241,148,000 | 82,811,813 | |||||||||
Shares issuable upon conversion of Series A convertible preferred shares |
334,926,000 | 334,926,000 | 115,015,797 | |||||||||
Shares issuable upon conversion of Series A+ convertible preferred shares |
157,896,000 | 157,896,000 | 54,222,527 | |||||||||
Shares issuable upon conversion of Series B convertible preferred shares |
352,107,646 | 352,107,646 | 120,916,087 | |||||||||
Shares issuable upon conversion of Series C convertible preferred shares |
413,415,759 | 542,794,072 | 186,399,063 | |||||||||
Shares issuable upon conversion of Series C+ convertible preferred shares |
29,919,039 | 170,632,018 | 58,596,160 | |||||||||
Shares issuable upon conversion of Series C++ convertible preferred shares |
— | 95,851,381 | 41,542,257 | |||||||||
Shares issuable upon conversion of Series D convertible preferred shares |
— | 145,205,580 | 177,632,040 |
19. |
Leases |
Year ended December 31, |
||||||||||||
2019 |
2020 |
2021 |
||||||||||
RMB |
RMB |
RMB |
||||||||||
Operating leases-Weighted average remaining lease term |
1.73 | 0.84 | 1.66 | |||||||||
Financing leases-Weighted average remaining lease term |
3.79 | 2.28 | 1.53 | |||||||||
Operating leases-Weighted average discount rate |
7.55 | % | 7.49 | % | 8.04 | % | ||||||
Financing leases-Weighted average discount rate |
9.50 | % | 8.20 | % | 8.39 | % |
Year ended December 31, |
||||||||||||
2019 |
2020 |
2021 |
||||||||||
RMB |
RMB |
RMB |
||||||||||
Operating lease cost |
27,099 | 42,447 | 47,905 | |||||||||
Financing lease cost: |
||||||||||||
Amortization of right-of-use |
60 | 161 | 204 | |||||||||
Interest on lease liabilities |
23 | 33 | 29 | |||||||||
Short-term lease cost |
6,016 | 10,612 | 13,902 | |||||||||
|
|
|
|
|
|
|||||||
Total |
33,198 |
53,253 |
62,040 |
|||||||||
|
|
|
|
|
|
Year ended December 31, |
||||||||||||
2019 |
2020 |
2021 |
||||||||||
RMB |
RMB |
RMB |
||||||||||
Cash paid for operating leases |
33,973 | 31,889 | 50,926 | |||||||||
Cash paid for financing leases: |
||||||||||||
Operating cash flows from finance leases |
5 | 16 | 41 | |||||||||
Financing cash flows from finance leases |
68 | 169 | 192 |
Year ended December 31, |
||||||||||||
2019 |
2020 |
2021 |
||||||||||
RMB |
RMB |
RMB |
||||||||||
Operating leases |
77,453 | 58,329 | 28,021 | |||||||||
Financing leases |
— | 304 | 19 |
19. |
Leases (continued) |
As of December 31, |
||||||||
2021 |
||||||||
Operating Leases |
Financing Leases |
|||||||
RMB |
RMB |
|||||||
2021 |
— | — | ||||||
2022 |
45,795 | 205 | ||||||
2023 |
14,368 | 75 | ||||||
2024 |
2,026 | — | ||||||
2025 and thereafter |
— | — | ||||||
Subtotal |
62,189 | 280 | ||||||
Less: imputed interest |
(3,863 | ) | (16 | ) | ||||
|
|
|
|
|||||
Lease liabilities |
58,326 |
264 |
||||||
|
|
|
|
20. |
Commitments and Contingencies |
21. |
Statutory Reserves and Restricted Net Asset |
21. |
Statutory Reserves and Restricted Net Asset (continued) |
As of December 31, |
||||||||||||
2020 |
2021 |
|||||||||||
RMB |
RMB |
USD |
||||||||||
(Note 2) |
||||||||||||
Assets |
||||||||||||
Current assets |
||||||||||||
Cash and cash equivalents |
32,145 | 8,483 | 1,331 | |||||||||
Short-term investments |
653,609 | 414,921 | 65,110 | |||||||||
Prepaid expense and other assets |
— | 14,993 | 2,353 | |||||||||
Amount due from its subsidiaries and the consolidated VIEs |
2,073 | 1,786 | 280 | |||||||||
Total current assets |
687,827 | 440,183 | 69,074 | |||||||||
Non-current assets |
||||||||||||
Long-term investments |
2,552,965 | 3,885,718 | 609,754 | |||||||||
Total non-current assets |
2,552,965 | 3,885,718 | 609,754 | |||||||||
Total assets |
3,240,792 |
4,325,901 |
678,828 |
|||||||||
Liabilities |
||||||||||||
Current liabilities |
||||||||||||
Accrued expenses and other current liabilities |
60,480 | 3,734 | 586 | |||||||||
Amount due to its subsidiaries and the consolidated VIEs |
— | 348,741 | 54,725 | |||||||||
Total current liabilities |
60,480 | 352,475 | 55,311 | |||||||||
Total liabilities |
60,480 |
352,475 |
55,311 |
|||||||||
Mezzanine equity |
||||||||||||
Series Pre-A convertible redeemable preferred shares (US$ 0.000005 par value per share; 241,148,000 and nil shares authorized, issued and outstanding as of December 31, 2020 and 2021, respectively) |
56,185 | — | — | |||||||||
Series A convertible redeemable preferred shares (US$ 0.000005 par value per share; 334,926,000 and nil shares authorized, issued and outstanding as of December 31, 2020 and 2021, respectively) |
129,323 | — | — | |||||||||
Series A+ convertible redeemable preferred shares (US$ 0.000005 par value per share; 157,896,000 and nil shares authorized, issued and outstanding as of December 31, 2020 and 2021, respectively) |
77,520 | — | — | |||||||||
Series B convertible redeemable preferred shares (US$ 0.000005 par value per share; 352,107,646 and nil shares authorized, issued and outstanding as of December 31, 2020 and 2021, respectively) |
497,106 | — | — | |||||||||
Series C convertible redeemable preferred shares (US$ 0.000005 par value per share; 542,794,072 and nil shares authorized, issued and outstanding as of December 31, 2020 and 2021, respectively) |
1,222,224 | — | — | |||||||||
Series C+ convertible redeemable preferred shares (US$ 0.000005 par value per share; 170,632,018 and nil shares authorized, issued and outstanding as of December 31, 2020 and 2021, respectively) |
490,571 | — | — | |||||||||
Series C++ convertible redeemable preferred shares (US$0.000005 par value per share; 120,971,053 and nil shares authorized, issued and outstanding as of December 31, 2020 and 2021, respectively) |
388,925 | — | — | |||||||||
Series D convertible redeemable preferred shares (US$0.000005 par value per share; 517,264,501 and nil shares authorized, issued and outstanding as of December 31, 2020 and 2021, respectively) |
1,975,482 | — | — | |||||||||
Total mezzanine equity |
4,837,336 |
— |
— |
|||||||||
Shareholders’ (Deficit)/Equity: |
||||||||||||
Ordinary shares (US$ 0.000005 par value; 10,000,000,000 , 1,203,526,000 shares issued and outstanding as of December 31, 2020; 8,900,000,000 Class A ordinary shares authorize d , 3,206,653,701 Class A ordinary shares issue d , 3,140,896,631 Class A ordinary shares outstanding as of December 31, 202 1; 1,000,000,000 Class B ordinary sh ares authorize d, 801,904,979 Clas s B ordinary sh ares issued and ou tstanding as of December 31, 20 21) |
41 |
134 | 21 | |||||||||
Additional paid-in capital |
— | 7,329,420 | 1,150,146 | |||||||||
Accumulated other comprehensive income/(loss) |
14,956 | (21,492 | ) | (3,373 | ) | |||||||
Accumulated deficit |
(1,672,021 | ) | (3,334,636 | ) | (523,277 | ) | ||||||
Total shareholders’ (deficit)/equity |
(1,657,024 |
) |
3,973,426 |
623,517 |
||||||||
Total liabilities, mezzanine equity and shareholders’ (deficit)/equity |
3,240,792 |
4,325,901 |
678,828 |
|||||||||
Year ended December 31, |
||||||||||||||||
2019 |
2020 |
2021 |
||||||||||||||
RMB |
RMB |
RMB |
USD |
|||||||||||||
(Note 2) |
||||||||||||||||
Operating revenue, net |
— | — | 2,279 | 358 | ||||||||||||
Operating costs and expenses |
(30,090 | ) | (229,413 | ) | (250,814 | ) | (39,358 | ) | ||||||||
Interest income |
1,212 | 2,293 | 8,666 | 1,360 | ||||||||||||
Fair value change of warrant |
— | (150,685 | ) | — | — | |||||||||||
Foreign currency exchange loss |
(16 | ) | (3 | ) | (2,114 | ) | (332 | ) | ||||||||
Income tax expense |
(118 | ) | (39 | ) | — | — | ||||||||||
Others, net |
— | — | 4 | 1 | ||||||||||||
Equity in loss of subsidiaries and VIEs |
(292,523 | ) | (286,022 | ) | (1,332,101 | ) | (209,036 | ) | ||||||||
Net loss |
(321,535 |
) |
(663,869 |
) |
(1,574,080 |
) |
(247,007 |
) | ||||||||
Deemed dividend on modification on preferred shares |
— | (67,975 | ) | — |
— |
|||||||||||
Deemed dividend upon issuance of warrants |
— | (90,268 | ) | — | — | |||||||||||
Preferred shares redemption value accretion |
(136,839 | ) | (285,668 | ) | (152,287 | ) | (23,897 | ) | ||||||||
Net loss attributable to ordinary shareholders |
(458,374 |
) |
(1,107,780 |
) |
(1,726,367 |
) |
(270,904 |
) | ||||||||
Other comprehensive income/(loss) |
||||||||||||||||
Foreign currency transaction adjustments |
27,771 | (14,008 | ) | (36,640 | ) | (5,750 | ) | |||||||||
Unrealized gains on available-for-sale investments, net of tax |
209 | 1,724 | 192 | 30 | ||||||||||||
Total comprehensive loss |
(293,555 |
) |
(676,153 |
) |
(1,610,528 |
) |
(252,727 |
) | ||||||||
Year ended December 31, |
||||||||||||||||
2019 |
2020 |
2021 |
||||||||||||||
RMB |
RMB |
USD |
||||||||||||||
(Note 2) |
||||||||||||||||
Cash Flows from Operating Activities: |
(2,827 |
) |
(28 |
) |
320,097 |
50,230 |
||||||||||
Cash Flows from Investing Activities: |
||||||||||||||||
Purchase of short-term investments |
— | (654,428 | ) | (1,875,171 | ) | (294,255 | ) | |||||||||
Cash received from loan repayment |
60,383 | — | 2,100,240 | 329,573 | ||||||||||||
Investment in subsidiaries |
(1,494,523 | ) | (1,554,670 | ) | (2,683,195 | ) | (421,052 | ) | ||||||||
Net cash used in investing activities |
(1,434,140 |
) |
(2,209,098 |
) |
(2,458,126 |
) |
(385,734 |
) | ||||||||
Cash Flows from Financing Activities: |
||||||||||||||||
Proceeds from issuance of convertible redeemable preferred shares, net |
1,491,983 | 2,048,986 | — | — | ||||||||||||
Proceeds from exercise of share option |
— | — | 2,971 | 466 | ||||||||||||
Payment for share repurchase |
— | — | (16,546 | ) | (2,596 | ) | ||||||||||
Proceeds from initial public offering, net |
— | — | 2,142,104 | 336,143 | ||||||||||||
Net cash provided by financing activities |
1,491,983 |
2,048,986 |
2,128,529 |
334,013 |
||||||||||||
Effect of exchange rate changes on cash and cash equivalents |
32,022 | (26,122 | ) | (14,162 | ) | (2,222 | ) | |||||||||
Net increase/(decrease) in cash and cash equivalents and restricted cash |
87,038 |
(186,262 |
) |
(23,662 |
) |
(3,713 |
) | |||||||||
Total cash and cash equivalents and restricted cash at beginning of year |
131,369 |
218,407 |
32,145 |
5,044 |
||||||||||||
Total cash and cash equivalents and restricted cash at end of year |
218,407 |
32,145 |
8,483 |
1,331 |
||||||||||||
1. | Schedule I has been provided pursuant to the requirements of Rule 12-04(a) and 5-04(c) of Regulation S-X, which require condensed financial information as to the financial position, changes in financial position and results of operations of a parent company as of the same dates and for the same periods for which audited consolidated financial statements have been presented when the restricted net assets of consolidated subsidiaries exceed 25 percent of consolidated net assets as of the end of the most recently completed fiscal year. |
2. | The condensed financial information of Waterdrop Inc. has been prepared using the same accounting policies as set out in the accompanying consolidated financial statements except that the equity method has been used to account for investments in its subsidiaries. |
3. | Certain information and footnote disclosures normally included in financial statements prepared in accordance with U.S. GAAP have been condensed or omitted. The footnote disclosures contain supplemental information relating to the operations of the Group and, as such, these statements should be read in conjunction with the notes to the consolidated financial statements of the Group as of December 31, 2020 and 2021 and the years ended 2019, 2020 and 2021. No dividend was paid by the Group’s subsidiaries to Waterdrop Inc. in 2019, 2020 and 2021. |
4. | As of December 31, 2021, there were no material contingencies, significant provisions of long term obligations, and mandatory dividend or redemption requirements of redeemable shares or guarantees of the Group, except for those which have been separately disclosed in the Consolidated Financial Statement, if any. |
Exhibit 2.5
DESCRIPTION OF RIGHTS OF EACH CLASS OF SECURITIES
REGISTERED UNDER SECTION 12 OF THE SECURITIES EXCHANGE ACT OF 1934
(THE EXCHANGE ACT)
American Depositary Shares (ADSs) each representing ten Class A ordinary shares of Waterdrop Inc., (the we, our, our company, or us) are listed and traded on the New York Stock Exchange and, in connection with this listing (but not for trading), the Class A ordinary shares are registered under Section 12(b) of the Exchange Act. This exhibit contains a description of the rights of (i) the holders of Class A ordinary shares and (ii) the holders of ADSs. Underlying Class A ordinary shares represented by the ADSs are held by Citibank, N.A., as depositary, and holders of ADSs will not be treated as holders of the Class A ordinary shares.
Description of Class A Ordinary Shares
The following is a summary of material provisions of our seventh amended and restated memorandum and articles of association (the Memorandum and Articles of Association), as well as the Companies Act (As Revised) of the Cayman Islands (the Companies Act) insofar as they relate to the material terms of our ordinary shares. Notwithstanding this, because it is a summary, it may not contain all the information that you may otherwise deem important. For more complete information, you should read the entire Memorandum and Articles of Association, which has been filed with the SEC as an exhibit to our Registration Statement on Form S-8 (File No. 333-261408).
Type and Class of Securities (Item 9.A.5 of Form 20-F)
Each Class A ordinary share has US$0.000005 par value. The respective number of Class A ordinary shares that have been issued as of the last day of the respective financial year is provided on the cover of the annual report on Form 20-F (the Form 20-F). Our Class A ordinary shares are issued in registered form, and are issued when registered in our register of members. Our company will not issue shares to bearer.
Preemptive Rights (Item 9.A.3 of Form 20-F)
Our shareholders do not have preemptive rights.
Limitations or Qualifications (Item 9.A.6 of Form 20-F)
We have a dual-class voting structure such that our ordinary shares are divided into Class A ordinary shares and Class B ordinary shares. Holders of our Class A ordinary shares and Class B ordinary shares will have the same rights except for voting and conversion rights. Each Class A ordinary share shall entitle the holder thereof to one vote on all matters subject to vote at our general meetings, and each Class B ordinary share shall entitle the holder thereof to nine votes on all matters subject to vote at our general meetings. Due to the super voting power of Class B ordinary share holder, the voting power of the Class A ordinary shares may be materially limited.
Rights of Other Types of Securities (Item 9.A.7 of Form 20-F)
Not applicable.
Rights of Ordinary Shares (Item 10.B.3 of Form 20-F)
Dividends
The holders of our ordinary shares are entitled to such dividends as may be declared by our board of directors or declared by our shareholders by ordinary resolution (provided that no dividend may be declared by our shareholders which exceeds the amount recommended by our directors). Our Memorandum and Articles of Association provide that dividends may be declared and paid out of our profits, realized or unrealized, or from any reserve set aside from profits which our board of directors determine is no longer needed. Under the laws of the Cayman Islands, our company may pay a dividend out of either profit or share premium account, provided that in no circumstances may a dividend be paid if this would result in our company being unable to pay its debts as they fall due in the ordinary course of business.
Voting Rights
Holders of Class A ordinary shares and Class B ordinary shares shall, at all times, vote together as one class on all matters submitted to a vote by the members at any general meeting of our company. Each Class A ordinary share shall be entitled to one vote on all matters subject to the vote at general meetings of our Company, and each Class B ordinary share shall be entitled to nine votes on all matters subject to the vote at general meetings of our Company. Voting at any meeting of shareholders is by show of hands unless a poll (before or on the declaration of the result of the show of hands) is demanded. A poll may be demanded by the chairperson of such meeting or any one shareholder present in person or by proxy.
An ordinary resolution to be passed at a meeting by the shareholders requires the affirmative vote of a simple majority of the votes attaching to the ordinary shares cast at a meeting, while a special resolution requires the affirmative vote of no less than two-thirds of the votes cast attaching to the outstanding and issued ordinary shares cast at a meeting. A special resolution will be required for important matters such as a change of name or making changes to our Memorandum and Articles of Association. Our shareholders may, among other things, divide or combine their shares by ordinary resolution.
Transfer of Ordinary Shares
Subject to the restrictions set out in our Memorandum and Articles of Association as set out below, any of our shareholders may transfer all or any of his or her ordinary shares by an instrument of transfer in the usual or common form or any other form approved by our board of directors.
2
Our board of directors may, in its absolute discretion, decline to register any transfer of any ordinary share which is not fully paid up or on which we have a lien. Our board of directors may also decline to register any transfer of any ordinary share unless:
| the instrument of transfer is lodged with us, accompanied by the certificate for the ordinary shares to which it relates and such other evidence as our board of directors may reasonably require to show the right of the transferor to make the transfer; |
| the instrument of transfer is in respect of only one class of ordinary shares; |
| the instrument of transfer is properly stamped, if required; |
| in the case of a transfer to joint holders, the number of joint holders to whom the ordinary share is to be transferred does not exceed four; and |
| a fee of such maximum sum as the New York Stock Exchange may determine to be payable or such lesser sum as our directors may from time to time require is paid to us in respect thereof. |
If our directors refuse to register a transfer they shall, within three months after the date on which the instrument of transfer was lodged, send to each of the transferor and the transferee notice of such refusal.
The registration of transfers may, after compliance with any notice required of New York Stock Exchange, be suspended and the register closed at such times and for such periods as our board of directors may from time to time determine, provided, however, that the registration of transfers shall not be suspended nor the register closed for more than 30 days in any year as our board may determine
Liquidation Rights
On the winding up of our company, if the assets available for distribution amongst our shareholders shall be more than sufficient to repay the whole of the share capital at the commencement of the winding up, the surplus shall be distributed amongst our shareholders in proportion to the par value of the shares held by them at the commencement of the winding up, subject to a deduction from those shares in respect of which there are monies due, of all monies payable to our company for unpaid calls or otherwise. If our assets available for distribution are insufficient to repay all of the paid-up capital, the assets will be distributed so that the losses are borne by our shareholders in proportion to the par value of the shares held by them.
Calls on Ordinary Shares and Forfeiture of Ordinary shares
Our board of directors may from time to time make calls upon shareholders for any amounts unpaid on their shares in a notice served to such shareholders at least 14 days prior to the specified time and place of payment. The shares that have been called upon and remain unpaid are subject to forfeiture.
3
Redemption, Repurchase and Surrender of Ordinary Shares
We may issue shares on terms that such shares are subject to redemption, at our option or at the option of the holders of these shares, on such terms and in such manner as may be determined by our board of directors. Our company may also repurchase any of our shares on such terms and in such manner as have been approved by our board of directors or by an ordinary resolution of our shareholders. Under the Companies Act, the redemption or repurchase of any share may be paid out of our Companys profits or out of the proceeds of a new issue of shares made for the purpose of such redemption or repurchase, or out of capital (including share premium account and capital redemption reserve) if our company can, immediately following such payment, pay its debts as they fall due in the ordinary course of business. In addition, under the Companies Act no such share may be redeemed or repurchased (a) unless it is fully paid up, (b) if such redemption or repurchase would result in there being no shares issued and outstanding or (c) if the company has commenced liquidation. In addition, our company may accept the surrender of any fully paid share for no consideration.
Requirements to Change the Rights of Holders of Ordinary Shares (Item 10.B.4 of Form 20-F)
Variations of Rights of Shares
If at any time, our share capital is divided into different classes of shares, the rights attached to any class may be materially adversely varied with the consent in writing of the holders of at least two-thirds (2/3) of the issued shares of that class or with the sanction of a special resolution passed at a separate meeting of the holders of the shares of that class. The rights conferred upon the holders of the shares of any class issued shall not, be deemed to be materially adversely varied by the creation, allotment or issue of further shares ranking pari passu with or subsequent to them or the redemption or purchase of any shares of any class by our company. The rights of the holders of shares shall not be deemed to be materially adversely varied by the creation or issue of shares with preferred or other rights including, without limitation, the creation of shares with enhanced or weighted voting rights.
Limitations on the Rights to Own Ordinary Shares (Item 10.B.6 of Form 20-F)
There are no limitations under the laws of the Cayman Islands or under the Memorandum and Articles of Association that limit the right of non-resident or foreign owners to hold or vote ordinary shares.
Provisions Affecting Any Change of Control (Item 10.B.7 of Form 20-F)
Anti-Takeover Provisions in the Memorandum and Articles of Association. Some provisions of our Memorandum and Articles of Association may discourage, delay or prevent a change of control of our company or management that shareholders may consider favorable, including provisions that:
4
| authorize our board of directors to issue preferred shares in one or more series and to designate the price, rights, preferences, privileges and restrictions of such preferred shares without any further vote or action by our shareholders; and |
| limit the ability of shareholders to requisition and convene general meetings of shareholders. |
However, under Cayman Islands law, our directors may only exercise the rights and powers granted to them under our Memorandum and Articles of Association for a proper purpose and for what they believe in good faith to be in the best interests of our company.
Ownership Threshold (Item 10.B.8 of Form 20-F)
There are no provisions under the laws of the Cayman Islands applicable to our company or under the Memorandum and Articles of Association that require our company to disclose shareholder ownership above any particular ownership threshold.
Differences between the Law of Different Jurisdictions (Item 10.B.9 of Form 20-F)
The Companies Act of the Cayman Islands is derived, to a large extent, from the older Companies Acts of England but does not follow recent English statutory enactments and accordingly there are significant differences between the Companies Act of the Cayman Islands and the current Companies Act of England. In addition, the Companies Act of the Cayman Islands differs from laws applicable to U.S. corporations and their shareholders. Set forth below is a summary of certain significant differences between the provisions of the Companies Act applicable to us and the laws applicable to companies incorporated in the United States and their shareholders.
Mergers and Similar Arrangements. The Companies Act permits mergers and consolidations between Cayman Islands companies and between Cayman Islands companies and non-Cayman Islands companies. For these purposes, (i) merger means the merging of two or more constituent companies and the vesting of their undertaking, property and liabilities in one of such companies as the surviving company, and (ii) a consolidation means the combination of two or more constituent companies into a consolidated company and the vesting of the undertaking, property and liabilities of such companies to the consolidated company. In order to effect such a merger or consolidation, the directors of each constituent company must approve a written plan of merger or consolidation, which must then be authorized by (a) a special resolution of the shareholders of each constituent company, and (b) such other authorization, if any, as may be specified in such constituent companys articles of association. The written plan of merger or consolidation must be filed with the Registrar of Companies of the Cayman Islands together with a declaration as to the solvency of the consolidated or surviving company, a list of the assets and liabilities of each constituent company and an undertaking that a copy of the certificate of merger or consolidation will be given to the members and creditors of each constituent company and that notification of the merger or consolidation will be published in the Cayman Islands Gazette. Court approval is not required for a merger or consolidation which is effected in compliance with these statutory procedures.
5
A merger between a Cayman parent company and its Cayman subsidiary or subsidiaries does not require authorization by a resolution of shareholders of that Cayman subsidiary if a copy of the plan of merger is given to every member of that Cayman subsidiary to be merged unless that member agrees otherwise. For this purpose a company is a parent of a subsidiary if it holds issued shares that together represent at least ninety percent (90%) of the votes at a general meeting of the subsidiary.
The consent of each holder of a fixed or floating security interest over a constituent company is required unless this requirement is waived by a court in the Cayman Islands.
Save in certain limited circumstances, a shareholder of a Cayman constituent company who dissents from the merger or consolidation is entitled to payment of the fair value of his shares (which, if not agreed between the parties, will be determined by the Cayman Islands court) upon dissenting to the merger or consolidation, provide the dissenting shareholder complies strictly with the procedures set out in the Companies Act. The exercise of dissenter rights will preclude the exercise by the dissenting shareholder of any other rights to which he or she might otherwise be entitled by virtue of holding shares, save for the right to seek relief on the grounds that the merger or consolidation is void or unlawful.
Separate from the statutory provisions relating to mergers and consolidations, the Companies Act also contains statutory provisions that facilitate the reconstruction and amalgamation of companies by way of schemes of arrangement, provided that the arrangement is approved by a majority in number of each class of shareholders and creditors with whom the arrangement is to be made, and who must in addition represent three-fourths in value of each such class of shareholders or creditors, as the case may be, that are present and voting either in person or by proxy at a meeting, or meetings, convened for that purpose. The convening of the meetings and subsequently the arrangement must be sanctioned by the Grand Court of the Cayman Islands. While a dissenting shareholder has the right to express to the court the view that the transaction ought not to be approved, the court can be expected to approve the arrangement if it determines that:
| the statutory provisions as to the required majority vote have been met; |
| the shareholders have been fairly represented at the meeting in question and the statutory majority are acting bona fide without coercion of the minority to promote interests adverse to those of the class; |
| the arrangement is such that may be reasonably approved by an intelligent and honest man of that class acting in respect of his interest; and |
| the arrangement is not one that would more properly be sanctioned under some other provision of the Companies Act. |
6
The Companies Act also contains a statutory power of compulsory acquisition which may facilitate the squeeze out of dissentient minority shareholder upon a tender offer. When a tender offer is made and accepted by holders of 90.0% of the shares affected within four months, the offeror may, within a two-month period commencing on the expiration of such four-month period, require the holders of the remaining shares to transfer such shares to the offeror on the terms of the offer. An objection can be made to the Grand Court of the Cayman Islands but this is unlikely to succeed in the case of an offer which has been so approved unless there is evidence of fraud, bad faith or collusion.
If an arrangement and reconstruction by way of scheme of arrangement is thus approved and sanctioned, or if a tender offer is made and accepted in accordance with the foregoing statutory procedures, a dissenting shareholder would have no rights comparable to appraisal rights, which would otherwise ordinarily be available to dissenting shareholders of Delaware corporations, providing rights to receive payment in cash for the judicially determined value of the shares.
Shareholders Suits. In principle, we will normally be the proper plaintiff to sue for a wrong done to us as a company, and as a general rule a derivative action may not be brought by a minority shareholder. However, based on English authorities, which would in all likelihood be of persuasive authority in the Cayman Islands, the Cayman Islands court can be expected to follow and apply the common law principles (namely the rule in Foss v. Harbottle and the exceptions thereto) so that a non-controlling shareholder may be permitted to commence a class action against or derivative actions in the name of the company to challenge actions where:
| a company acts or proposes to act illegally or ultra vires; |
| the act complained of, although not ultra vires, could only be effected duly if authorized by more than a simple majority vote that has not been obtained; and |
| those who control the company are perpetrating a fraud on the minority. |
Indemnification of Directors and Executive Officers and Limitation of Liability. Cayman Islands law does not limit the extent to which a companys Memorandum and Articles of Association may provide for indemnification of officers and directors, except to the extent any such provision may be held by the Cayman Islands courts to be contrary to public policy, such as to provide indemnification against civil fraud or the consequences of committing a crime. Our Memorandum and Articles of Association provide that that we shall indemnify our officers and directors against all actions, proceedings, costs, charges, expenses, losses, damages or liabilities incurred or sustained by such directors or officer, other than by reason of such persons dishonesty, willful default or fraud, in or about the conduct of our companys business or affairs (including as a result of any mistake of judgment) or in the execution or discharge of his duties, powers, authorities or discretions, including, without prejudice to the generality of the foregoing, any costs, expenses, losses or liabilities incurred by such director or officer in defending (whether successfully or otherwise) any civil proceedings concerning our company or its affairs in any court whether in the Cayman Islands or elsewhere. This standard of conduct is generally the same as permitted under the Delaware General Corporation Law for a Delaware corporation.
7
In addition, we have entered into indemnification agreements with our directors and executive officers that provide such persons with additional indemnification beyond that provided in our Memorandum and Articles of Association.
Insofar as indemnification for liabilities arising under the Securities Act may be permitted to our directors, officers or persons controlling us under the foregoing provisions, we have been informed that in the opinion of the SEC, such indemnification is against public policy as expressed in the Securities Act and is therefore unenforceable.
Directors Fiduciary Duties. Under Delaware corporate law, a director of a Delaware corporation has a fiduciary duty to the corporation and its shareholders. This duty has two components: the duty of care and the duty of loyalty. The duty of care requires that a director act in good faith, with the care that an ordinarily prudent person would exercise under similar circumstances. Under this duty, a director must inform himself of, and disclose to shareholders, all material information reasonably available regarding a significant transaction. The duty of loyalty requires that a director acts in a manner he reasonably believes to be in the best interests of the corporation. He must not use his corporate position for personal gain or advantage. This duty prohibits self-dealing by a director and mandates that the best interest of the corporation and its shareholders take precedence over any interest possessed by a director, officer or controlling shareholder and not shared by the shareholders generally. In general, actions of a director are presumed to have been made on an informed basis, in good faith and in the honest belief that the action taken was in the best interests of the corporation. However, this presumption may be rebutted by evidence of a breach of one of the fiduciary duties. Should such evidence be presented concerning a transaction by a director, the director must prove the procedural fairness of the transaction, and that the transaction was of fair value to the corporation.
As a matter of Cayman Islands law, a director of a Cayman Islands company is in the position of a fiduciary with respect to the company and therefore it is considered that he owes the following duties to the companya duty to act bona fide in the best interests of the company, a duty not to make a profit based on his position as director (unless the company permits him to do so), a duty not to put himself in a position where the interests of the company conflict with his personal interest or his duty to a third party, and a duty to exercise powers for the purpose for which such powers were intended. A director of a Cayman Islands company owes to the company a duty to exercise the skill they actually possess and such care and diligence that a reasonably prudent person would exercise in comparable circumstances. It was previously considered that a director need not exhibit in the performance of his duties a greater degree of skill than may reasonably be expected from a person of his knowledge and experience. However, English and Commonwealth courts have moved towards an objective standard with regard to the required skill and care and these authorities are likely to be followed in the Cayman Islands.
8
Shareholder Action by Written Consent. Under the Delaware General Corporation Law, a corporation may eliminate the right of shareholders to act by written consent by amendment to its certificate of incorporation. Cayman Islands law and our Memorandum and Articles of Association provide that our shareholders may approve corporate matters by way of a unanimous written resolution signed by or on behalf of each shareholder who would have been entitled to vote on such matter at a general meeting without a meeting being held.
Shareholder Proposals. Under the Delaware General Corporation Law, a shareholder has the right to put any proposal before the annual meeting of shareholders; provided it complies with the notice provisions in the governing documents. A special meeting may be called by the board of directors or any other person authorized to do so in the governing documents, but shareholders may be precluded from calling special meetings.
The Companies Act provides shareholders with only limited rights to requisition a general meeting, and does not provide shareholders with any right to put any proposal before a general meeting. However, these rights may be provided in a companys articles of association. Our Memorandum and Articles of Association allow any one or more of our shareholders holding shares which carry in aggregate not less than one-tenth of the total number votes attaching to all issued and the outstanding shares of our company entitled to vote at general meetings to requisition an extraordinary general meeting of our shareholders, in which case our board is obliged to convene an extraordinary general meeting and to put the resolutions so requisitioned to a vote at such meeting. Other than this right to requisition a shareholders meeting, our Memorandum and Articles of Association do not provide our shareholders with any other right to put proposals before annual general meetings or extraordinary general meetings. As a Cayman Islands exempted company, we are not obliged by law to call shareholders annual general meetings.
Cumulative Voting. Under the Delaware General Corporation Law, cumulative voting for elections of directors is not permitted unless the corporations certificate of incorporation specifically provides for it. Cumulative voting potentially facilitates the representation of minority shareholders on a board of directors since it permits the minority shareholder to cast all the votes to which the shareholder is entitled on a single director, which increases the shareholders voting power with respect to electing such director. There are no prohibitions in relation to cumulative voting under the laws of the Cayman Islands but our Memorandum and Articles of Association do not provide for cumulative voting. As a result, our shareholders are not afforded any less protections or rights on this issue than shareholders of a Delaware corporation.
Removal of Directors. Under the Delaware General Corporation Law, a director of a corporation with a classified board may be removed only for cause with the approval of a majority of the issued and outstanding shares entitled to vote, unless the certificate of incorporation provides otherwise. Under our Memorandum and Articles of Association, directors may be removed with or without cause, by an ordinary resolution of our shareholders. A director will also cease to be a director if he (i) becomes bankrupt or makes any arrangement or composition with his creditors; (ii) dies or is found to be or becomes of unsound mind; (iii) resigns his office by notice in writing; (iv) without special leave of absence from our board, is absent from meetings of our board for three consecutive meetings and our board resolves that his office be vacated; or (v) is removed from office pursuant to any other provision of our articles of association.
9
Transactions with Interested Shareholders. The Delaware General Corporation Law contains a business combination statute applicable to Delaware corporations whereby, unless the corporation has specifically elected not to be governed by such statute by amendment to its certificate of incorporation, it is prohibited from engaging in certain business combinations with an interested shareholder for three years following the date that such person becomes an interested shareholder. An interested shareholder generally is a person or a group who or which owns or owned 15% or more of the targets outstanding voting share within the past three years. This has the effect of limiting the ability of a potential acquirer to make a two-tiered bid for the target in which all shareholders would not be treated equally. The statute does not apply if, among other things, prior to the date on which such shareholder becomes an interested shareholder, the board of directors approves either the business combination or the transaction which resulted in the person becoming an interested shareholder. This encourages any potential acquirer of a Delaware corporation to negotiate the terms of any acquisition transaction with the targets board of directors.
Cayman Islands law has no comparable statute. As a result, we cannot avail ourselves of the types of protections afforded by the Delaware business combination statute. However, although Cayman Islands law does not regulate transactions between a company and its significant shareholders, it does provide that such transactions must be entered into bona fide in the best interests of the company and not with the effect of constituting a fraud on the minority shareholders.
Dissolution; Winding up. Under the Delaware General Corporation Law, unless the board of directors approves the proposal to dissolve, dissolution must be approved by shareholders holding 100% of the total voting power of the corporation. Only if the dissolution is initiated by the board of directors may it be approved by a simple majority of the corporations outstanding shares. Delaware law allows a Delaware corporation to include in its certificate of incorporation a supermajority voting requirement in connection with dissolutions initiated by either an order of the courts of the Cayman Islands or by the board of directors.
10
Under Cayman Islands law, a company may be wound up by either an order of the courts of the Cayman Islands or by a special resolution of its members or, if the company is unable to pay its debts as they fall due, by an ordinary resolution of its members. The court has authority to order winding up in a number of specified circumstances including where it is, in the opinion of the court, just and equitable to do so.
Variation of Rights of Shares. Under the Delaware General Corporation Law, a corporation may vary the rights of a class of shares with the approval of a majority of the outstanding shares of such class, unless the certificate of incorporation provides otherwise. Under our Memorandum and Articles of Association, if our share capital is divided into more than one class of shares, the rights attached to any such class may, subject to any rights or restrictions for the time being attached to any class, only be materially adversely varied with the consent in writing of the holders of at least two-thirds of the issued shares of that class or with the sanction of a special resolution passed at a separate meeting of the holders of the shares of that class. The rights conferred upon the holders of the shares of any class issued with preferred or other rights shall not, subject to any rights or restrictions for the time being attached to the shares of that class, be deemed to be materially adversely varied by the creation, allotment or issue of further shares ranking pari passu with or subsequent to them or the redemption or purchase of any shares of any class by our company. The rights of the holders of shares shall not be deemed to be materially adversely varied by the creation or issue of shares with preferred or other rights including, without limitation, the creation of shares with enhanced or weighted voting rights.
Amendment of Governing Documents. Under the Delaware General Corporation Law, a corporations governing documents may be amended with the approval of a majority of the outstanding shares entitled to vote, unless the certificate of incorporation provides otherwise. Under the Companies Act and our Memorandum and Articles of Association, our Memorandum and Articles of Association may only be amended by a special resolution of our shareholders.
Rights of Non-resident or Foreign Shareholders. There are no limitations imposed by our Memorandum and Articles of Association on the rights of non-resident or foreign shareholders to hold or exercise voting rights on our shares. In addition, there are no provisions in our Memorandum and Articles of Association that require our company to disclose shareholder ownership above any particular ownership threshold.
Changes in Capital (Item 10.B.10 of Form 20-F)
Our shareholders may from time to time by ordinary resolution:
| increase its share capital by new shares of such amount as it thinks expedient; |
| consolidate and divide all or any of its share capital into shares of a larger amount than its existing shares; |
| subdivide its shares, or any of them, into shares of an amount smaller than that fixed by the Memorandum, provided that in the subdivision the proportion between the amount paid and the amount, if any, unpaid on each reduced share shall be the same as it was in case of the share from which the reduced share is derived; and |
| cancel any shares that, at the date of the passing of the resolution, have not been taken or agreed to be taken by any person and diminish the amount of its share capital by the amount of the shares so cancelled. |
11
Our shareholders may by special resolution reduce its share capital and any capital redemption reserve in any manner authorized by the Companies Act.
Debt Securities (Item 12.A of Form 20-F)
Not applicable.
Warrants and Rights (Item 12.B of Form 20-F)
Not applicable.
Other Securities (Item 12.C of Form 20-F)
Not applicable.
Description of American Depositary Shares (Items 12.D.1 and 12.D.2 of Form 20-F)
Citibank, N.A. acts as the depositary for the American Depositary Shares. Citibanks depositary offices are located at 388 Greenwich Street, New York, New York 10013. American Depositary Shares are frequently referred to as ADSs and represent ownership interests in securities that are on deposit with the depositary. ADSs may be represented by certificates that are commonly known as American Depositary Receipts or ADRs. The depositary typically appoints a custodian to safekeep the securities on deposit. In this case, the custodian is Citibank, N.A. Hong Kong, located at 9/F Citi Tower, One Bay East, 83 Hoi Bun Road, Kwun Tong, Kowloon, Hong Kong.
We have appointed Citibank as depositary pursuant to a deposit agreement. A copy of the deposit agreement is on file with the SEC under cover of a Registration Statement on Form F-6. You may obtain a copy of the deposit agreement from the SECs Public Reference Room at 100 F Street, N.E., Washington, D.C. 20549 and from the SECs website (www.sec.gov). Please refer to Registration Number 333-255650 when retrieving such copy.
We are providing you with a summary description of the material terms of the ADSs and of your material rights as an owner of ADSs. Please remember that summaries by their nature lack the precision of the information summarized and that the rights and obligations of an owner of ADSs will be determined by reference to the terms of the deposit agreement and not by this summary. We urge you to review the deposit agreement in its entirety. The deposit agreement has been filed with the SEC as exhibit 4.3 to the registration statement on Form S-8 (File No. 333-261408). The portions of this summary description that are italicized describe matters that may be relevant to the ownership of ADSs but that may not be contained in the deposit agreement.
12
Each ADS represents the right to receive, and to exercise the beneficial ownership interests in, ten Class A ordinary shares that are on deposit with the depositary and/or custodian. An ADS also represents the right to receive, and to exercise the beneficial interests in, any other property received by the depositary or the custodian on behalf of the owner of the ADS but that has not been distributed to the owners of ADSs because of legal restrictions or practical considerations. We and the depositary may agree to change the ADS-to-Share ratio by amending the deposit agreement. This amendment may give rise to, or change, the depositary fees payable by ADS owners. The custodian, the depositary and their respective nominees will hold all deposited property for the benefit of the holders and beneficial owners of ADSs. The deposited property does not constitute the proprietary assets of the depositary, the custodian or their nominees. Beneficial ownership in the deposited property will under the terms of the deposit agreement be vested in the beneficial owners of the ADSs. The depositary, the custodian and their respective nominees will be the record holders of the deposited property represented by the ADSs for the benefit of the holders and beneficial owners of the corresponding ADSs. A beneficial owner of ADSs may or may not be the holder of ADSs. Beneficial owners of ADSs will be able to receive, and to exercise beneficial ownership interests in, the deposited property only through the registered holders of the ADSs, the registered holders of the ADSs (on behalf of the applicable ADS owners) only through the depositary, and the depositary (on behalf of the owners of the corresponding ADSs) directly, or indirectly, through the custodian or their respective nominees, in each case upon the terms of the deposit agreement.
If you become an owner of ADSs, you will become a party to the deposit agreement and therefore will be bound to its terms and to the terms of any ADR that represents your ADSs. The deposit agreement and the ADR specify our rights and obligations as well as your rights and obligations as an owner of ADSs and those of the depositary. As an ADS holder you appoint the depositary to act on your behalf in certain circumstances. The deposit agreement and the ADRs are governed by New York law. However, our obligations to the holders of Class A ordinary shares will continue to be governed by the laws of the Cayman Islands, which may be different from the laws in the United States.
In addition, applicable laws and regulations may require you to satisfy reporting requirements and obtain regulatory approvals in certain circumstances. You are solely responsible for complying with such reporting requirements and obtaining such approvals. Neither the depositary, the custodian, us or any of their or our respective agents or affiliates shall be required to take any actions whatsoever on your behalf to satisfy such reporting requirements or obtain such regulatory approvals under applicable laws and regulations.
As an owner of ADSs, we will not treat you as one of our shareholders and you will not have direct shareholder rights. The depositary will hold on your behalf the shareholder rights attached to the Class A ordinary shares underlying your ADSs. As an owner of ADSs you will be able to exercise the shareholders rights for the Class A ordinary shares represented by your ADSs through the depositary only to the extent contemplated in the deposit agreement. To exercise any shareholder rights not contemplated in the deposit agreement you will, as an ADS owner, need to arrange for the cancellation of your ADSs and become a direct shareholder.
13
The manner in which you own the ADSs (e.g., in a brokerage account vs. as registered holder, or as holder of certificated vs. uncertificated ADSs) may affect your rights and obligations, and the manner in which, and extent to which, the depositarys services are made available to you. As an owner of ADSs, you may hold your ADSs either by means of an ADR registered in your name, through a brokerage or safekeeping account, or through an account established by the depositary in your name reflecting the registration of uncertificated ADSs directly on the books of the depositary (commonly referred to as the direct registration system or DRS). The direct registration system reflects the uncertificated (book-entry) registration of ownership of ADSs by the depositary. Under the direct registration system, ownership of ADSs is evidenced by periodic statements issued by the depositary to the holders of the ADSs. The direct registration system includes automated transfers between the depositary and The Depository Trust Company (DTC), the central book-entry clearing and settlement system for equity securities in the United States. If you decide to hold your ADSs through your brokerage or safekeeping account, you must rely on the procedures of your broker or bank to assert your rights as ADS owner. Banks and brokers typically hold securities such as the ADSs through clearing and settlement systems such as DTC. The procedures of such clearing and settlement systems may limit your ability to exercise your rights as an owner of ADSs. Please consult with your broker or bank if you have any questions concerning these limitations and procedures. All ADSs held through DTC will be registered in the name of a nominee of DTC, which nominee will be the only holder of such ADSs for purposes of the deposit agreement and any applicable ADR. This summary description assumes you have opted to own the ADSs directly by means of an ADS registered in your name and, as such, we will refer to you as the holder. When we refer to you, we assume the reader owns ADSs and will own ADSs at the relevant time.
The registration of the Class A ordinary shares in the name of the depositary or the custodian shall, to the maximum extent permitted by applicable law, vest in the depositary or the custodian the record ownership in the applicable Class A ordinary shares with the beneficial ownership rights and interests in such Class A ordinary shares being at all times vested with the beneficial owners of the ADSs representing the Class A ordinary shares. The depositary or the custodian shall at all times be entitled to exercise the beneficial ownership rights in all deposited property, in each case only on behalf of the holders and beneficial owners of the ADSs representing the deposited property.
Dividends and Distributions
As a holder of ADSs, you generally have the right to receive the distributions we make on the securities deposited with the custodian. Your receipt of these distributions may be limited, however, by practical considerations and legal limitations. Holders of ADSs will receive such distributions under the terms of the deposit agreement in proportion to the number of ADSs held as of the specified record date, after deduction of the applicable fees, taxes and expenses.
Distributions of Cash
Whenever we make a cash distribution for the securities on deposit with the custodian, we will deposit the funds with the custodian. Upon receipt of confirmation of the deposit of the requisite funds, the depositary will arrange for the funds received in a currency other than U.S. dollars to be converted into U.S. dollars and for the distribution of the U.S. dollars to the holders, subject to the laws and regulations of the Cayman Islands.
The conversion into U.S. dollars will take place only if practicable and if the U.S. dollars are transferable to the United States. The depositary will apply the same method for distributing the proceeds of the sale of any property (such as undistributed rights) held by the custodian in respect of securities on deposit.
14
The distribution of cash will be made net of the fees, expenses, taxes and governmental charges payable by holders under the terms of the deposit agreement. The depositary will hold any cash amounts it is unable to distribute in a non-interest bearing account for the benefit of the applicable holders and beneficial owners of ADSs until the distribution can be effected or the funds that the depositary holds must be escheated as unclaimed property in accordance with the laws of the relevant states of the United States.
Distributions of Shares
Whenever we make a free distribution of Class A ordinary shares for the securities on deposit with the custodian, we will deposit the applicable number of Class A ordinary shares with the custodian. Upon receipt of confirmation of such deposit, the depositary will either distribute to holders new ADSs representing the Class A ordinary shares deposited or modify the ADS-to- Class A ordinary shares ratio, in which case each ADS you hold will represent rights and interests in the additional Class A ordinary shares so deposited. Only whole new ADSs will be distributed. Fractional entitlements will be sold and the proceeds of such sale will be distributed as in the case of a cash distribution.
The distribution of new ADSs or the modification of the ADS-to-Class A ordinary shares ratio upon a distribution of Class A ordinary shares will be made net of the fees, expenses, taxes and governmental charges payable by holders under the terms of the deposit agreement. In order to pay such taxes or governmental charges, the depositary may sell all or a portion of the new Class A ordinary shares so distributed.
No such distribution of new ADSs will be made if it would violate a law (e.g., the U.S. securities laws) or if it is not operationally practicable. If the depositary does not distribute new ADSs as described above, it may sell the Class A ordinary shares received upon the terms described in the deposit agreement and will distribute the proceeds of the sale as in the case of a distribution of cash.
Distributions of Rights
Whenever we intend to distribute rights to subscribe for additional Class A ordinary shares, we will give prior notice to the depositary and we will assist the depositary in determining whether it is lawful and reasonably practicable to distribute rights to subscribe for additional ADSs to holders.
The depositary will establish procedures to distribute rights to subscribe for additional ADSs to holders and to enable such holders to exercise such rights if it is lawful and reasonably practicable to make the rights available to holders of ADSs, and if we provide all of the documentation contemplated in the deposit agreement (such as opinions to address the lawfulness of the transaction). You may have to pay fees, expenses, taxes and other governmental charges to subscribe for the new ADSs upon the exercise of your rights. The depositary is not obligated to establish procedures to facilitate the distribution and exercise by holders of rights to subscribe for new Class A ordinary shares other than in the form of ADSs.
The depositary will not distribute the rights to you if:
| We do not timely request that the rights be distributed to you or we request that the rights not be distributed to you; or |
15
| We fail to deliver satisfactory documents to the depositary; or |
| It is not reasonably practicable to distribute the rights. |
The depositary will sell the rights that are not exercised or not distributed if such sale is lawful and reasonably practicable. The proceeds of such sale will be distributed to holders as in the case of a cash distribution. If the depositary is unable to sell the rights, it will allow the rights to lapse.
Elective Distributions
Whenever we intend to distribute a dividend payable at the election of shareholders either in cash or in additional shares, we will give prior notice thereof to the depositary and will indicate whether we wish the elective distribution to be made available to you. In such case, we will assist the depositary in determining whether such distribution is lawful and reasonably practicable.
The depositary will make the election available to you only if it is reasonably practicable and if we have provided all of the documentation contemplated in the deposit agreement. In such case, the depositary will establish procedures to enable you to elect to receive either cash or additional ADSs, in each case as described in the deposit agreement.
If the election is not made available to you, you will receive either cash or additional ADSs, depending on what a shareholder in the Cayman Islands would receive upon failing to make an election, as more fully described in the deposit agreement.
Other Distributions
Whenever we intend to distribute property other than cash, Class A ordinary shares or rights to subscribe for additional Class A ordinary shares, we will notify the depositary in advance and will indicate whether we wish such distribution to be made to you. If so, we will assist the depositary in determining whether such distribution to holders is lawful and reasonably practicable.
If it is reasonably practicable to distribute such property to you and if we provide to the depositary all of the documentation contemplated in the deposit agreement, the depositary will distribute the property to the holders in a manner it deems practicable.
The distribution will be made net of fees, expenses, taxes and governmental charges payable by holders under the terms of the deposit agreement. In order to pay such taxes and governmental charges, the depositary may sell all or a portion of the property received.
The depositary will not distribute the property to you and will sell the property if:
| We do not request that the property be distributed to you or if we request that the property not be distributed to you; or |
| We do not deliver satisfactory documents to the depositary; or |
16
| The depositary determines that all or a portion of the distribution to you is not reasonably practicable. |
The proceeds of such a sale will be distributed to holders as in the case of a cash distribution.
Redemption
Whenever we decide to redeem any of the securities on deposit with the custodian, we will notify the depositary in advance. If it is practicable and if we provide all of the documentation contemplated in the deposit agreement, the depositary will provide notice of the redemption to the holders.
The custodian will be instructed to surrender the shares being redeemed against payment of the applicable redemption price. The depositary will convert into U.S. dollars upon the terms of the deposit agreement the redemption funds received in a currency other than U.S. dollars and will establish procedures to enable holders to receive the net proceeds from the redemption upon surrender of their ADSs to the depositary. You may have to pay fees, expenses, taxes and other governmental charges upon the redemption of your ADSs. If less than all ADSs are being redeemed, the ADSs to be retired will be selected by lot or on a pro rata basis, as the depositary may determine.
Changes affecting Class A ordinary shares
The Class A ordinary shares held on deposit for your ADSs may change from time to time. For example, there may be a change in nominal or par value, split-up, cancellation, consolidation or any other reclassification of such Class A ordinary shares or a recapitalization, reorganization, merger, consolidation or sale of assets of the Company.
If any such change were to occur, your ADSs would, to the extent permitted by law and the deposit agreement, represent the right to receive the property received or exchanged in respect of the Class A ordinary shares held on deposit. The depositary may in such circumstances deliver new ADSs to you, amend the deposit agreement, the ADRs and the applicable Registration Statement(s) on Form F-6, call for the exchange of your existing ADSs for new ADSs and take any other actions that are appropriate to reflect as to the ADSs the change affecting the Shares. If the depositary may not lawfully distribute such property to you, the depositary may sell such property and distribute the net proceeds to you as in the case of a cash distribution.
Issuance of ADSs upon Deposit of Class A ordinary shares
Upon completion of the offering, the Class A ordinary shares being offered pursuant to the prospectus will be deposited by us with the custodian. Upon receipt of confirmation of such deposit, the depositary will issue ADSs to the underwriters named in the prospectus.
After the closing of the offer, the depositary may create ADSs on your behalf if you or your broker deposit Class A ordinary shares with the custodian. The depositary will deliver these ADSs to the person you indicate only after you pay any applicable issuance fees and any charges and taxes payable for the transfer of the Class A ordinary shares to the custodian. Your ability to deposit Class A ordinary shares and receive ADSs may be limited by U.S. and Cayman Islands legal considerations applicable at the time of deposit.
17
The issuance of ADSs may be delayed until the depositary or the custodian receives confirmation that all required approvals have been given and that the Class A ordinary shares have been duly transferred to the custodian. The depositary will only issue ADSs in whole numbers.
When you make a deposit of Class A ordinary shares, you will be responsible for transferring good and valid title to the depositary. As such, you will be deemed to represent and warrant that:
| The Class A ordinary shares are duly authorized, validly issued, fully paid, non-assessable and legally obtained. |
| All preemptive (and similar) rights, if any, with respect to such Class A ordinary shares have been validly waived or exercised. |
| You are duly authorized to deposit the Class A ordinary shares. |
| The Class A ordinary shares presented for deposit are free and clear of any lien, encumbrance, security interest, charge, mortgage or adverse claim, and are not, and the ADSs issuable upon such deposit will not be, restricted securities (as defined in the deposit agreement). |
| The Class A ordinary shares presented for deposit have not been stripped of any rights or entitlements. |
If any of the representations or warranties are incorrect in any way, we and the depositary may, at your cost and expense, take any and all actions necessary to correct the consequences of the misrepresentations.
Transfer, Combination, and Split Up of ADRs
As an ADR holder, you will be entitled to transfer, combine or split up your ADRs and the ADSs evidenced thereby. For transfers of ADRs, you will have to surrender the ADRs to be transferred to the depositary and also must:
| ensure that the surrendered ADR is properly endorsed or otherwise in proper form for transfer; |
| provide such proof of identity and genuineness of signatures as the depositary deems appropriate; |
| provide any transfer stamps required by the State of New York or the United States; and |
| pay all applicable fees, charges, expenses, taxes and other government charges payable by ADR holders pursuant to the terms of the deposit agreement, upon the transfer of ADRs. |
18
To have your ADRs either combined or split up, you must surrender the ADRs in question to the depositary with your request to have them combined or split up, and you must pay all applicable fees, charges and expenses payable by ADR holders, pursuant to the terms of the deposit agreement, upon a combination or split up of ADRs.
Withdrawal of Class A ordinary shares Upon Cancellation of ADSs
As a holder, you will be entitled to present your ADSs to the depositary for cancellation and then receive the corresponding number of underlying Class A ordinary shares at the custodians offices. Your ability to withdraw the Class A ordinary shares held in respect of the ADSs may be limited by U.S. and Cayman Islands legal considerations applicable at the time of withdrawal. In order to withdraw the Class A ordinary shares represented by your ADSs, you will be required to pay to the depositary the fees for cancellation of ADSs and any charges and taxes payable upon the transfer of the Class A ordinary shares. You assume the risk for delivery of all funds and securities upon withdrawal. Once canceled, the ADSs will not have any rights under the deposit agreement.
If you hold ADSs registered in your name, the depositary may ask you to provide proof of identity and genuineness of any signature and such other documents as the depositary may deem appropriate before it will cancel your ADSs. The withdrawal of the Class A ordinary shares represented by your ADSs may be delayed until the depositary receives satisfactory evidence of compliance with all applicable laws and regulations. Please keep in mind that the depositary will only accept ADSs for cancellation that represent a whole number of securities on deposit.
You will have the right to withdraw the securities represented by your ADSs at any time except for:
| Temporary delays that may arise because (i) the transfer books for the Class A ordinary shares or ADSs are closed, or (ii) Class A ordinary shares are immobilized on account of a shareholders meeting or a payment of dividends. |
| Obligations to pay fees, taxes and similar charges. |
| Restrictions imposed because of laws or regulations applicable to ADSs or the withdrawal of securities on deposit. |
The deposit agreement may not be modified to impair your right to withdraw the securities represented by your ADSs except to comply with mandatory provisions of law.
Voting Rights
As a holder, you generally have the right under the deposit agreement to instruct the depositary to exercise the voting rights for the Class A ordinary shares represented by your ADSs. The voting rights of holders of Class A ordinary shares are described in the section of this prospectus titled Description of Share Capital.
At our request, the depositary will distribute to you any notice of shareholders meeting received from us together with information explaining how to instruct the depositary to exercise the voting rights of the securities represented by ADSs. In lieu of distributing such materials, the depositary may distribute to holders of ADSs instructions on how to retrieve such materials upon request.
19
If the depositary timely receives voting instructions from a holder of ADSs, it will endeavor to vote the securities (in person or by proxy) represented by the holders ADSs in accordance with such voting instructions.
Securities for which no voting instructions have been received will not be voted (except as otherwise contemplated in the deposit agreement). Please note that the ability of the depositary to carry out voting instructions may be limited by practical and legal limitations and the terms of the securities on deposit. We cannot assure you that you will receive voting materials in time to enable you to return voting instructions to the depositary in a timely manner.
Amendments and Termination
We may agree with the depositary to modify the deposit agreement at any time without your consent. We undertake to give holders of ADSs 30 days prior notice of any modifications that would materially prejudice any of their substantial rights under the deposit agreement. We will not consider to be materially prejudicial to your substantial rights any modifications or supplements that are reasonably necessary for the ADSs to be registered under the Securities Act or to be eligible for book-entry settlement, in each case without imposing or increasing the fees and charges you are required to pay. In addition, we may not be able to provide you with prior notice of any modifications or supplements that are required to accommodate compliance with applicable provisions of law.
You will be bound by the modifications to the deposit agreement if you continue to hold your ADSs after the modifications to the deposit agreement become effective. The deposit agreement cannot be amended to prevent you from withdrawing the Class A ordinary shares represented by your ADSs (except as permitted by law).
We have the right to direct the depositary to terminate the deposit agreement. Similarly, the depositary may in certain circumstances on its own initiative terminate the deposit agreement. In either case, the depositary must give notice to the holders at least 30 days before termination. Until termination, your rights under the deposit agreement will be unaffected.
After termination, the depositary will continue to collect distributions received (but will not distribute any such property until you request the cancellation of your ADSs) and may sell the securities held on deposit. After the sale, the depositary will hold the proceeds from such sale and any other funds then held for the holders of ADSs in a non-interest bearing account. At that point, the depositary will have no further obligations to holders other than to account for the funds then held for the holders of ADSs still outstanding (after deduction of applicable fees, taxes and expenses).
In connection with any termination of the deposit agreement, the depositary may make available to owners of ADSs a means to withdraw the Class A ordinary shares represented by ADSs and to direct the depositary of such Class A ordinary shares into an unsponsored American depositary share program established by the depositary. The ability to receive unsponsored American depositary shares upon termination of the deposit agreement would be subject to satisfaction of certain U.S. regulatory requirements applicable to the creation of unsponsored American depositary shares and the payment of applicable depositary fees.
20
Books of Depositary
The depositary will maintain ADS holder records at its depositary office. You may inspect such records at such office during regular business hours but solely for the purpose of communicating with other holders in the interest of business matters relating to the ADSs and the deposit agreement.
The depositary will maintain in New York facilities to record and process the issuance, cancellation, combination, split-up and transfer of ADSs. These facilities may be closed from time to time, to the extent not prohibited by law.
Transmission of Notices, Reports and Proxy Soliciting Material
The depositary will make available for your inspection at its office all communications that it receives from us as a holder of deposited securities that we make generally available to holders of deposited securities. Subject to the terms of the deposit agreement, the depositary will send you copies of those communications or otherwise make those communications available to you if we ask it to.
Limitations on Obligations and Liabilities
The deposit agreement limits our obligations and the depositarys obligations to you. Please note the following:
| We and the depositary are obligated only to take the actions specifically stated in the deposit agreement without negligence or bad faith. |
| The depositary disclaims any liability for any failure to carry out voting instructions, for any manner in which a vote is cast or for the effect of any vote, provided it acts in good faith and in accordance with the terms of the deposit agreement. |
| The depositary disclaims any liability for any failure to accurately determine the lawfulness or practicality of any action, for the content of any document forwarded to you on our behalf or for the accuracy of any translation of such a document, for the investment risks associated with investing in Class A ordinary shares, for the validity or worth of the Class A ordinary shares, for any tax consequences that result from the ownership of ADSs or other deposited property, for the credit-worthiness of any third party, for allowing any rights to lapse under the terms of the deposit agreement, for the timeliness of any of our notices or for our failure to give notice or for any act or omission of or information provided by DTC or any DTC participant. |
| The depositary shall not be liable for acts or omissions of any successor depositary in connection with any matter arising wholly after the resignation or removal of the depositary. |
21
| We and the depositary will not be obligated to perform any act that is inconsistent with the terms of the deposit agreement. |
| We and the depositary disclaim any liability if we or the depositary are prevented or forbidden from or subject to any civil or criminal penalty or restraint on account of, or delayed in, doing or performing any act or thing required by the terms of the deposit agreement, by reason of any provision, present or future of any law or regulation, including regulations of any stock exchange or by reason of present or future provision of any provision of our articles of association, or any provision of or governing the securities on deposit, or by reason of any act of God or war or other circumstances beyond our control. |
| We and the depositary disclaim any liability by reason of any exercise of, or failure to exercise, any discretion provided for in the deposit agreement or in our articles of association or in any provisions of or governing the securities on deposit. |
| We and the depositary further disclaim any liability for any action or inaction in reliance on the advice or information received from legal counsel, accountants, any person presenting Shares for deposit, any holder of ADSs or authorized representatives thereof, or any other person believed by either of us in good faith to be competent to give such advice or information. |
| We and the depositary also disclaim liability for the inability by a holder or beneficial holder to benefit from any distribution, offering, right or other benefit that is made available to holders of Class A ordinary shares but is not, under the terms of the deposit agreement, made available to you. |
| We and the depositary may rely without any liability upon any written notice, request or other document believed to be genuine and to have been signed or presented by the proper parties. |
| We and the depositary also disclaim liability for any consequential or punitive damages for any breach of the terms of the deposit agreement. |
| We and the depositary disclaim liability arising out of losses, liabilities, taxes, charges or expenses resulting from the manner in which a holder or beneficial owner of ADSs holds ADSs, including resulting from holding ADSs through a brokerage account. |
| No disclaimer of any Securities Act liability is intended by any provision of the deposit agreement. |
| Nothing in the deposit agreement gives rise to a partnership or joint venture, or establishes a fiduciary relationship, among us, the depositary and you as ADS holder. |
| Nothing in the deposit agreement precludes Citibank (or its affiliates) from engaging in transactions in which parties adverse to us or the ADS owners have interests, and nothing in the deposit agreement obligates Citibank to disclose those transactions, or any information obtained in the course of those transactions, to us or to the ADS owners, or to account for any payment received as part of those transactions. |
22
Foreign Currency Conversion
The depositary will arrange for the conversion of all foreign currency received into U.S. dollars if such conversion is practical, and it will distribute the U.S. dollars in accordance with the terms of the deposit agreement. You may have to pay fees and expenses incurred in converting foreign currency, such as fees and expenses incurred in complying with currency exchange controls and other governmental requirements.
If the conversion of foreign currency is not practical or lawful, or if any required approvals are denied or not obtainable at a reasonable cost or within a reasonable period, the depositary may take the following actions in its discretion:
| Convert the foreign currency to the extent practical and lawful and distribute the U.S. dollars to the holders for whom the conversion and distribution is lawful and practical. |
| Distribute the foreign currency to holders for whom the distribution is lawful and practical. |
| Hold the foreign currency (without liability for interest) for the applicable holders. |
Governing Law/Waiver of Jury Trial
The deposit agreement, the ADRs and the ADSs will be interpreted in accordance with the laws of the State of New York. The rights of holders of Class A ordinary shares (including Class A ordinary shares represented by ADSs) are governed by the laws of the Cayman Islands.
As an owner of ADSs, you irrevocably agree that any legal action arising out of the Deposit Agreement, the ADSs or the ADRs, involving the Company or the Depositary, may only be instituted in a state or federal court in the city of New York.
AS A PARTY TO THE DEPOSIT AGREEMENT, YOU IRREVOCABLY WAIVE, TO THE FULLEST EXTENT PERMITTED BY APPLICABLE LAW, YOUR RIGHT TO TRIAL BY JURY IN ANY LEGAL PROCEEDING ARISING OUT OF THE DEPOSIT AGREEMENT OR THE ADRs AGAINST US AND/OR THE DEPOSITARY.
The deposit agreement provides that, to the extent permitted by law, ADS holders waive the right to a jury trial of any claim they may have against us or the depositary arising out of or relating to our Class A ordinary shares, the ADSs or the deposit agreement, including any claim under U.S. federal securities laws. If we or the depositary opposed a jury trial demand based on the waiver, the court would determine whether the waiver was enforceable in the facts and circumstances of that case in accordance with applicable case law. However, you will not be deemed, by agreeing to the terms of the deposit agreement, to have waived our or the depositarys compliance with U.S. federal securities laws and the rules and regulations promulgated thereunder.
23
Exhibit 4.27
Exclusive Business Cooperation Agreement
This Exclusive Business Cooperation Agreement (this Agreement) is made and entered into by and between the following parties on December 8, 2021, in Beijing, the Peoples Republic of China (China or the PRC).
Party A: | Beijing Absolute Health Co., Ltd. | |
Address: | 201, 2nd Floor, Tower C, No. 2, Lize 2nd Middle Park, Chaoyang District, Beijing; |
Party B: | Beijing Guangmu Weichen Technology Co., Ltd. | |
Address: | 231 South, No. 2202 B, 2nd Floor, Building No. 1, No. 208, Lize 1st Middle Park, Chaoyang District, Beijing; |
In this Agreement, each of Party A and Party B shall be hereinafter referred to as a Party individually, and as the Parties collectively.
Whereas:
1. | Party A is a wholly foreign-owned enterprise established in China, and has sufficient capacity and resources for providing technical development, technical promotion, technical transfer, technical consultation, technical services and organizing cultural and artistic exchange activities; |
2. | Party B is a company established in China with exclusive domestic capital and, is permitted by the relevant PRC government authorities to engage in technical development, technical consultation, technology transfer and promotion; retailing of Class I and II medical devices; health management (excluding medical treatment activities which need approvals); health consultation (excluding medical treatment activities which need approvals); software development; basis software services; application software services (excluding medical softwares); computer system services; data processing; enterprise management; market researching; economics and trading consultancy; enterprise management consulting; enterprise planning; advertisement designing, producing, agency and distribution; organizing exhibition activities; meeting services; packaging design; model design; trademark agency; organizing cultural and artistic exchange activities (excluding performances); Internet information services. The businesses conducted by Party B currently and at any time during the term of this Agreement are collectively referred to as the Principal Business; |
3. | Party A is willing to provide Party B with technical support, consultation and other services on an exclusive basis in relation to the Principal Business during the term of this Agreement, utilizing its advantages in technology, team, and information, and Party B is willing to accept such services provided by Party A or Party As designee(s), each on the terms set forth herein. |
Now, therefore, through mutual discussion, the Parties have reached the following agreements:
1
1. | Services Provided by Party A |
1.1 | Party B hereby appoints Party A as Party Bs exclusive services provider to provide Party B with comprehensive technical support, consulting services and other services during the term of this Agreement, in accordance with the terms and conditions of this Agreement, including but not limited to the following: |
(1) | Licensing Party B to use the related software legally owned by Party A; |
(2) | Development, maintenance and updating of related application software necessary for Party Bs business; |
(3) | Design, installation, daily management, maintenance and updating of network systems, hardware equipment and database; |
(4) | Technical support and training for employees of Party B; |
(5) | Assisting Party B in consulting, collection and research of technology and market information (excluding market research business that wholly foreign-owned enterprises are prohibited from conducting under PRC law); |
(6) | Providing business and management consultation for Party B; |
(7) | Providing marketing and promotional services for Party B; |
(8) | Provide customer order management and customer services for Party B; |
(9) | Leasing of equipment or properties; and |
(10) | Other related services requested by Party B from time to time to the extent permitted under PRC law. |
1.2 | Party B agrees to accept all the services provided by Party A. The Parties agree that Party A may designate its affiliates or other qualified service providers (such designated party may execute certain agreements described in Section 1.5 of this Agreement with Party B) to provide Party B with the services specified in this Agreement. Party B further agrees that unless with Party As prior written consent, during the term of this Agreement, Party B shall not directly or indirectly accept the same or any similar services provided by any third party and shall not establish similar corporation relationships with any third party regarding the matters contemplated by this Agreement. Both Parties agree that Party A may appoint or designate other parties to provide Party B with the services under this Agreement (the designated parties may enter into certain agreements as described in Section 1.3 with Party B). |
1.3 | Party A shall be entitled to inspect the accounts of Party B either on regularly basis or from time to time, and Party B shall ensure accurate and timely account recording and provide Party A with its accounts at the request of Party A. During the validity term of this Agreement and subject to any applicable laws, Party B agrees to cooperate with Party A and its shareholders (including, direct or indirect shareholders ) to audit the Party Bs accounts (including, without limitation, audit of related-party transactions and other aspects), to provide Party A, its shareholders and/or the auditors appointed by Party A with related information and data concerning the operation, business, clients, finance and employees of Party B and Party Bs subsidiaries, and agrees that Party As shareholders may disclose such information and data to satisfy its listed securities regulatory requirements. The Parties agree that, during the validity term of this Agreement, Party A shall be entitled to consolidate the financial results of Party B into that of Party A in accordance with applicable accounting standards as if Party B was a wholly owned subsidiary of Party A. However, Party A shall not bear any legal liabilities for any debts or other obligations or risks of Party B. |
2
1.4 | If Party B goes into liquidation or dissolution for any reason, to the extent permitted by the PRC laws, Party B shall form a liquidation team comprising members recommended by Party A to manage the properties of Party B and its subsidiaries. In such case, notwithstanding the enforceability of this Agreement, Party B agrees that it shall deliver all liquidated assets of Party B to Party A in accordance with PRC laws and regulations. |
1.5 | Service Providing Methodology and Financial Support |
1.5.1 | Party A and Party B agree that during the term of this Agreement, where necessary, Party B may enter into further service agreements with Party A or any other party designated by Party A, which shall provide the specific contents, methods, personnel, and fees for the specific services. |
1.5.2 | To fulfill this Agreement, Party A and Party B agree that during the term of this Agreement, where necessary, Party B may enter into equipment or property lease agreements with Party A or any other party designated by Party A which shall permit Party B to use Party As relevant equipment or property based on the business needs of Party B. |
1.5.3 | Party B hereby grants to Party A an irrevocable and exclusive option to purchase from Party B, at Party As sole discretion, any or all of the assets and business of Party B, to the extent permitted under PRC law, and at the lowest purchase price permitted by PRC law. The Parties shall then enter into a separate assets or business transfer agreement, specifying the terms and conditions of the transfer of the assets. |
1.5.4 | In order to ensure that the cash flow requirements in the ordinary course of business of Party B are satisfied and/or offset any losses arising from its course of business, Party A may provide financial support for Party B depending on the actual conditions ( but only within the scope and in a manner permitted by PRC laws). Party A may provide financial support for Party B by means of bank entrusted loans or other applicable lending methods, and enter into separate necessary agreements with Party B. |
3
1.6 | The Parties agree that the services provided by Party A to Party B under this Agreement shall be also applicable to the subsidiaries controlled by Party B, and Party B shall cause the subsidiaries controlled by it to exercise rights and perform obligations under this Agreement. |
2. | The Calculation and Payment of the Service Fees |
2.1 | During the term of this Agreement, the fees that Party B shall pay to Party A shall be calculated in the following way: |
2.1.1 | With regard to services provided by Party A to Party B, Party B shall pay Party A service fees annually. The service fees under this Agreement shall be the balance of the 100% gross consolidated profits of Party B for any financial year after offsetting the accumulated losses (if any) of Party B and its subsidiaries for the preceding financial years and deducting the working capital, expenses, taxes and other statutory contributions required for any financial year, and reasonable operation profits determined in accordance with applicable PRC tax law principles and tax practice. |
2.1.2 | In the event that Party A transfers technology to Party B or Party A is entrusted by Party B to develop software or other technology, or Party A leases equipment or properties to Party B, the technology transfer fees, entrusted development fees or rents shall be determined by the Parties based on the actual situation. |
2.1.3 | In addition to the service fees, Party B shall bear all the reasonable expenses, advance payments and out-of-pocket expenses in any form paid or incurred by Party A when performing or providing services, and shall pay Party A compensation accordingly. |
2.1.4 | The Parties shall respectively bear the taxes and fees for its execution and performance of this Agreement payable in accordance with laws. If requested by Party A, Party B shall use its best effort to assist Party A to obtain the treatment of exemption from value-added taxes on all or any part of its service fees income under this Agreement. |
Party B hereby acknowledges and agrees that, without prior written consent of Party A or persons designated by Party A, Party B will not conduct or prompt any activities or transactions that may materially affect Party Bs assets, business, personnel, obligations, rights or operations, or conduct or promote any activities or transactions that may materially affect Party Bs ability to perform its obligations under this Agreement.
4
3. | Intellectual Property Rights and Confidentiality Clauses |
3.1 | Party A shall have sole and exclusive ownership, rights and interests in any and all intellectual properties arising out of or created or developed during the performance of this Agreement, including but not limited to copyrights, patents, rights for patent applications, software, technical secrets, trade secrets and others. Party A shall be entitled to exercise such rights with no consideration. |
3.2 | For the needs of Party Bs business, Party A agrees that Party B may register part of the intellectual properties designated by Party A under Party Bs name. Notwithstanding the foregoing, if requested by Party A, Party B shall execute all appropriate documents, take all appropriate actions, submit all documents and/or applications, render all appropriate assistance and conduct other activities deemed to be necessary by Party A at its sole discretion, in order to grant the ownership, right or interest of any such intellectual properties to Party A, and/or to strengthen the protections for Party As rights for such intellectual properties. Party B unconditionally and irrevocably authorizes Party A to use any intellectual property registered in the name of Party B with no consideration. |
3.3 | The Parties acknowledge that the existence and the terms of this Agreement and any oral or written information exchanged between the Parties in connection with the preparation and performance of this Agreement are regarded as confidential information. Each Party shall maintain confidentiality of all such confidential information, and without obtaining the written consent of the other Party, it shall not disclose any relevant confidential information to any third party, except for the information that: (a) is or will be in the public domain (other than through the receiving Partys unauthorized disclosure); (b) is under the obligation to be disclosed pursuant to the applicable laws or regulations, rules of any stock exchange, or orders of the court or other government authorities; or (c) is required to be disclosed by any Party to its shareholders, directors, employees, legal counsels or financial advisors regarding the transaction contemplated hereunder, provided that such shareholders, directors, employees, legal counsels or financial advisors shall be bound by the confidentiality obligations similar to those set forth in this Section. Disclosure of any confidential information by the shareholders, director, employees of or agencies engaged by any Party shall be deemed disclosure of such confidential information by such Party and such Party shall be held liable for breach of this Agreement. |
4. | Representations and Warranties |
4.1 | Party A hereby represents, warrants and covenants as follows: |
5
4.1.1 | Party A is a wholly foreign-owned enterprise legally established and validly existing in accordance with the laws of China; Party A or the service providers designated by Party A will obtain all government permits and licenses necessary for providing the service under this Agreement before providing such services. |
4.1.2 | Party A has taken all necessary corporate actions, obtained all necessary authorizations as well as all consents and approvals from third parties and government agencies (if required) for the execution, delivery and performance of this Agreement. Party As execution, delivery and performance of this Agreement do not violate any explicit requirements under any law or regulation. |
4.1.3 | This Agreement constitutes Party As legal, valid and binding obligations, enforceable against it in accordance with its terms. |
4.2 | Party B hereby represents, warrants and covenants as follows: |
4.2.1 | Party B is a company legally established and validly existing in accordance with the laws of China, and Party B has obtained and will maintain all government permits and licenses required to engage in the Principal Business. |
4.2.2 | Party B has taken all necessary corporate actions, obtained all necessary authorizations as well as all consents and approvals from third parties and government agencies (if required) for the execution, delivery and performance of this Agreement. Party Bs execution, delivery and performance of this Agreement do not violate any explicit requirements under any law or regulation. |
4.2.3 | This Agreement constitutes Party Bs legal, valid and binding obligations, and shall be enforceable against it in accordance with its terms. |
4.2.4 | There is no occurred and ongoing litigation, arbitration or other judicial or administrative procedures that will affect Party Bs performance of the obligations under this Agreement, and no one has threatened to take the abovementioned actions to Party Bs knowledge. |
4.2.5 | Party B shall pay Party A the service fees in full and in time in accordance with the provisions of this Agreement. |
6
5. | Term of Agreement |
5.1 | This Agreement shall become effective upon duly executed by both Parties and shall remain effective permanently unless expressly provided hereof or determined to be terminated by Party A in writing. |
5.2 | During the term of this Agreement, each Party shall renew its operation term upon the expiration thereof, so as to enable this Agreement to remain effective. This Agreement shall be terminated upon the expiration of the operation term of a Party if the application for the renewal of its operation term is not approved or permitted by the competent government authorities. |
5.3 | Both Parties covenant that, in the event that Party A is permitted to directly hold the equity in Party B and Party A and/or its affiliates or branches are permitted to engage in Party Bs business under PRC laws, this Agreement shall be terminated immediately upon the equity in Party B is transferred to Party A according to the Exclusive Option Agreement entered into by and between Party B direct and indirect existing shareholders on the same day of this Agreement. |
5.4 | The rights and obligations of the Parties under Sections 3, 6, 7 and this Section 5.4 shall survive the termination of this Agreement. |
6. | Governing Law and Resolution of Disputes |
6.1 | The execution, effectiveness, construction, performance, amendment and termination of this Agreement and the resolution of disputes hereunder shall be governed by the laws of the PRC. |
6.2 | In the event of occurrence of any dispute arising from or with respect to the interpretation and performance of this Agreement, the Parties shall first resolve the dispute through friendly negotiations. Where the dispute is not solved within thirty (30) days after delivery of request for friendly negotiation by any Party to other Parties, either Party may submit the relevant dispute to the China International Economic and Trade Arbitration Commission for arbitration in accordance with its arbitration rules. The arbitration tribunal shall be consisted of three (3) arbitrators appointed according to abovementioned arbitration rules, one (1) arbitrator shall be appointed by the claimant, one (1) arbitrator shall be appointed by the respondent, and the third arbitrator shall be appointed by the negotiated designation of the first two arbitrators. The place of arbitration shall be Beijing. The arbitration award shall be final and binding on the Parties. |
6.3 | Under the appropriate circumstances permitted by PRC laws, the arbitral tribunal may grant any remedies, including temporary and permanent injunctive remedies (such as injunctive remedies for commercial activities, or injunctive remedies for forced transfer of assets), actual performance of contractual obligations, remedies for Party Bs equity or assets and rulings ordering Party B to wind up. Subject to PRC laws, while waiting for the formation of the arbitration tribunal or under appropriate circumstances, both Parties are entitled to seek temporary injunctive remedies or other temporary remedies from the court with jurisdiction to support the arbitration. In this regard, both Parties have reached a consensus that subject to applicable laws, the courts of Hong Kong, Cayman Islands, PRC and the location of Party Bs main assets shall all be deemed to have jurisdiction . |
7
6.4 | During the process of arbitration regarding any dispute arising from or with respect to the interpretation and performance of this Agreement or any other dispute, the Parties shall continue to exercise their respective rights under this Agreement and perform their respective obligations under this Agreement except for the matters under dispute. |
7. | Breach of Agreement and Indemnification |
7.1 | If Party B materially breaches any provision under this Agreement, Party A is entitled to terminate this Agreement and/or require Party B to compensate the losses. This Section 7.1 shall not prejudice any other rights of Party A under this Agreement. |
7.2 | Unless otherwise required by the applicable laws, Party B shall not terminate this Agreement in any event. |
7.3 | Party B shall indemnify Party A and hold Party A harmless from any losses, damages, obligations or expenses caused by any lawsuit, requests or other demands raised against Party A arising from or caused by the services provided by Party A to Party B pursuant this Agreement, except where such losses, damages, obligations or expenses arise from the gross negligence or willful misconduct of Party A. |
8. | Force Majeure |
8.1 | In the case of any force majeure events (Force Majeure) such as earthquakes, typhoons, floods, fires, flu, wars, strikes or any other events that cannot be predicted and are unpreventable and unavoidable by the affected Party, which directly causes the failure of either Party to perform or fully perform this Agreement, the Party affected by such Force Majeure shall not be liable for such failure in performance, partial performance. However, the Party affected by such Force Majeure shall give the other Party written notices without any delay, and shall provide details evidencing such event within 15 days after sending out such notice, explaining the reasons for such failure in performance, partial performance or delay in performance. |
8.2 | If such Party claiming Force Majeure fails to notify the other Party and furnish it with proof pursuant to the above provision, such Party shall not be excused from the non-performance of its obligations hereunder. The Party so affected by the event of Force Majeure shall use reasonable efforts to minimize the consequences of such Force Majeure and to promptly resume performance hereunder whenever the causes of such excuse are cured. Should the Party so affected by the event of Force Majeure fail to resume performance hereunder when the causes of such excuse are cured, such Party shall be liable to the other Party. |
8
8.3 | In the event of Force Majeure, the Parties shall immediately consult with each other to find an equitable solution and shall use all reasonable endeavours to minimize the consequences of such Force Majeure. |
9. Notices
9.1 | All notices and other communications required to be given or otherwise made pursuant to this Agreement shall be delivered personally, or sent by registered mail, prepaid postage, a commercial courier service or facsimile transmission to the receiving Partys following address with an additional copy delivered via email. The dates on which notices shall be deemed to have been effectively given shall be determined as follows: |
9.1.1 | Notices given by personal delivery, express services or registered mail, postage prepaid shall be deemed effectively given on the date of receipt or rejection at the designated address of notices; |
9.1.2 | Notices given by facsimile transmission shall be deemed effectively given on the date of successful delivery (which shall be evidenced by the automatically generated transmission confirmation message). |
9.1.3 | Notice given by e-mail shall be deemed effectively given on the date of successful delivery if the sending party receive a system massage indicating the delivery was successful or do not receive a system massage indication the e-mail has not been delivered or has been returned within 24 hours. However, if the e-mail is delivered later than 5:00 pm or on a non-business day at the place of delivery, the next business day of the date shown on the date record shall be the date of successful delivery. |
9.2 | For the purpose of notices, the addresses of the Parties are as follows: |
Party A: Beijing Absolute Health Co., Ltd.
Mailing Address: 201, 2nd Floor, Tower C, No. 2, Lize 2nd Middle Park, Chaoyang District, Beijing
Attn: SONG Nan
Tel.: 13601193404
Email: songnan@shuidi-inc.com
9
Party B: Beijing Guangmu Weichen Technology Co., Ltd.
Mailing Address: 231 South, No. 2202 B, 2nd Floor, Building No. 1, No. 208, Lize 1st Middle Park, Chaoyang District, Beijing
Attn: XING Liang
Tel.: 18513505608
Email: xingliang@shuidi-inc.com
9.3 | Any Party may at any time change its address for notices by a notice delivered to the other Party in accordance with the terms of this Section. |
10. | Assignment |
10.1 | Without Party As prior written consent, Party B shall not assign its rights and obligations under this Agreement to any third party. |
10.2 | Party B agrees that Party A may assign its obligations and rights under this Agreement to any third party and in case of such assignment, Party A is only required to give written notice to Party B and does not need any consent from Party B for such assignment. |
11. | Severability |
In the event that one or several of the provisions of this Agreement are held to be invalid, illegal or unenforceable in any aspect in accordance with any laws or regulations, the validity, legality or enforceability of the remaining provisions of this Agreement shall not be affected or compromised in any aspect. The Parties shall negotiate in good faith to replace such invalid, illegal or unenforceable provisions with effective provisions that accomplish to the greatest extent permitted by law and the intentions of the Parties, and the economic effect of such effective provisions shall be as close as possible to the economic effect of those invalid, illegal or unenforceable provisions.
12. | Amendments and Supplements |
This Agreement may be amended or supplemented by a written agreement executed by both Parties. Any amendment agreement and supplementary agreement duly executed by the Parties hereto with regard to this Agreement shall constitute an integral part of this Agreement, and shall have equal legal validity as this Agreement.
13. | Entire Agreement |
Except for the amendments, supplements or revision in writing executed after the execution of this Agreement, this Agreement shall constitute the entire agreement reached by and among the Parties hereto with respect to the subject matter hereof, and shall supersede all prior oral and written consultations, representations and contracts reached with respect to the subject matter of this Agreement
10
14. | Waivers |
Any Party may waive the terms and conditions of this Agreement, provided that such waiver must be provided in writing and executed by both Parties. The waiver by a Party in certain circumstances with respect to a breach by the other Party shall not be deemed as a waiver with respect to any similar breach in other circumstances.
15. | Language and Counterparts |
This Agreement is written in Chinese in two copies. Each Party has one copy. Each copy shall have the same effect.
[The reminder of this page is intentionally left blank.]
11
IN WITNESS WHEREOF, the Parties have caused their authorized representatives to execute this Exclusive Business Cooperation Agreement on the date first mentioned above, which shall take effects in accordance with provisions hereof.
Party A: Beijing Absolute Health Co., Ltd. (seal)
Authorized Representative: /s / SHEN Peng
(Company seal: /s/ Beijing Absolute Health Co., Ltd.)
Party B: Beijing Guangmu Weichen Technology Co., Ltd. (seal)
Authorized Representative: /s/ SUN Xiaolei
(Company seal: /s/ Beijing Guangmu Weichen Technology Co., Ltd.)
Signature Page to Exclusive Business Cooperation Agreement
Exhibit 4.28
Exclusive Option Agreement
This Exclusive Option Agreement (this Agreement) is executed by and among the following Parties as of December 8, 2021, in Beijing, the Peoples Republic of China (China or the PRC):
Party A: | Beijing Absolute Health Co., Ltd., a limited liability company organized and existing under the laws of the PRC, with its registered address at 201, 2nd Floor, Tower C, No. 2, Lize 2nd Middle Park, Chaoyang District, Beijing; |
Party B: | Shareholders of Party C as listed in Annex 1 to this Agreement |
Party C: | Beijing Guangmu Weichen Technology Co., Ltd., a limited liability company organized and existing under the laws of the PRC, with its registered address at 231 South, No. 2202 B, 2nd Floor, Building No. 1, No. 208, Lize 1st Middle Park, Chaoyang District, Beijing; |
In this Agreement, each of Party A, Party B and Party C shall be hereinafter referred to as a Party individually, and as the Parties collectively.
Whereas:
1. | Party B are the shareholders of Party C and as of the date hereof hold all of the equity interests in Party C. As of the date hereof, the amount of Party Bs capital contribution and shareholding percentage in Party Cs registered capital is specified in Annex I. Party C is a limited liability company established and registered in Beijing. |
2. | Party B agrees to grant Party A an exclusive option right pursuant to this Agreement, and Party A agrees to accept such exclusive option right upon exercise of which to purchase all or part of the equity interests held by Party B in Party C. |
In this regard, the Parties have reached the following agreement upon mutual discussion and negotiation:
1. | Sale and Purchase of Equity Interest |
1.1 | Option Granted |
Party B hereby irrevocably grants Party A an irrevocable and exclusive right to purchase, or designate one or more persons (each, a Designee) to purchase the equity interests in Party C then held by Party B one or more times at any time in part or in whole at Party As sole and absolute discretion at the price described in Section 1.3 herein to the extent permitted by PRC laws (such right being the Equity Interest Purchase Option). Except for Party A and the Designee(s), no other person shall be entitled to the Equity Interest Purchase Option or other rights with respect to the equity interests of Party B. Party C hereby agrees to the grant by Party B of the Equity Interest Purchase Option to Party A. Each of Party B hereby waives its respective preemptive right regarding Party Cs equity under Party Cs articles of association and PRC laws, and hereby irrevocably agrees to transfer Party Cs equity to Party A and/or the Designee. The term person as used herein shall refer to individuals, corporations, partnerships, partners, enterprises, trusts or non-corporate organizations.
1
1.2 | Steps for Exercise of the Equity Interest Purchase Option |
Subject to the provisions of the laws and regulations of China, Party A may exercise the Equity Interest Purchase Option by issuing a written notice to Party B (the Equity Interest Purchase Option Notice), specifying:(a) Party As or the Designee(s) decision to exercise the Equity Interest Purchase Option; (b) the respective portion of equity interests to be purchased by Party A or the Designee from Party B (the Optioned Interests); and (c) the date for purchasing the Optioned Interests or the date for the transfer of the Optioned Interests. If Party A and/or other foreign-invested or foreign entities designated by Party A are permitted to directly hold part or all of Party Cs equity interests and engage in foreign investment restriction/prohibition business through Party C under the laws and regulations of PRC, Party A shall issue the Equity Interest Purchase Option Notice as soon as practicable. The proportion of Party Cs equity interests that the Designee(s) purchase(s) from Party B shall not be less than the maximum limit of Party Cs equity interests permitted under PRC laws to be held by Party A and/or other foreign-invested or foreign entities designated by Party A.
1.3 | Equity Interest Purchase Price |
The total price for the purchase by Party A of all equity interest held by Party B upon exercise of the Equity Interest Purchase Option by Party A shall equal to the amount of registered capital contributed by Party B in Party C for such Optioned Interests (or such price may be as set forth in the equity share transfer contract to be executed between Party A (or the Designee) and Party B separately, provided that such price does not violate PRC laws and regulations and is acceptable to Party A, if required by Party A); if Party A exercises the Equity Interest Purchase Option to purchase part of the Optioned Interests held by Party B in Party C, then the purchase price shall be calculated on a pro rata basis. If at the time when Party A exercises the Equity Interest Purchase Option, the PRC laws impose mandatory requirements on the purchase price of such Optioned Interests, such that the minimum price permitted under PRC law is higher than the aforementioned price, then the purchase price shall be such minimum price permitted by PRC law (collectively, the Equity Interest Purchase Price).
1.4 | Transfer of Optioned Interests |
For each exercise of the Equity Interest Purchase Option:
1.4.1 | Party B shall cause Party C to promptly convene a shareholders meeting, at which a resolution shall be adopted approving Party Bs transfer of the Optioned Interests to Party A and/or the Designee(s); |
2
1.4.2 | Party B shall obtain written statements from the other shareholders of Party C giving consent to the transfer of the Optioned Interests by Party B to Party A and/or the Designee(s) and waiving any right of first refusal with respect thereto; |
1.4.3 | Party B shall execute an share transfer contract with respect to each transfer with Party A and/or each Designee (whichever is applicable), in accordance with the provisions of this Agreement and the Equity Interest Purchase Option Notice regarding the Optioned Interests; |
1.4.4 | Related Parties shall execute all other necessary contracts, agreements or documents with relevant parties, obtain all necessary government approvals and permits, and conduct all necessary actions, so as to transfer valid ownership of the Optioned Interests to Party A and/or the Designee(s), unencumbered by any security interests, and cause Party A and/or the Designee(s) to become the registered owner(s) of the Optioned Interests. For the purpose of this Section and this Agreement, security interests shall include securities, mortgages, third partys rights or interests, any stock options, acquisition right, right of first refusal, right to offset, ownership retention or other security arrangements, but shall be deemed to exclude any security interest created by this Agreement, Party Bs Equity Interest Pledge Agreement and Party Bs Power of Attorney. Party Bs Equity Interest Pledge Agreement as used in this Agreement shall refer to the Interest Pledge Agreement executed by and among Party A, Party B and Party C on the date hereof and any modification, amendment and restatement thereto.; Party Bs Power of Attorney as used in this Agreement shall refer to the Power of Attorney executed by Party B on the date hereof granting Party A with a power of attorney and any modification, amendment and restatement thereto. |
1.5 | Assets Purchase Option |
Party C hereby grants Party A an irrevocable and exclusive right to purchase, or Designee(s) to purchase the any part of or all of the assets of Party C at Party As sole and absolute discretion to the extent permitted by PRC laws and at the price permitted by PRC laws. Under such circumstances, Party A or the Designee(s) and Party C shall otherwise execute an asset transfer contract to agree on the terms and conditions of such asset transfer. Assets under this contract refer to assets directly or indirectly owned or controlled by the company from time to time and related to the companys business operations, including current assets, capital equity for outbound investment, fixed assets, and intangible assets (including but not limited to patent and non-patented technology), deferred assets, the available benefits under all contracts entered into, and any other benefits that should be obtained by the company, including assets directly or indirectly owned or controlled by the companys branches and offices from time to time.
3
2. | Covenants |
2.1 | Covenants regarding Party C |
Party B (as a shareholder of Party C) and Party C hereby covenant as follows:
2.1.1 | Without the prior written consent of Party A, they shall not in any manner supplement, change or amend the articles of association of Party C, increase or decrease Party Cs registered capital, or change its structure of registered capital in other manners; |
2.1.2 | They shall maintain Party Cs corporate existence in accordance with good financial and business standards and practices, obtain and maintain all necessary government licenses and permits by prudently and effectively operating its business and handling its affairs; |
2.1.3 | Without the prior written consent of Party A, Party C shall not at any time following the date hereof, sell, transfer, mortgage or dispose of in any manner any material assets of Party C or legal or beneficial interest exceeding RMB 100,000 in the material business or revenues of Party C, or allow the encumbrance thereon of any security interest; |
2.1.4 | Without the prior written consent of Party A, Party C shall not incur, inherit, guarantee or suffer the existence of any debt, except for payables incurred in the ordinary course of business other than through loans; |
2.1.5 | Party C shall always operate its businesses within the ordinary course of business to maintain the asset value of Party C and refrain from any action/omission that may adversely affect Party Cs operating status and asset value; |
2.1.6 | Without the prior written consent of Party A, Party C shall not execute any major contract or any other contract inconsistent with the major contract at present, except the contracts in the ordinary course of business (for the purpose of this subsection, a contract with a price exceeding RMB 100,000 shall be deemed a major contract); |
2.1.7 | Without the prior written consent of Party A, they shall not cause Party C to provide any person with any loan or credit, or provide guarantee to the debt of any third parties; |
2.1.8 | They shall provide Party A with information on Party Cs business operations and financial condition at Party As request; |
2.1.9 | If requested by Party A, they shall procure and maintain insurance in respect of Party Cs assets and business from an insurance carrier acceptable to Party A, at an amount and type of coverage typical for companies that operate similar businesses; |
4
2.1.10 | Without the prior written consent of Party A, they shall not cause or permit Party C to merge, consolidate with, acquire or invest in any person; |
2.1.11 | They shall immediately notify Party A of the occurrence or possible occurrence of any litigation, arbitration or administrative proceedings relating to Party Cs assets, business, revenue or equity interest; |
2.1.12 | To maintain the ownership by Party C of all of its assets, they shall execute all necessary or appropriate documents, take all necessary or appropriate actions, file all necessary or appropriate complaints, and raise necessary or appropriate defenses against all claims; |
2.1.13 | Without the prior written consent of Party A, Party C shall not in any manner distribute dividends to its shareholders, provided that upon Party As written request, Party C shall immediately distribute all distributable profits to its shareholders; |
2.1.14 | At the request of Party A, they shall appoint any person designated by Party A as the director or executive director, shareholder representative supervisor or other company management personnel who should be appointed and removed by shareholders of Party C; |
2.1.15 | Without Party As prior written consent, they shall not engage in any business in competition with Party A or its affiliates; |
2.1.16 | Unless otherwise required by PRC law, Party C shall not be dissolved or liquated without prior written consent by Party A; |
2.1.17 | If Party C is dissolved and liquidated in accordance with PRC laws, Party A may exercise Equity Interest Purchase Option and exercise all investor rights to Party C, and distribute Party Cs remaining properties in accordance with the laws (i.e., remaining properties after paying liquidation expenses, employee salaries, social insurance expenses and statutory compensation, paying taxes owed paying off company debts). If Party A does not exercise the Equity Interest Purchase Option by then, Party B shall timely donate the liquidation proceeds of Party C to Party A or any person designated by Party A in accordance with PRC laws. |
2.2 | Covenants of Party B |
Party B hereby covenants as follows:
2.2.1 | Without the prior written consent of Party A, Party B shall not sell, transfer, mortgage or dispose of in any other manner any legal or beneficial interest in the equity interests in Party C held by Party B, or allow the encumbrance thereon, except for the interest placed in accordance with Party Bs Equity Interest Pledge Agreement and Party Bs Power of Attorney; |
5
2.2.2 | Without the prior written consent of Party A, Party B shall cause the shareholders meeting and/or the directors (or the executive director) of Party C not to approve any sale, transfer, mortgage or disposition in any other manner of any legal or beneficial interest in the equity interests in Party C held by Party B, or allow the encumbrance thereon of any security interest, except for the approval of interest placed in accordance with Party Bs Equity Interest Pledge Agreement and Party Bs Power of Attorney; |
2.2.3 | Without the prior written consent of Party A, Party B shall cause the shareholders meeting and/or the directors (or the executive director) of Party C not to approve the merger or consolidation with any person, or the acquisition of or investment in any person; |
2.2.4 | Party B shall immediately notify Party A of the occurrence or possible occurrence of any litigation, arbitration or administrative proceedings relating to the equity interests in Party C held by Party B; |
2.2.5 | Party B shall ensure the shareholders (shareholders meeting) or the directors (or the executive director) of Party C to vote in favor of the transfer of the Optioned Interests as set forth in this Agreement and to take any and all other actions that may be requested by Party A; |
2.2.6 | To the extent necessary to maintain Party Bs ownership in Party C, Party B shall execute all necessary or appropriate documents, take all necessary or appropriate actions, file all necessary or appropriate complaints, and raise necessary or appropriate defenses against all claims; |
2.2.7 | Party B shall appoint any designee of Party A as the director or the executive director of Party C, at the request of Party A; |
2.2.8 | Party B hereby waives all of its right of first refusal (if any) in the event that other shareholders of Party C transfer equity interests to Party A. Party B gives consent to the execution by each of the other shareholders of Party C with Party A and Party C of the exclusive option agreement, the equity interest pledge agreement and the power of attorney similar to this Agreement, Party Bs Equity Interest Pledge Agreement and Party Bs Power of Attorney, and undertakes not to take any action in conflict with such documents executed by such other shareholders; |
2.2.9 | Party B shall promptly donate all such profit, interest, dividend or proceeds of liquidation received from Party C to Party A or any other person designated by Party A in accordance with the applicable PRC laws; |
6
2.2.10 | If Party B fails to fulfill its tax obligations under applicable laws which results in the impediment for Party A to exercise of Equity Interest Purchase Option and/or asset purchase option, Party A shall be entitled to require Party B to perform such tax obligations, or require Party B to pay such taxes to Party A, and Party A will pay such taxes; and |
2.2.11 | Party B shall strictly abide by the provisions of this Agreement and other contracts jointly or separately executed by and among Party B, Party C and Party A, perform the obligations hereunder and thereunder, and refrain from any action/omission that may affect the effectiveness and enforceability thereof. To the extent that Party B has any remaining rights with respect to the equity interests subject to this Agreement hereunder or under the Party Bs Equity Interest Pledge Agreement or under the Party Bs Power of Attorney, Party B shall not exercise such rights except in accordance with the written instructions of Party A. |
3. | Representations and Warranties |
Party B and Party C hereby represent and warrant to Party A, jointly and severally, as of the date of this Agreement and each date of the transfer of the Optioned Interests, that:
3.1 | They have the power, capacity and authority to execute and deliver this Agreement and any share transfer contract to which they are parties concerning each transfer of the Optioned Interests as described thereunder (each, a Transfer Contract), and to perform their obligations under this Agreement and any Transfer Contracts. Party B and Party C agree to enter into Transfer Contracts substantially consistent with the terms of this Agreement upon Party As exercise of the Equity Interest Purchase Option. This Agreement and the Transfer Contracts to which they are parties constitute or will constitute their legal, valid and binding obligations and shall be enforceable against them in accordance with the provisions thereof; |
3.2 | Party B and Party C have obtained any and all approvals and consents from the competent government authorities and third parties (if required) for the execution, delivery and performance of this Agreement. |
3.3 | The execution and delivery of this Agreement or any Transfer Contracts and the obligations under this Agreement or any Transfer Contracts shall not: (i) cause any violation of any applicable laws of China; (ii) be inconsistent with the articles of association, bylaws or other organizational documents of Party C; (iii) cause the violation of any contracts or instruments to which they are a party or which are binding on them, or constitute any breach under any contracts or instruments to which they are a party or which are binding on them; (iv) cause any violation of any condition for the grant and/or continued effectiveness of any licenses or permits issued to either of them; or (v) cause the suspension or revocation of or imposition of additional conditions to any licenses or permits issued to either of them; |
7
3.4 | Party B has the legal and complete title to the equity interests held by it in Party C. Except for Party Bs Equity Interest Pledge Agreement and Party Bs Power of Attorney, Party B has not placed any security interest or encumbrances on such equity interests; |
3.5 | Party C represents that Party C has good and sellable ownership of all assets, and there are no liens, mortgages, claims and other security rights and third-party rights on Party Cs assets; |
3.6 | Party C represents that Party C does not have any outstanding debts, except for (i) debt incurred during the ordinary course of business; and (ii) debts disclosed to Party A for which Party As written consent has been obtained. |
3.7 | Party C represents that Party C has complied with all PRC laws and regulations applicable to the acquisition of asset; and |
3.8 | Party C represents that there is no pending or threatened litigation, arbitration or administrative proceedings relating to the equity interests in Party C, assets of Party C or Party C. |
4. | Effective Date and Term |
4.1 | This Agreement shall become effective upon execution by the Parties, and remain effective until all equity interests held by Party B in Party C have been transferred or assigned to Party A and/or any other person designated by Party A in accordance with this Agreement. |
4.2 | During the term this Agreement, Party A may decide to terminate this Agreement unconditionally by issuing a written notice to Party B in advance without any liability at Party As own discretion. Except as otherwise required by PRC laws, Party B and Party C shall have no right to unilaterally terminate this agreement. |
5. | Governing Law and Resolution of Disputes |
5.1 | Governing Law |
The execution, effectiveness, interpretation, performance, amendment and termination of this Agreement and the resolution of disputes hereunder shall be governed by the laws of the PRC.
8
5.2 | Methods of Resolution of Disputes |
In the event of any dispute with respect to the interpretation and performance of this Agreement, the Parties shall first resolve the dispute through friendly negotiations. In the event the Parties fail to reach an agreement on the dispute within thirty (30) days upon a written notice requesting a negotiated settlement sent by one Party to the other Party, either Party may submit the relevant dispute to the China International Economic and Trade Arbitration Commission in Beijing for arbitration, in accordance with the arbitration rules of such arbitration commission effective at that time. The arbitration tribunal shall be consisted of three (3) arbitrators appointed according to abovementioned arbitration rules, one (1) arbitrator shall be appointed by the claimant, one (1) arbitrator shall be appointed by the respondent, and the third arbitrator shall be appointed by the negotiated designation of the first two arbitrators. The place of the hearing of the arbitration shall be Beijing. The arbitration award shall be final and binding on both Parties.
5.3 | Under the appropriate circumstances permitted by PRC laws, the arbitral tribunal may grant any remedies, including temporary and permanent injunctive remedies (such as injunctive remedies for commercial activities, or injunctive remedies for forced transfer of assets), actual performance of contractual obligations, remedies for Party Bs equity or assets and rulings ordering Party B to wind up. As permitted by PRC laws, while waiting for the formation of the arbitration tribunal or under appropriate circumstances, both Parties are entitled to seek temporary injunctive remedies or other temporary remedies to support the arbitration. In this regard, both Parties have reached a consensus that the courts of Hong Kong courts, Cayman Islands, PRC and the courts of where Party Bs main assets are located shall all be deemed to have jurisdiction without violating applicable laws. |
5.4 | Upon the occurrence of any disputes arising from the interpretation and performance of this Agreement or during the pending arbitration of any dispute, except for the matters under dispute, the Parties shall continue to exercise their respective rights under this Agreement and perform their respective obligations under this Agreement. |
6. | Taxes and Fees |
Each Party shall pay any and all transfer and registration taxes, expenses and fees incurred thereby or levied thereon in accordance with the laws of China in connection with the preparation and execution of this Agreement and the Transfer Contracts, as well as the consummation of the transactions contemplated under this Agreement and the Transfer Contracts.
7. | Notices |
7.1 | All notices and other communications required to be given or otherwise made pursuant to this Agreement shall be delivered personally, or sent by registered mail, prepaid postage, a commercial courier service or facsimile transmission to the receiving Partys following address with an additional copy delivered via email. The dates on which notices shall be deemed to have been effectively given shall be determined as follows: |
7.1.1 | Notices given by personal delivery, express services or registered mail, postage prepaid shall be deemed effectively given on the date of signed receipt or rejection; |
9
7.1.2 | Notices given by facsimile transmission shall be deemed effectively given on the date of successful delivery (which shall be evidenced by the automatically generated transmission confirmation message). |
7.1.3 | Notice given by e-mail shall be deemed effectively given on the date of successful delivery if the sending party receive a system massage indicating the delivery was successful or do not receive a system massage indication the e-mail has not been delivered or has been returned within 24 hours. However, if the e-mail is delivered later than 5:00 pm or on a non-business day at the place of delivery, the next business day of the date shown on the date record shall be the date of successful delivery. |
7.2 | For the purpose of notices, the contact information of the Parties are as follows: |
Party A: Beijing Absolute Health Co., Ltd.
Address: 201, 2nd Floor, Tower C, No. 2, Lize 2nd Middle Park, Chaoyang District, Beijing
Attn: SONG Nan
Telephone: 13601193404
Email: songnan@shuidi-inc.com
If to Party B and Party C:
Address: 231 South, No. 2202 B, 2nd Floor, Building No. 1, No. 208, Lize 1st Middle Park, Chaoyang District, Beijing
Attn: XING Liang
Telephone: 18513505608
Email: xingliang@shuidi-inc.com
7.3 | Any Party may at any time change its address for notices by a notice delivered to the other Party in accordance with the terms of this Section. |
8. | Confidentiality |
The Parties acknowledge that the existence and the terms of this Agreement, and any oral or written information exchanged between the Parties in connection with the preparation and performance of this Agreement are regarded as confidential information. Each Party shall maintain confidentiality of all such confidential information, and without obtaining the written consent of other Parties, it shall not disclose any relevant confidential information to any third parties, except for the information that: (a) is or will be in the public domain (other than through the receiving Partys unauthorized disclosure); (b) is under the obligation to be disclosed pursuant to the applicable laws or regulations, rules of any stock exchange, or orders of the court or other government authorities; or (c) is required to be disclosed by any Party to its shareholders, directors, employees, legal counsels or financial advisors regarding the transaction contemplated hereunder, provided that such shareholders, directors, employees, legal counsels, or financial advisors shall be bound by the confidentiality obligations similar to those set forth in this Section. Disclosure of any confidential information by the shareholders, director, employees of, or agencies engaged by any Party shall be deemed disclosure of such confidential information by such Party and such Party shall be held liable for breach of this Agreement.
10
9. | Further Warranties |
The Parties agree to promptly execute documents that are reasonably required for or are conducive to the implementation of the provisions and purposes of this Agreement and take further actions that are reasonably required for or are conducive to the implementation of the provisions and purposes of this Agreement.
10. | Breach of Agreement |
10.1 | If Party B or Party C materially breaches any provision under this Agreement, Party A is entitled to terminate this Agreement and/or require Party B or Party C to compensate the losses. This Section 10 shall not prejudice any other rights of Party A under this Agreement. |
10.2 | Unless otherwise required by the applicable laws, Party B or Party C shall not terminate this Agreement in any event. |
11. | Miscellaneous |
11.1 | Amendments, changes and supplements |
The amendment, change and supplement to this Agreement shall be made by all of the Parties in writing agreement.
11.2 | Entire agreement |
Except for the amendments, supplements or changes in writing executed after the execution of this Agreement, this Agreement shall constitute the entire agreement reached by and among the Parties hereto with respect to the subject matter hereof, and shall supersede all prior oral and written consultations, representations and contracts reached with respect to the subject matter of this Agreement.
11.3 | Headings |
The headings of this Agreement are for convenience only, and shall not be used to interpret, explain or otherwise affect the meanings of the provisions of this Agreement.
11.4 | Language |
This Agreement is written in both Chinese in four copies, each Party having one copy.
11
11.5 | Severability |
In the event that one or several of the provisions of this Agreement are held to be invalid, illegal or unenforceable in any aspect in accordance with any laws or regulations, the validity, legality or enforceability of the remaining provisions of this Agreement shall not be affected or compromised in any respect. The Parties shall strive in good faith to replace such invalid, illegal or unenforceable provisions with effective provisions that accomplish to the greatest extent permitted by law and the intentions of the Parties, and the economic effect of such effective provisions shall be as close as possible to the economic effect of those invalid, illegal or unenforceable provisions.
11.6 | Successors |
The terms of this Agreement shall be binding on the Parties hereto and their respective successors and permitted assigns by each Party, and shall be valid.
11.7 | Survival |
11.7.1 | Any obligations that occurred or that are due in connection with this Agreement before the expiration or early termination of this Agreement shall survive the expiration or early termination thereof. |
11.7.2 | The provisions of Sections 5, 8, 10 and this Section 11.7 shall survive the termination of this Agreement. |
11.8 | Waivers |
Any Party may waive the terms and conditions of this Agreement, provided that such a waiver must be provided in writing and shall require the signatures of the Parties. No waiver by any Party in certain circumstances with respect to a breach by other Parties shall operate as a waiver by such a Party with respect to any similar breach in other circumstances.
[The reminder of this page is intentionally left blank.]
12
IN WITNESS WHEREOF, the Parties have caused their authorized representatives to execute this Exclusive Option Agreement as of the date first above written.
Party A: Beijing Absolute Health Co., Ltd. (seal) |
Authorized Representative: /s/ SHEN Peng |
(Company seal: /s/ Beijing Absolute Health Co., Ltd.) |
Party B: /s/ SUN Xiaolei |
Party B: /s/ LIU Nian |
Party C: Beijing Guangmu Weichen Technology Co., Ltd. (seal) |
Authorized Representative: /s/ SUN Xiaolei |
(Company seal: /s/ Beijing Guangmu Weichen Technology Co., Ltd.) |
Signature Page to Exclusive Option Agreement
Exhibit 4.29
Equity Interest Pledge Agreement
This Equity Interest Pledge Agreement (this Agreement) has been executed by and among the following parties on December 8, 2021 in Beijing, the Peoples Republic of China (China or PRC).
Party A: | Beijing Absolute Health Co., Ltd. (hereinafter the Pledgee), a limited liability company established and existing under the laws of the PRC, with its registered address at 201, 2nd Floor, Tower C, No. 2, Lize 2nd Middle Park, Chaoyang District, Beijing. | |
Party B: | Party Cs all shareholders as listed in Annex I of this Agreement (Herein- after referred to individually as Pledgor, collectively as Pledgors); and | |
Party C: | Beijing Guangmu Weichen Technology Co., Ltd., a limited liability company established and existing under the laws of the PRC, with its registered address at 231 South, No. 2202 B, 2nd Floor, Building No. 1, No. 208, Lize 1st Middle Park, Chaoyang District, Beijing. |
In this Agreement, each of Pledgee, Pledgors and Party C shall be referred to individually as a Party, collectively as the Parties.
Whereas:
1. | Pledgors are the registered shareholders of Party C and lawfully hold all the equity of Party C. As of the effective date of this Agreement, Party Cs ownership structure is as shown in Annex I hereto. Party C is a limited liability company registered in Beijing, China. Party C acknowledges the respective rights and obligations of Pledgors and Pledgee under this Agreement, and intends to provide any necessary assistance in registering the Pledge; |
2. | Pledgee is a wholly foreign owned enterprise registered in China. Pledgee and Party C which is wholly owned by the Pledgors have executed an Exclusive Business Cooperation Agreement (as defined below) in Beijing; Pledgee, Pledgors and Party C have executed an Exclusive Option Agreement (as defined below); each Pledgor has executed a Power of Attorney (as defined below) in favor of Pledgee. |
3. | To ensure that Party C and Pledgors fully perform their obligations under the Exclusive Business Cooperation Agreement, the Exclusive Option Agreement and the Power of Attorney, each Pledgor hereby pledges to the Pledgee all of the equity interest that such Pledgor holds in Party C as security for fulfillment by Party C and Pledgors of their obligations under the Exclusive Business Cooperation Agreement, the Exclusive Option Agreement and the Power of Attorney . |
To perform the provisions of the Transaction Documents (as defined below), the Parties have mutually agreed to execute this Agreement upon the following terms.
1
Section 1 Definitions
Unless otherwise provided herein, the terms below shall have the following meanings:
1.1 | Pledge: shall refer to the security interest granted by Pledgors to Pledgee pursuant to Section 2 of this Agreement, i.e., the right of Pledgee to be compensated on a preferential basis with the conversion, auction or sales price of the Equity Interest. |
1.2 | Equity Interest: shall refer to all equity interests in Party C lawfully owned by Pledgors as of the date of this Agreement (for details of Equity Interest of each Pledgor, please refer to Annex I), and all of the equity interests hereafter acquired by Pledgors in Party C. |
1.3 | Term of Pledge: shall refer to the term set forth in Section 3 of this Agreement. |
1.4 | Transaction Documents: the Exclusive Business Cooperation Agreement executed on December 8, 2021 (Exclusive Business Cooperation Agreement) by and between Party C and Pledgee; the Exclusive Option Agreement executed on December 9, 2021 (Exclusive Option Agreement) by and among Party C, Pledgors and Pledgee and the Power of Attorney executed by the Pledgors on December 8, 2021 (Power of Attorney), and any modification, amendment and/or restatement to the aforementioned documents. |
1.5 | Contract Obligations: shall refer to all the obligations of Pledgors under the Exclusive Option Agreement, the Loan Agreement, the Power of Attorney and this Agreement; all the obligations of Party C under the Exclusive Business Cooperation Agreement, the Exclusive Option Agreement, the Loan Agreement and this Agreement. |
1.6 | Secured Indebtedness: shall refer to all the direct, indirect and derivative losses and losses of anticipated profits, suffered by Pledgee, incurred as a result of any Event of Default. The amount of such loss shall be calculated in accordance with the reasonable business plan and profit forecast of Pledgee, the consulting and service fees payable to Pledgee under the Exclusive Business Cooperation Agreement, all expenses occurred in connection with enforcement by Pledgee of Pledgors and/or Party Cs Contract Obligations and etc.. |
1.7 | Event of Default: shall refer to any of the circumstances set forth in Section 7 of this Agreement. |
1.8 | Notice of Default: shall refer to the notice issued by Pledgee in accordance with this Agreement declaring an Event of Default. |
2
Section 2 The Pledge
2.1 | Pledgors agree to pledge all the Equity Interest as security for performance of the Contract Obligations and payment of the Secured Indebtedness under this Agreement. Party C hereby assents that Pledgors pledge the Equity Interest to the Pledgee pursuant to this Agreement. |
2.2 | During the term of the Pledge, Pledgee is entitled to receive dividends distributed on the Equity Interest. Pledgors may receive dividends distributed on the Equity Interest only with prior written consent of Pledgee. Dividends received by Pledgors on Equity Interest after deduction of individual income tax paid by Pledgors shall be, as required by Pledgee, (1) deposited into an account designated and supervised by Pledgee and used to secure the Contract Obligations and pay the Secured Indebtedness prior and in preference to any other payment; or (2) unconditionally donated to Pledgee or any other person designated by Pledgee to the extent permitted under applicable PRC laws. |
2.3 | Pledgors may subscribe for capital increase in Party C only with prior written consent of Pledgee. Any equity interest obtained by Pledgors as a result of such Pledgors subscription of the increased registered capital of Party C shall also be deemed as Equity Interest. |
2.4 | In the event that Party C is required by PRC law to be liquidated or dissolved, any interest distributed to Pledgors upon Party Cs dissolution or liquidation shall, upon the request of the Pledgee, be (1) deposited into an account designate and supervised by Pledgee and used to secure the Contract Obligations and pay the Secured Indebtedness prior and in preference to any other payment; or (2) unconditionally donated to Pledgee or any other person designated by Pledgee under the premise of compliance with applicable PRC laws. |
Section 3 Term of Pledge
3.1 | The Pledge shall become effective on such date when the pledge of the Equity Interest contemplated herein has been registered with relevant administration for market regulation (the AMR), and thereafter shall be continuously valid until all Contract Obligations have been fulfilled and all Secured Indebtedness have been repaid up. Pledgors and Party C shall (a) register the Pledge hereof in the shareholders register of Party C within 3 business days following the execution of this Agreement, and (b) fulfill the registration of the Pledge hereof at AMR as soon as possible following the execution of this Agreement. The Parties jointly confirm that for the purpose of registering the Pledge with the AMR, the Parties and other shareholders of Party C shall, submit a copy of this Agreement or an equity pledge agreement executed in the form required by the local AMR where Party C resides which shall truly reflect the information of the Pledge hereunder (the AMR Equity Pledge Agreement) to the AMR. Where there is any inconsistency between AMR Equity Pledge Agreement and this Agreement and Transaction Documents, this Agreement and Transaction Documents shall prevail. Pledgors and Party C shall submit all necessary documents and complete all necessary procedures, pursuant to the PRC laws and regulations and the requirements of relevant AMR, to ensure that the Pledge shall be registered as soon as possible after filing. |
3
3.2 | During the Term of the Pledge, in the event the Pledgors and/or Party C fail to perform the Contract Obligations or pay Secured Indebtedness, the Pledgee shall have the right, but not the obligation, to exercise the Pledge in accordance with the provisions of this Agreement. |
Section 4 Custody of Records for Equity Interest subject to Pledge
4.1 | During the Term of the Pledge set forth in this Agreement, the Pledgors shall deliver to the Pledgees custody the capital contribution certificate for the Equity Interest and the shareholders register containing the Pledge within one week from the execution of this Agreement. The Pledgee shall have custody of such documents during the entire Term of the Pledge set forth in this Agreement. |
Section 5 Representations and Warranties of Pledgors and Party C
As of the execution of this Agreement, Pledgors and Party C hereby jointly and respectively represent and warrant to Pledgee that:
5.1 | Pledgors are the sole legal and beneficial owner of the Equity Interest. |
5.2 | Pledgee shall have the right to dispose of and transfer the Equity Interest in accordance with the provisions set forth in this Agreement. |
5.3 | Except for the Pledge and the Transaction Documents, Each Pledgor has not placed any security interest or other encumbrance on the Equity Interest. |
5.4 | Pledgors and Party C have obtained any and all approvals and consents from applicable government authorities and third parties (if required) for execution, delivery and performance of this Agreement. |
5.5 | The execution, delivery and performance of this Agreement will not: (i) violate any relevant PRC laws; (ii) conflict with Party Cs Sections of association or other constitutional documents; (iii) result in any breach of or constitute any default under any contract or instrument to which it is a party or by which it is otherwise bound; (iv) result in any violation of any related condition for the grant and/or maintenance of any permit or approval granted to any Party; or (v) cause any permit or approval granted to any Party to be suspended, cancelled or attached with additional conditions. |
Section 6 Covenants of Pledgors and Party C
6.1 | During the term of this Agreement, Pledgors and Party C hereby jointly and respectively covenant to the Pledgee: |
6.1.1 | Pledgors shall not transfer the Equity Interest, place or permit the existence of any security interest or other encumbrance on the Equity Interest or any portion thereof, without the prior written consent of Pledgee, except for the performance of the Transaction Documents; |
4
6.1.2 | Pledgors and Party C shall comply with the provisions of all laws and regulations related to the pledge of rights, and within ten (10) days of receipt of any notice, order or recommendation issued or prepared by relevant competent authorities regarding the Pledge, shall present the aforementioned notice, order or recommendation to Pledgee, and shall comply with the aforementioned notice, order or recommendation or submit objections and representations with respect to the aforementioned matters upon Pledgees reasonable request or upon consent of Pledgee; |
6.1.3 | Pledgors and Party C shall promptly notify Pledgee of any event or notice received by Pledgors that may cause any impact on the Equity Interest or any portion thereof, as well as any event or notice received by Pledgors that may have an impact on any guarantees and other obligations of Pledgors arising out of this Agreement. |
6.1.4 | To maintain the validity of this Agreement, Party C shall complete the registration for the extension of its operation term within three (3) months prior to the expiration of its operation term. |
6.2 | Pledgors agree that the rights acquired by Pledgee in accordance with this Agreement with respect to the Pledge shall not be interrupted or harmed by Pledgors or any heirs or representatives of such Pledgors or any other persons through any legal proceedings. |
6.3 | To protect or perfect the security interest granted by this Agreement for fulfillment of Contract Obligations and repayment of Secured Indebtedness, Pledgors hereby undertake to execute in good faith and to cause other parties who have an interest in the Pledge to execute all certificates, agreements, deeds and/or covenants required by Pledgee. Pledgors also undertake to perform and to cause other parties who have an interest in the Pledge to perform actions required by Pledgee, to facilitate the exercise by Pledgee of its rights and authority granted thereto by this Agreement, and to enter into all relevant documents regarding ownership of Equity Interest with Pledgee or designee(s) of Pledgee (natural persons/legal persons). Pledgors undertake to provide Pledgee within a reasonable time with all notices, orders and decisions regarding the Pledge that are required by Pledgee. |
6.4 | Pledgors hereby undertake to comply with and perform all guarantees, promises, agreements, representations and conditions under this Agreement. In the event of failure or partial performance of its guarantees, promises, agreements, representations and conditions, Pledgors shall indemnify Pledgee for all losses resulting therefrom. |
5
Section 7 Event of Default
7.1 | The following circumstances shall be deemed Event of Default: |
7.1.1 | Pledgors any breach to any obligations under the Transaction Documents and/or this Agreement. |
7.1.2 | Party Cs any breach to any obligations under the Transaction Documents and/or this Agreement. |
7.2 | Upon notice or discovery of the occurrence of any circumstances or event that may lead to the aforementioned circumstances described in Section 7.1, Pledgors and Party C shall immediately notify Pledgee in writing accordingly. |
7.3 | Unless an Event of Default set forth in this Section 7.1 has been successfully resolved to Pledgees satisfaction within twenty (20) days after the Pledgee and/or Party C delivers a notice to the Pledgors requesting rectification of such Event of Default, Pledgee may issue a Notice of Default to Pledgors in writing at any time thereafter, demanding the exercise of Pledge in accordance with the provisions of Section 8 of this Agreement. |
Section 8 Exercise of Pledge
8.1 | Pledgee shall issue a Notice of Default to Pledgors when exercising the Pledge. |
8.2 | Subject to the provisions of Section 7.3, Pledgee may exercise the right to enforce the Pledge at any time after the issuance of the Notice of Default. Once Pledgee elects to enforce the Pledge, Pledgors shall cease to be entitled to any rights or interests associated with the Equity Interest. |
8.3 | After Pledgee issues a Notice of Default to Pledgors in accordance with Section 8.1, Pledgee may exercise any remedy measure under applicable PRC laws, the Transaction Documents and this Agreement, including but not limited to being paid in priority with the Equity Interest based on the monetary valuation that such Equity Interest is converted into or from the proceeds from auction or sale of the Equity Interest. The Pledgee shall not be liable for any loss incurred by its duly exercise of such rights and powers. |
8.4 | The proceeds from exercise of the Pledge by Pledgee shall be used to pay for tax and expenses incurred as result of disposing the Equity Interest and to perform Contract Obligations and pay the Secured Indebtedness to the Pledgee prior and in preference to any other payment. After the payment of the aforementioned amounts, the remaining balance shall be returned to Pledgors or any other person who have rights to such balance under applicable laws or be deposited to the local notary public office where such Pledgor resides, with all expense incurred being borne by such Pledgor. To the extent permitted under applicable PRC laws, Pledgors shall unconditionally donate the aforementioned proceeds to Pledgee or any other person designated by Pledgee. |
6
8.5 | Pledgee may exercise any remedy measure available simultaneously or in any order. Pledgee may exercise the right to being paid in priority with the Equity Interest based on the monetary valuation that such Equity Interest is converted into or from the proceeds from auction or sale of the Equity Interest under this Agreement, without exercising any other remedy measure first. |
8.6 | Pledgee is entitled to designate an attorney or other representatives to exercise the Pledge on its behalf, and Pledgors or Party C shall not raise any objection to such exercise. |
8.7 | When Pledgee disposes of the Pledge in accordance with this Agreement, Pledgors and Party C shall provide necessary assistance to enable Pledgee to enforce the Pledge in accordance with this Agreement. |
8.8 | Any expenses incurred by the Pledgee in disposing of the Pledge in accordance with this Agreement (including appointing its lawyers or other agents to exercise its pledge) shall be borne by Party C. |
Section 9 Breach of Agreement
9.1 | If Pledgors or Party C conducts any material breach of any term of this Agreement, Pledgee shall have right to terminate this Agreement and/or require Pledgors or Party C to indemnify all damages; this Section 9 shall not prejudice any other rights of Pledgee herein; |
9.2 | Pledgors and Party C shall not have any right to terminate this Agreement in any event unless otherwise required by the applicable laws. |
Section 10 Assignment
10.1 | Without Pledgees prior written consent, Pledgors and Party C shall not have the right to donate or assign their rights and obligations under this Agreement. |
10.2 | This Agreement shall be binding on Pledgors and his/her heirs and permitted assigns, and shall be valid with respect to Pledgee and each of his/her heirs and assigns. |
10.3 | At any time, Pledgee may assign any and all of its rights and obligations under the Transaction Documents and under this Agreement to its designee(s), in which case the designee shall have the rights and obligations of Pledgee under the Transaction Documents and this Agreement, as if it were the original party to the Transaction Documents and this Agreement. |
7
10.4 | In the event of a change in Pledgee due to an assignment, Pledgors and/or Party C shall, at the request of Pledgee, execute a new pledge agreement with the new pledgee on the same terms and conditions as this Agreement, and register the same with the relevant AMR. |
10.5 | Pledgors and Party C shall strictly abide by the provisions of this Agreement and other contracts jointly or separately executed by the Parties hereto or any of them, including the Transaction Documents, perform the obligations hereunder and thereunder, and refrain from any action/omission that may affect the effectiveness and enforceability thereof. Any remaining rights of Pledgors with respect to the Equity Interest pledged hereunder shall not be exercised by any Pledgors except in accordance with the written instructions of Pledgee. |
Section 11 Termination
11.1 | This Agreement shall be terminated upon the fulfillment of all Contract Obligations and the full repayment of all Secured Indebtedness. Upon the fulfillment of all Contract Obligations and the full repayment of all Secured Indebtedness by Pledgors and Party C, Pledgee shall release the Pledge under this Agreement upon Pledgors request as soon as reasonably practicable and shall assist Pledgors to de-register the Pledge from the shareholders register of Party C and cancel the registration of Pledge with relevant AMR. |
11.2 | The provisions under Sections 9, 13, 14 and 11.2 herein of this Agreement shall survive the expiration or termination of this Agreement. |
Section 12 Handling Fees and Other Expenses
All fees and out of pocket expenses relating to this Agreement, including but not limited to legal costs, costs of production, stamp tax and any other taxes and fees, shall be borne by Party C.
Section 13 Confidentiality
The Parties acknowledge that the existence and the terms of this Agreement and any oral or written information exchanged between the Parties in connection with the preparation and performance this Agreement are regarded as confidential information. Each Party shall maintain the confidentiality of all such confidential information, and without obtaining the written consent of the other Party, it shall not disclose any relevant confidential information to any third parties, except for the information that: (a) is or will be in the public domain (other than through the receiving Partys unauthorized disclosure); (b) is under the obligation to be disclosed pursuant to the applicable laws or regulations, rules of any stock exchange, or orders of the court or other government authorities; or (c) is required to be disclosed by any Party to its shareholders, directors, employees, legal counsels or financial advisors regarding the transaction contemplated hereunder, provided that such shareholders, directors, employees, legal counsels or financial advisors shall be bound by the confidentiality obligations similar to those set forth in this Section. Disclosure of any confidential information by the shareholders, director, employees of or agencies engaged by any Party shall be deemed disclosure of such confidential information by such Party and such Party shall be held liable for breach of this Agreement.
8
Section 14 Governing Law and Resolution of Disputes
14.1 | The execution, effectiveness, construction, performance, amendment and termination of this Agreement and the resolution of disputes hereunder shall be governed by the laws of the PRC. |
14.2 | In the event of occurrence of any dispute arising from or with respect to the interpretation and performance of this Agreement, the Parties shall first resolve the dispute through friendly negotiations. Where the dispute is not solved within 30 days after delivery of request for friendly negotiation by any Party to other Parties, either Party may submit the relevant dispute to the China International Economic and Trade Arbitration Commission for arbitration in accordance with its arbitration rules. The place of arbitration shall be Beijing. The arbitration tribunal shall be consisted of three (3) arbitrators appointed according to abovementioned arbitration rules, one (1) arbitrator shall be appointed by the claimant, one (1) arbitrator shall be appointed by the respondent, and the third arbitrator shall be appointed by the negotiated designation of the first two arbitrators. The arbitration award shall be final and binding on the Parties. |
14.3 | Where appropriate, the arbitration tribunal or arbitrators may, in accordance with this Section 14 and/or applicable PRC law, rule on remedies in respect of Party Cs equity or assets or the assets of the Pledgors, including restrictions on business operations, restrictions or prohibitions on transfers or selling equity or assets or proposing to liquidate Party C. In addition, during the formation of the arbitration tribunal, the Pledgee has the right to grant interim relief to any court of competent jurisdiction (including the courts of PRC, Hong Kong and the Cayman Islands). |
14.4 | During the process of arbitration regarding any dispute arising from or with respect to the interpretation and performance of this Agreement or any other dispute, the Parties shall continue to exercise their respective rights under this Agreement and perform their respective obligations under this Agreement except for the matters under dispute. |
Section 15 Notices
15.1 | All notices and other communications required or permitted to be given pursuant to this Agreement shall be delivered personally or sent by registered mail, postage prepaid, by a commercial courier service or by facsimile transmission to the address of such party below. A confirmation copy of each notice shall also be sent by E-mail. The dates on which notices shall be deemed to have been effectively given shall be determined as follows: |
9
15.1.1 | Notices given by personal delivery, courier service, registered mail or prepaid postage shall be deemed effectively given on the date of receipt or refusal at the address set forth below. |
15.1.2 | Notices given by facsimile transmission shall be deemed effectively given on the date of successful transmission to the Fax no. set forth below (as evidenced by an automatically generated confirmation of transmission). |
15.1.3 | Notice given by e-mail shall be deemed effectively given on the date of successful delivery if the sending party receive a system massage indicating the delivery was successful or do not receive a system massage indication the e-mail has not been delivered or has been returned within 24 hours. However, if the e-mail is delivered later than 5:00 pm or on a non-business day at the place of delivery, the next business day of the date shown on the date record shall be the date of successful delivery. |
15.2 | For the purpose of notices, the addresses of the Parties are as follows: |
Party A: Beijing Absolute Health Co., Ltd.
Address: 201, 2nd Floor, Tower C, No. 2, Lize 2nd Middle Park, Chaoyang District, Beijing
Attn: SONG Nan
Telephone: 13601193404
Email: songnan@shuidi-inc.com
If to Party B and Party C:
Address: 231 South, No. 2202 B, 2nd Floor, Building No. 1, No. 208, Lize 1st Middle Park, Chaoyang District, Beijing
Attn: XING Liang
Telephone: 18513505608
Email: xingliang@shuidi-inc.com
15.3 | Any Party may at any time change its address for notices by a notice delivered to the other Parties in accordance with the terms of this Section. |
Section 16 Severability
In the event that one or several of the provisions of this Contract are found to be invalid, illegal or unenforceable in any aspect in accordance with any laws or regulations, the validity, legality or enforceability of the remaining provisions of this Contract shall not be affected or compromised in any respect. The Parties shall strive in good faith to replace such invalid, illegal or unenforceable provisions with effective provisions that accomplish to the greatest extent permitted by law and the intentions of the Parties, and the economic effect of such effective provisions shall be as close as possible to the economic effect of those invalid, illegal or unenforceable provisions.
10
Section 17 Effectiveness
17.1 | This Agreement shall become effective upon execution by the Parties |
17.2 | Any amendments, supplements and changes to this Agreement shall be in writing and shall become effective upon completion of the governmental filing procedures (if applicable) after the affixation of the signatures or seals of the Parties. |
Section 18 Language and Counterparts
This Agreement is written in Chinese in five copies. The Pledgors, the Pledgee and Party C shall hold one copy respectively and the other copy shall be used for registration.
[The Remainder of this page is intentionally left blank]
11
IN WITNESS WHEREOF, the Parties have caused their authorized representatives to execute this Equity Interest Pledge Agreement as of the date first above written.
Party A: Beijing Absolute Health Co., Ltd. (seal)
Authorized Representative: /s / SHEN Peng
(Company seal: /s/ Beijing Absolute Health Co., Ltd.)
Party B: /s/ SUN Xiaolei
Party B: /s/ LIU Nian
Party C: Beijing Guangmu Weichen Technology Co., Ltd. (seal)
Authorized Representative: /s/ SUN Xiaolei
(Company seal: /s/ Beijing Guangmu Weichen Technology Co., Ltd.)
Signature Page to Equity Interest Pledge Agreement
Annex I Party Cs Ownership Structure Name of Shareholder SUN Xiaolei LIU Nian Total Annex I to Equity
Interest Pledge Agreement
Subscribed
Registered
Capital (RMB)
Shareholding
Percentage
990,000.00
99
%
10,000.000
1
%
1,000,000.00
100
%
Exhibit 4.30
Power of Attorney
I, SUN Xiaolei, a citizen of the Peoples Republic of China (China or the PRC) whose Identification Card No. is [***], and a holder of 99% of the registered capital of Beijing Guangmu Weichen Technology Co., Ltd. (Guangmu Weichen) as of the date of this Power of Attorney, hereby irrevocably authorize and entrust Beijing Absolute Health Co., Ltd. (WFOE) to exercise the following rights and handle the following matters on my behalf relating to all equity interests held by me now and in the future (My Shareholding) in Guangmu Weichen, during the term of this Power of Attorney:
WFOE or any person(s) designated by WFOE (including but not limited to directors of WFOEs parent company Waterdrop Group HK Limited, successors of such directors and liquidators in replacement of such directors, excluding any non-independent persons or persons who may result in the conflicts of interest) (Agent) is hereby authorized to act on my behalf as my sole and exclusive agent to exercise the rights with respect to all matters concerning My Shareholding, including without limitation to: (1) as the shareholders proxy, convening and attending shareholders meetings of Guangmu Weichen according to the companys articles of association, (2) exercising all of the shareholders rights and shareholders voting rights that I am entitled to under the laws of China and the articles of association of Guangmu Weichen (including any other shareholder voting rights stipulated after the amendments to the articles of association), including without limitation handling the sale, transfer, pledge or disposition of My Shareholding in part or in whole, (3) representing myself in appointing and nominating any legal representative, director, supervisor, chief manager and other executive of Guangmu Weichen, and (4) sign the notice of the shareholders meeting, the meeting minutes and resolutions on behalf of the shareholders, and submit the documents required for the approval, registration and filing related to the companys operation to the relevant government departments (including the company registration management department) on behalf of the shareholders.
Without limiting the generality of the powers granted hereunder, the Agent shall have the power and authority to, on behalf of myself, execute: (1) the Exclusive Option Agreement executed on December 8, 2021 by and among me, WFOE, Guangmu Weichen and other related parties, and (2) the Equity Interest Pledge Agreement executed on December 8, 2021 by and among me, WFOE, Guangmu Weichen and other related parties (in each case, including any modification, amendment or restatement to the aforementioned documents, collectively referred to as the Transaction Documents), and any documents and agreements I shall sign as required in the aforesaid agreements (including without limitation the Share Transfer Contract as described under the Exclusive Option Agreement).
All the actions associated with My Shareholding conducted by the Agent shall be deemed as my own actions, and all the documents related to My Shareholding executed by the Agent shall be deemed to be executed by me. I hereby acknowledge and ratify the actions taken by the Agent and the documents executed by the Agent in relation to My Shareholding.
1
The Agent has the right to re-authorize or assign one or multiple matters and its rights related to such matters under this Power of Attorney to any other person or entity at its own discretion and without obtaining my prior consent. If required by PRC laws, the Agent shall designate a qualified PRC citizen to handle such matters and exercise such rights as set forth in this Power of Attorney.
During the period that I am a shareholder of Guangmu Weichen, This Power of Attorney shall be irrevocable and continuously effective and valid from the date of execution of this Power of Attorney. This Power of Attorney takes effect as of the date hereof and shall become effective until all equity or all assets of Guangmu Weichen have been transferred to the WFOE and/or other entities or individuals designated by it in accordance with the Exclusive Option Agreement signed by the parties on the date of execution of this Power of Attorney.
I hereby declare and covenant the following: (1) I am a Chinese citizen with full capacity and a registered lawful shareholder of Guangmu Weichen. I have full and independent legal status and legal capacity, and have been duly authorized to sign, deliver and perform this Power of Attorney. I can independently act as a party of litigation, (2) There is no litigation, arbitration or other judicial or administrative action that has arisen and is pending that will affect my ability to perform the obligations under this Power of Attorney, (3) natural person shareholders have made proper arrangements and signed necessary documents to ensure that in the event of his or her death, incapacity, bankruptcy, divorce or other events that may affect their exercise of equity, the heirs, guardians, creditors, spouses and other persons who may acquire equity or related rights as a result, shall not affect or hinder the performance of this Power of Attorney.
During the term of this Power of Attorney, I hereby waive all the rights associated with My Shareholding, which have been authorized to the Agent through this Power of Attorney, and shall not exercise such rights by myself.
This Power of Attorney is dated on December 8, 2021.
The Remainder of this page is intentionally left blank
2
Principal: /s/ SUN Xiaolei
Accepted by: Beijing Absolute Health Co., Ltd. (seal)
Authorized Representative: /s/ SHEN Peng
(Company seal: /s/ Beijing Absolute Health Co., Ltd.)
Signature Page to Power of Attorney
Exhibit 4.31
Power of Attorney
I, LIU Nian, a citizen of the Peoples Republic of China (China or the PRC) whose Identification Card No. is [***] and a holder of 1% of the registered capital of Beijing Guangmu Weichen Technology Co., Ltd. (Guangmu Weichen) as of the date of this Power of Attorney, hereby irrevocably authorize and entrust Beijing Absolute Health Co., Ltd. (WFOE) to exercise the following rights and handle the following matters on my behalf relating to all equity interests held by me now and in the future (My Shareholding) in Guangmu Weichen, during the term of this Power of Attorney:
WFOE or any person(s) designated by WFOE (including but not limited to directors of WFOEs parent company Waterdrop Group HK Limited, successors of such directors and liquidators in replacement of such directors, excluding any non-independent persons or persons who may result in the conflicts of interest) (Agent) is hereby authorized to act on my behalf as my sole and exclusive agent to exercise the rights with respect to all matters concerning My Shareholding, including without limitation to: (1) as the shareholders proxy, convening and attending shareholders meetings of Guangmu Weichen according to the companys articles of association, (2) exercising all of the shareholders rights and shareholders voting rights that I am entitled to under the laws of China and the articles of association of Guangmu Weichen (including any other shareholder voting rights stipulated after the amendments to the articles of association), including without limitation handling the sale, transfer, pledge or disposition of My Shareholding in part or in whole, (3) representing myself in appointing and nominating any legal representative, director, supervisor, chief manager and other executive of Guangmu Weichen, and (4) sign the notice of the shareholders meeting, the meeting minutes and resolutions on behalf of the shareholders, and submit the documents required for the approval, registration and filing related to the companys operation to the relevant government departments (including the company registration management department) on behalf of the shareholders.
Without limiting the generality of the powers granted hereunder, the Agent shall have the power and authority to, on behalf of myself, execute: (1) the Exclusive Option Agreement executed on December 8, 2021 by and among me, WFOE, Guangmu Weichen and other related parties, and (2) the Equity Interest Pledge Agreement executed on December 8, 2021 by and among me, WFOE, Guangmu Weichen and other related parties (in each case, including any modification, amendment or restatement to the aforementioned documents, collectively referred to as the Transaction Documents), and any documents and agreements I shall sign as required in the aforesaid agreements (including without limitation the Share Transfer Contract as described under the Exclusive Option Agreement).
All the actions associated with My Shareholding conducted by the Agent shall be deemed as my own actions, and all the documents related to My Shareholding executed by the Agent shall be deemed to be executed by me. I hereby acknowledge and ratify the actions taken by the Agent and the documents executed by the Agent in relation to My Shareholding.
1
The Agent has the right to re-authorize or assign one or multiple matters and its rights related to such matters under this Power of Attorney to any other person or entity at its own discretion and without obtaining my prior consent. If required by PRC laws, the Agent shall designate a qualified PRC citizen to handle such matters and exercise such rights as set forth in this Power of Attorney.
During the period that I am a shareholder of Guangmu Weichen, This Power of Attorney shall be irrevocable and continuously effective and valid from the date of execution of this Power of Attorney. This Power of Attorney takes effect as of the date hereof and shall become effective until all equity or all assets of Guangmu Weichen have been transferred to the WFOE and/or other entities or individuals designated by it in accordance with the Exclusive Option Agreement signed by the parties on the date of execution of this Power of Attorney.
I hereby declare and covenant the following: (1) I am a Chinese citizen with full capacity and a registered lawful shareholder of Guangmu Weichen. I have full and independent legal status and legal capacity, and have been duly authorized to sign, deliver and perform this Power of Attorney. I can independently act as a party of litigation, (2) There is no litigation, arbitration or other judicial or administrative action that has arisen and is pending that will affect my ability to perform the obligations under this Power of Attorney, (3) natural person shareholders have made proper arrangements and signed necessary documents to ensure that in the event of his or her death, incapacity, bankruptcy, divorce or other events that may affect their exercise of equity, the heirs, guardians, creditors, spouses and other persons who may acquire equity or related rights as a result, shall not affect or hinder the performance of this Power of Attorney.
During the term of this Power of Attorney, I hereby waive all the rights associated with My Shareholding, which have been authorized to the Agent through this Power of Attorney, and shall not exercise such rights by myself.
This Power of Attorney is dated on December 8, 2021.
The Remainder of this page is intentionally left blank
2
Principal: /s/ LIU Nian
Accepted by: Beijing Absolute Health Co., Ltd. (seal)
Authorized Representative: /s/ SHEN Peng
(Company seal: /s/ Beijing Absolute Health Co., Ltd.)
Signature Page to Power of Attorney
Exhibit 4.32
Spousal Consent Letter
The undersigned, YAN Shi, (Identification Card No. [***]), is the lawful spouse of LIU Nian (Identification Card No. [***]). I hereby confirm I have understood, and unconditionally and irrevocably issue this Spousal Consent Letter in respect of the equity interest held by LIU Nian in Beijing Guangmu Weichen Technology Co., Ltd. (Guangmu Weichen) as following:
I have understood:
(1) | All of the equity interests held by LIU Nian in Guangmu Weichen will be disposed of in accordance with the Exclusive Option Agreement executed on December 8, 2021 by and among LIU Nian and Beijing Absolute Health Co., Ltd. (WFOE) and related parties, and such equity interests are subject to the control formed by WFOE and/or its subsidiaries through a series of agreement arrangements. |
(2) | All of the equity interests held by LIU Nian in Guangmu Weichen will be disposed of in accordance with the Equity Interest Pledge Agreement executed on December 8, 2021 by and among LIU Nian, WFOE, Guangmu Weichen and related parties. |
(3) | All of the equity interests held by LIU Nian in Guangmu Weichen will be disposed of in accordance with the Power of Attorney executed on December 8, 2021 issued by LIU Nian to WFOE. |
I hereby confirm I understand and agree that LIU Nian executed the Exclusive Option Agreement, the Equity Interest Pledge Agreement and the Power of Attorney (in each case, including any modification, amendment or restatement to the aforementioned documents, collectively referred to as the Transaction Documents), and to dispose of the corresponding equity and interest attached thereto in Guangmu Weichen in accordance with the Transaction Documents. I will not take any action at any time to impede the arrangements for the disposal of the aforesaid shareholding.
I hereby confirm and agree that the equity interests and any rights and interests attached thereto in Guangmu Weichen currently and hereafter held by my spouse is her individual property, and shall not constitute the jointly owned properties between my spouse and I, which my spouse is entitled to dispose of on her own. I hereby unconditionally and irrevocably waive any right or interest with respect to such equity interest and its corresponding assets that I may be entitled to under any applicable laws, and undertake not to raise any claim with respect to such equity interest and its corresponding assets, including claiming that such equity interest and its corresponding assets constitute the jointly owned property between my spouse and me, and thereby claiming to participate in the daily operation and management of Guangmu Weichen or cast vote or in any way impact the decision of my spouse regarding such equity interests or any rights and interest attached thereto.
1
I further confirm that, no separate authority or consent on my part is required for LIU Nian to perform the Transaction Documents, amend or terminate the Transaction Documents.
I hereby undertake to execute all necessary documents and take all necessary actions to ensure appropriate performance of the Transaction Documents (as amended from time to time).
I hereby agree and covenant that, if I acquire any equity interests or any rights or interest attached thereto from Guangmu Weichen for any reason, I shall be bound by the Transaction Documents (as amended from time to time), and comply with the obligations of shareholders of Guangmu Weichen under the Transaction Documents (as amended from time to time). For such purpose, at the request of WFOE, I will execute a series of written documents with the form and substance substantially the same as the Transaction Documents (as amended from time to time).
I hereby further confirm, covenant and undertake, in all cases, including without limitation, the occurrence of the divorce between my spouse and me, my spouse shall be entitled to independently dispose the equity interest and the corresponding assets he/she holds in Guangmu Weichen, and I will not take any actions that may affect or prevent my spouses performance of her duties under the Transaction Documents, including but not limited to raising any claim for the equity interest in Guangmu Weichen or any rights endowed under the Transaction Documents.
I hereby agree and covenant that, I will not act in any manner or any claim or file a lawsuit that conflicts with the arrangement contemplated under the Transaction Documents or this Spousal Consent Letter at any time whether direct or indirect, active or passive.
The Spousal Consent Letter is dated on December 8, 2021.
(Signature page to Spousal Consent Letter)
Signatory: /s/ Yan Shi
EXHIBIT 8.1
List of Significant Subsidiaries and VIEs of the Registrant
Subsidiaries |
Place of Incorporation | |
Waterdrop Group HK Limited | Hong Kong | |
Beijing Absolute Health Ltd. | PRC | |
Shanghai Danzheng Health Technology Co., Ltd. | PRC | |
Consolidated Variable Interest Entities |
Place of Incorporation | |
Beijing Shuidi Hubao Technology Co., Ltd. | PRC | |
Beijing Shuidi Hulian Technology Co., Ltd. | PRC | |
Beijing Zhuiqiu Jizhi Technology Co., Ltd. | PRC | |
Beijing Zongqing Xiangqian Technology Co., Ltd. | PRC | |
Beijing Guangmu Weichen Technology Co., Ltd. | PRC | |
Subsidiaries of Consolidated Variable Interest Entities |
Place of Incorporation | |
Tianjin Jingbin Internet Technology Co., Ltd. | PRC | |
Shuidi Insurance Brokerage Co., Ltd. | PRC | |
Miaoyi Hulian (Beijing) Technology Co., Ltd. | PRC | |
Tairui Insurance Agency Co., Ltd. | PRC | |
Beijing Yifan Fengshun Medical Technology Co., Ltd. | PRC |
Exhibit 12.1
Certification by the Principal Executive Officer
Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002
I, Peng Shen, certify that:
1. I have reviewed this annual report on Form 20-F of Waterdrop Inc.;
2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;
3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the company as of, and for, the periods presented in this report;
4. The companys other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) for the company and have:
(a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the company, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;
(b) [reserved];
(c) Evaluated the effectiveness of the companys disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and
(d) Disclosed in this report any change in the companys internal control over financial reporting that occurred during the period covered by the annual report that has materially affected, or is reasonably likely to materially affect, the companys internal control over financial reporting; and
5. The companys other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the companys auditors and the audit committee of the companys board of directors (or persons performing the equivalent functions):
(a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the companys ability to record, process, summarize and report financial information; and
(b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the companys internal control over financial reporting.
Date: April 28, 2022 | ||
By: | /s/ Peng Shen | |
Name: | Peng Shen | |
Title: | Chief Executive Officer |
Exhibit 12.2
Certification by the Principal Financial Officer
Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002
I, Kangping Shi, certify that:
1. I have reviewed this annual report on Form 20-F of Waterdrop Inc.;
2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;
3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the company as of, and for, the periods presented in this report;
4. The companys other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) for the company and have:
(a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the company, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;
(b) [reserved];
(c) Evaluated the effectiveness of the companys disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and
(d) Disclosed in this report any change in the companys internal control over financial reporting that occurred during the period covered by the annual report that has materially affected, or is reasonably likely to materially affect, the companys internal control over financial reporting; and
5. The companys other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the companys auditors and the audit committee of the companys board of directors (or persons performing the equivalent functions):
(a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the companys ability to record, process, summarize and report financial information; and
(b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the companys internal control over financial reporting.
Date: April 28, 2022 | ||
By: | /s/ Kangping Shi | |
Name: | Kangping Shi | |
Title: | Chief Financial Officer |
Exhibit 13.1
Certification by the Principal Executive Officer
Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002
In connection with the Annual Report of Waterdrop Inc. (the Company) on Form 20-F for the year ended December 31, 2021 as filed with the Securities and Exchange Commission on the date hereof (the Report), I, Peng Shen, Chief Executive Officer of the Company, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that to my knowledge:
(1) The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and
(2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.
Date: April 28, 2022 | ||
By: | /s/ Peng Shen | |
Name: | Peng Shen | |
Title: | Chief Executive Officer |
Exhibit 13.2
Certification by the Principal Financial Officer
Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002
In connection with the Annual Report of Waterdrop Inc. (the Company) on Form 20-F for the year ended December 31, 2021 as filed with the Securities and Exchange Commission on the date hereof (the Report), I, Kangping Shi, Chief Financial Officer of the Company, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that to my knowledge:
(1) The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and
(2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.
Date: April 28, 2022 | ||
By: | /s/ Kangping Shi | |
Name: | Kangping Shi | |
Title: | Chief Financial Officer |
Exhibit 15.1
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We consent to the incorporation by reference in Registration Statement No. 333-261408 on Form S-8 of our report dated April 28, 2022, relating to the financial statements of Waterdrop Inc., appearing in this Annual Report on Form 20-F for the year ended December 31, 2021.
/s/ Deloitte Touche Tohmatsu Certified Public Accountants LLP
Deloitte Touche Tohmatsu Certified Public Accountants LLP
Beijing, the Peoples Republic of China
April 28, 2022
Exhibit 15.2
9/F, Office Tower C1, Oriental Plaza, 1 East Chang An Avenue Beijing 100738, P. R. China Tel: +86 10 8525 5500 Fax: +86 10 6525 5511 / 8525 5522 Beijing · Shanghai · Shenzhen · Hong Kong www.hankunlaw.com |
![]() | |||
Consent of Han Kun Law Offices
To:
Waterdrop Inc.
Block C, Wangjing Science and Technology Park
No. 2 Lize Zhonger Road
Chaoyang District, Beijing 100102
Peoples Republic of China
Date: April 28, 2022
Dear Sirs,
We consent to the reference to our firm under the headings Item 3.DRisk FactorsRisks Related to Our Corporate Structure and Item 4.COrganizational StructureContractual Arrangements with the Variable Interest Entities and Their Shareholders in Waterdrop Inc.s Annual Report on Form 20-F for the year ended December 31, 2021, which will be filed with the Securities and Exchange Commission (the SEC) on the date hereof, and further consent to the incorporation by reference of the summaries of our opinion under these headings into the Registration Statement on Form S-8 (File No. 333-261408) that was filed on November 30, 2021. We also consent to the filing of this consent letter with the SEC as an exhibit to the Annual Report on Form 20-F for the year ended December 31, 2021.
Yours faithfully,
/s/ HAN KUN LAW OFFICES
HAN KUN LAW OFFICES
CONFIDENTIALITY. This document contains confidential information which may be protected by privilege from disclosure. Unless you are the intended or authorised recipient, you shall not copy, print, use or distribute it or any part thereof or carry out any act pursuant thereto and shall advise Han Kun Law Offices immediately by telephone, e-mail or facsimile and return it promptly by mail. Thank you.